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Chapter 1
Parts of  this chapter have been published in:
Maduro, C. et al. (2016) Fitting the Puzzle Pieces: the Bigger Picture of  XCI. Trends Biochem Sci 41 (2), 
138-47. 
Introduction  
Dimorphic sexes, can be found in most animal species, but determination of  sex is 
achieved in a wide variety of  ways. Some species determine sex by environmental cues 
[1], other species employ genetic sex determination either with or without distinguishable 
sex chromosomes [2].  In species with sex chromosomes, the sex chromosomes are 
entitled X and Y when the male is the heterogametic sex, as for example in mammals, 
and Z and W when the female is the heterogametic sex, as for example in birds. The 
mammalian sex chromosomes X and Y originated from an ancient autosomal pair 
about 180 MYA [3, 4]. The ancient autosomal pair evolved to the proto-X and proto-Y 
after acquisition of  mutational changes of  Sox3 leading to the sex-determining gene Sry 
on the proto-Y. Once male specific, the proto-Y accumulated additional male beneficial 
genes and became progressively more diverged from the proto-X as a consequence 
of  different rearrangements and decay of  the Y chromosome, resulting in loss of  
recombination between the two chromosomes. Loss of  recombination consequently 
initiated a form of  selection to keep the cluster of  sexually antagonistic genes as a unit 
on the Y chromosome [3-5]. Being unable to recombine, the X and Y chromosome 
evolved independently into the heterologous sex chromosomes we know today [6].  The 
X chromosome retained more than a thousand genes as it is still able to recombine with 
its homologue in females preventing its degeneration.  In contrast, the Y chromosome 
has lost more than 95% of  its original gene content as the Y chromosome degenerated 
over time [7]. In species with highly differentiated sex chromosomes however, dosage 
differences between the sexes occurs when sex chromosomes diverge and requires a 
form of  compensation in either sex (Figure 1) [8]. 
Dosage compensation 
The mammalian X and Y chromosome now differ greatly in size and in gene content. 
The X chromosome has been enriched in genes mainly involved in cognition, sex and 
reproduction [9, 10], whereas the Y chromosome mainly contains genes involved in 
male sex determination and spermatogenesis [11]. These differences between the sex 
chromosomes results in unequal gene dosage between males and females and such 
a dosage imbalance, equivalent to a monosomy, would affect the overall fitness of  
the species. For that reason, several species with sex chromosome dosage imbalances 
have developed different ways of  coping with dosage differences between the sexes. 
Comparing dosage compensation mechanisms of  eutherian mammals, flies and 
nematodes, representing three independent origins of  male heterogamety, showed that 
the result of  dosage compensation in these species was the same: equalized expression 
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of  X-encoded genes in male and female [8]. All these species show in one sex, specific 
complexes composed of  RNA and/or protein that target an entire chromosome for 
stable and inheritable changes in transcription levels through epigenetic modifications 
[12]. Nevertheless, the actual mechanisms for dosage compensation between eutherian 
mammals, flies and nematodes are very different [8]. In Caenorhabditis elegans for example, 
in which males are XO and hermaphrodites are XX, reduced expression of  both X 
chromosomes in hermaphrodites results in an equalized dosage of  X encoded gene 
expression between the sexes [13]. In Drosophila melanogaster however, with XY males 
and XX females, a 2 fold over expression of  the male X encoded genes achieves dosage 
compensation [14-16]. In mammals, sex is also determined by an XX female and XY 
male system, but in contrast to Drosophila melanogaster in which expression in males is 
adjusted, dosage compensation in mammals is achieved by inactivating one of  the two 
X chromosomes in females. This process is known as X-chromosome inactivation 
(XCI), silencing of  chromosome wide transcription on one of  the two X chromosomes 
which stays inactive throughout life. 
X chromosome inactivation: the initial hypothesis 
Random X chromosome inactivation was proposed in 1961 by Mary Lyon and was 
first described as the Lyon hypothesis [17, 18]. Based on the finding that the Barr body 
contained either one of  the two X chromosomes in the female mammalian nucleus, 
Mary Lyon postulated that equalization of  X-encoded gene dosage between males and 
females is achieved by transcriptional silencing of  one X chromosome in females. The 
Lyon hypothesis consisted of  four key elements with regard to XCI [17, 18]. First, each 
female cell contained one active X chromosome (Xa) and one inactive X chromosome 
(Xi). Second, inactivation of  one of  the two X chromosomes occurred early in 
development of  the female embryo. Third, which X chromosome was inactivated 
was randomly determined; either the maternal or the paternal X chromosome was 
inactivated. And finally, all daughter cells would have the inactivation pattern of  the 
parental cell, thus clonal expansion of  the X inactivation pattern in the embryo would 
result in mosaic females. This paper, initially based solely on mouse studies, was 
followed by a fuller development of  the hypothesis in 1962, focusing more on human 
X-linked conditions [19]. Mary Lyons hypothesis provided a unifying hypothesis which 
was brought together from various earlier work: the discovery of  the Barr body [20], 
cytological and theoretical studies of  Susumo Ohno on sex chromosome biology and 
Ohno’s law [21, 22] and studies on sex disorders in humans [23, 24], explaining these 
findings for the first time. In addition, this hypothesis was also independently published 
by Beutler [25] based on results from a human X-linked disorder, glucose-6-phosphate 
dehydrogenase deficiency. Together these papers provided the scientific community 
with sufficient evidence to support this hypothesis and explained a longstanding 
problem of  dosage compensation and function of  sex chromosomes, now known as 
XCI. One of  the unresolved issues regarding dosage compensation by means of  XCI is 
described in Ohno’s law [21]: “XCI itself  cannot correct for the expression imbalance 
between the sex chromosomes and autosomes, which is the result of  having only one 
active X chromosome in females and males, sex chromosome monosomy, as opposed 
to 2 active chromosomes for all the other autosomes”. Therefore Ohno hypothesized 
that the genes on the single active X chromosome in male and female undergo a 
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2-fold upregulation based on the negative effects of  aneuploidy. Even though there 
seems to be enough evidence to prove a 2-fold upregulation of  X-linked genes [26-
30], there also seems to be an equal number of  studies showing this is actually not 
the case [31-35].  Whether or not Ohno’s law applies to eutherian mammals is thus 
still controversial, mainly because of  different techniques and thresholds used in the 
analysis of  expression data and therefore still remains an open question [4, 36, 37]. 
Nevertheless, close examination of  a wide range of  studies indicates that dose sensitive 
genes, for instance genes encoding proteins acting in stoichiometric protein complexes, 
are clearly upregulated, whereas lowly expressed genes are not [32, 34].
          
Figure 1: Evolution of  the X and Y chromosome. The X and Y chromosome evolved over 180 MYA 
from an ancient autosomal pair. After acquiring the male sex-determining gene Sry on the proto-Y, the Y 
chromosome accumulated more male specific genes (black) and degenerated over time, which resulted in 
a need for a two-fold upregulation of  genes lost from the Y chromosome (green) on the X chromosome 
to compensate for their loss on the Y chromosome. A two-fold upregulation of  these genes leads to a 
4-fold upregulation in female cells forcing the co-evolution of  a second dosage compensation mechanism, 
XCI, which is achieved by spreading of  the lncRNA Xist (red) along the X chromosome in cis.   
XCI in the mouse  
In the mouse, XCI occurs in two rounds (Figure 2). Around the 2- to 4-cell stage, 
cells in female embryos initiate imprinted XCI (iXCI), leading to exclusive inactivation 
of  the paternal X chromosome (Xp) [38, 39]. As the embryo further develops into 
a blastocyst, XCI is reversed in the inner cell mass (ICM) by reactivation of  the Xp 
[40]. Subsequent initiation of  random XCI (rXCI) occurs in the embryoblast just 
after implantation around embryonic day 5.5 [40, 41], but iXCI persists in the extra 
embryonic tissues [42]. Mouse embryonic stem (ES) cells are derived from the ICM 
with two active X chromosomes and undergo rXCI upon differentiation, recapitulating 
rXCI in vitro. rXCI can be divided into three main phases: initiation, establishment 
and maintenance of  XCI [43]. In the initiation phase, the cell ensures one active X 
chromosome per diploid genome, in a process regulated by activators and inhibitors of  
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XCI leading to mono-allelic up-regulation of  the X-linked long non-coding RNA gene 
Xist.  In the establishment phase, Xist RNA spreads and coats the entire future inactive 
X chromosome (Xi) in cis, resulting in loss of  active histone marks and gain of  inactive 
histone marks, contributing to the silencing process [44-47]. These modifications are 
catalyzed by enzymes directly and indirectly recruited by Xist through several functional 
domains, most of  them repeats, that are also involved in Xist localization to the Xi. 
Once XCI is complete, the Xi is maintained and clonally propagated to all daughter 
cells.  
     
Figure 2: XCI in the mouse occurs in two waves. After the two-cell stage cells initiate imprinted XCI (iXCI), 
always inactivating the paternal X chromosome (Xp) and keep the maternal X chromosome active (shown as 
orange cells). As the embryo develops, cells in the inner cell mass (ICM) of  the blastocyst reactivate their paternal 
X chromosome (green cells). After reactivation, these cells will initiate random XCI (rXCI) in the embryoblast 
resulting in a mosaic embryo with cells having either the Xp or Xm inactivated (orange or blue cells).   
 
XCI counting and initiation: the models  
Random XCI is initiated when the number of  X chromosomes exceeds one per diploid 
genome. The cell must ensure that only one X chromosome is inactivated, inactivation 
or continued activity of  both X chromosomes is lethal, underscoring the need for tight 
regulation of  the XCI process. Over the years many models have been proposed for 
XCI counting and initiation including the blocking factor model, the symmetry-breaking 
model, the alternate states model, the X-pairing model and the stochastic model. The 
blocking factor model states that a limiting autosomally encoded factor blocks XCI on 
one of  the two X chromosomes in female cells and on the single X chromosome in 
male cells. The cell is thus able to count the number of  X chromosomes based on the 
excess of  autosomes over X chromosomes and determine whether enough blocking 
factor is present to inhibit XCI [48]. However, conclusive evidence supporting this 
model has not been found. The symmetry breaking model is based on the blocking 
factor model as it also suggests blocking of  XCI on one of  the two X chromosomes in 
female cells and on the single X chromosome in male cells. However, this model predicts 
that it is a blocking complex, which forms on the X chromosome and inhibits XCI. 
This circumvents the problem of  having a single factor present in the cell as proposed 
in the blocking factor model. There has however not been any report on complexes 
forming on the active X chromosome (Xa) so far [49]. Another model proposed is the 
alternate states model in which XCI is intrinsically determined by the chromatin state 
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of  the X prior to XCI [50]. The different states of  sister chromatid cohesin are transient 
and are mutually exclusively locked at the onset of  XCI, ensuring random XCI. The 
different states may represent blocking factor binding to one chromosome, accessibility 
or transcriptional differences between the two X chromosomes [51]. However, further 
evidence for this model has yet to be found as well. The X-pairing model is based on 
the observation that prior to up-regulation of  Xist, the regulatory regions of  Xist of  
both X chromosomes have been found to transiently move in spatial proximity with 
an increased frequency [52-54]. When investigating live-cell dynamics and the outcome 
of  pairing in differentiating ES cells, an increased X chromosome mobility was found 
during differentiation followed by a reduced mobility during pairing. The increased 
mobility during differentiation might facilitate the onset of  pairing by increasing the 
frequency of  collisions between the two loci and/or different nuclear compartments 
and the reduced mobility during pairing suggests some form of  binding of  the two 
regulatory regions on the X chromosomes. Pairing is very transient and the suggested 
outcome of  pairing is monoallelic repression of  XCI on one X chromosome which 
could lead to monoallelic promotion of  XCI on the other X chromosome [55]. It is 
hypothesized that during these movements the future Xa and Xi are being determined. 
The genomic regions that were identified as required for X- pairing cover Xite and the 
Tsix promoter, as well as the X pairing region (Xpr) which overlaps with Slc16a2 [53, 
54]. Tsix and Xite are located in close proximity to Xist and are involved in negative 
regulation of  Xist by generating antisense transcripts. The role of  the Slc16a2 region in 
XCI seems to be restricted to the X-pairing process itself. A recent study identified an 
interaction between CTCF and Tsix RNA as a key mechanism required for X-pairing 
[56]. The authors demonstrated that CTCF binds Tsix RNA with a higher affinity 
compared to DNA, and propose that during transcription, CTCF is recruited by Tsix 
RNA to be loaded onto its genomic locus. Both knockdown of  Tsix/Xite and CTCF 
results in reduced pairing [56, 57], and a reduction in X-pairing leads to reduced initiation 
of  XCI, observed as a reduction in Xist expression [56]. In contrast, in another study 
a reduction in Xist expression was not observed upon knockdown of  CTCF, although 
the effects on X-pairing were not investigated [58]. Despite the effects of  ES cell 
differentiation on spatial movement of  Xist and other pairing elements, a recent study 
provides evidence arguing against a functional role for X- pairing in XCI [59]. In this 
study, XCI is unaffected on the remaining wild type X chromosome in ES cells carrying 
a heterozygous deletion encompassing all the regions identified as required for pairing, 
including Xist, Tsix, Xite and Slc16a2. Moreover, heterokaryotic ES cells containing 
a male and a female nucleus show no preference for XCI of  an X chromosome 
located in the male or female nucleus [59]. X-pairing might therefore reflect changes 
in the transcriptional activity of  XCI specific genes coincidentally recruited to nuclear 
locations or entities with a higher local concentration of  transcription factors (such as 
transcription factories). Taken together X- pairing is an intriguing phenomenon, but 
its implications should be carefully considered with respect to a functional role for X- 
pairing in XCI initiation.
 The above-mentioned deterministic models predict a tightly regulated XCI 
counting and initiation process in which a single X is inactivated in every diploid female 
cell. Studies with tetraploid XXXX embryos indicated that two X chromosomes are 
inactivated, predicting one active X chromosome per diploid genome [60]. Interestingly, 
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in differentiating XXXX tetraploid ES cells however, the presence of  three or four 
inactivated X chromosomes in a significant percentage of  cells suggested that XCI is not 
so tightly regulated as the above mentioned models imply [43, 60]. In addition, female 
diploid cells consistently show XCI on both X chromosomes in a small percentage 
of  differentiating ES cells. Based on these and other observations, a stochastic model 
was postulated. This model states that each X chromosome has a certain independent 
probability to be inactivated, and that this probability is proportional to the X: ploidy ratio. 
This could explain all the possible outcomes of  XCI in XXXX tetraploid ES cells. The 
outcome of  the rXCI process, according to the stochastic model, is a resultant of  three key 
driving factors: a probability for each X chromosome in a cell nucleus to be inactivated, the 
probability to initiate XCI being proportional to X:ploidy ratio and a feedback mechanism 
leading to one active X per diploid genome.  Because more and more data indicate this 
stochastic model to be true, we opt for the stochastic model for initiation of  XCI. 
XCI counting and initiation: a stochastic feedback-mediated process  
During initiation of  rXCI the number of  X chromosomes is determined with respect 
to the genomic context. Initiation of  XCI is a stochastic process, in which every X 
chromosome has an intrinsic probability to be inactivated [60]. This process is 
orchestrated by trans-acting X encoded activators and autosomally encoded inhibitors 
of  XCI. The balance between these opposing factors will determine whether Xist is 
upregulated and if  XCI will occur. In this balance, XCI-inhibitors represent the ploidy 
of  a cell, while XCI-activators represent the number of  X chromosomes present. 
These trans-acting regulatory factors act through a cis-regulatory locus controlling the 
expression of  Xist.  
The cis-X inactivation center  
Genetic studies in mice and humans with X-to-autosome translocations have revealed 
that an X-linked control locus, the X inactivation center (Xic) is necessary for XCI to 
occur. Recently, it has been proposed that the Xic can be divided into a cis-Xic and a 
trans-Xic, containing all the cis and trans acting factors involved in XCI respectively [61]. 
The cis-Xic contains all cis- acting genes important for XCI [51]. Three key cis-acting 
genes, Xist, Tsix and Xite are non-coding genes from which the transcripts are spliced 
and polyadenylated. Xist is required in cis for silencing of  the X chromosome as loss 
of  function studies indicated that the mutated X chromosome could not be inactivated 
in ES cells, causing complete skewing of  XCI towards the wild-type X chromosome 
[62, 63]. Accumulation and spreading of  Xist RNA on the Xi in cis results in depletion 
of  RNA polymerase II and other components of  the transcription machinery, 
recruitment of  the chromatin remodeling complexes, including Polycomb repressive 
complex 2 (PRC2), which trimethylates lysine 27 on histone H3 (H3K27me3) and 
several other complexes, leading to further changes of  several histone modifications 
including histone-H3K9 methylation, histone-H4 deacetylation and histone-macroH2A 
accumulation which further contribute to the silencing process [64]. 
 Xist RNA is retained in the nucleus and accumulation and spreading of  Xist 
is restricted to the Xi and does not localize to neighboring chromosomes. The silent 
state is kept throughout life, but Xist is not required for the maintenance of  XCI as 
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a conditional deletion of  Xist after XCI has occurred does not reactivate silenced 
genes [43]. The different epigenetic modifications during XCI work synergistically in 
maintaining the silent state.  In a study involving an inducible Xist expression system 
in ES cells, it was shown that Xist mediated silencing can be divided into two steps: 
primary inactivation and maintenance of  the inactive state. The primary inactivation 
phase is reversible, requires Xist and encompasses the first 72 hours of  differentiation. 
However, maintenance of  the inactive state is irreversible, independent on Xist and 
separated from the primary inactivation phase by approximately one cell division. In 
ES cell differentiation there is thus a transition from reversible to irreversible XCI. 
Xist expression has to be induced early enough to allow primary inactivation to take 
effect before silencing becomes irreversible and independent of  Xist expression. Thus 
initiation of  Xist-mediated silencing has to occur during the critical window of  ±48-72 
hours of  differentiation [65].  
 Tsix and X chromosome intergenic transcript element (Xite) are negative 
regulators of  Xist. Xite is an enhancer of  Tsix and was shown to be important for 
transiently maintaining Tsix expression on the Xa [66]. Tsix transcription is antisense to 
and completely overlaps with Xist, hence the name. Tsix transcripts only localize to the 
Xic and are expressed from both X chromosomes prior to XCI. After XCI, expression of  
Tsix only transiently continues on the future active X chromosome (Xa) [67]. The exact 
mechanism of  Tsix-mediated repression of  Xist remains unknown, however several 
mechanisms have been proposed. First of  all, because Tsix is transcribed antisense to 
Xist, transcriptional interference has been proposed as a mechanism to repress Xist 
[12, 68]. In addition, the Xist/Tsix duplex RNA formation and processing by the RNAi 
pathway has been proposed to play a role by siRNA-mediated deposition of  chromatin 
remodeling complexes [12, 69]. Recruitment of  chromatin remodeling complexes by Tsix 
RNA to the Xist promoter was also implicated in Tsix-mediated repression of  Xist [35]. 
Furthermore, Tsix was suggested to be involved in pairing of  the two X chromosomes, 
as described above, which suggests a role for Tsix in initiation of  XCI [54].   
 
The cis-X inactivation center: cis-activators  
Four non-coding cis-acting activators of  XCI have been described: Jpx, Ftx, Xpr and 
XistAR. A mutation of Ftx in male cells results in reduced transcript levels of  Xist, Tsix 
and Jpx [70] and a deletion of  Jpx blocks XCI and is female lethal [71].The Xpr region is 
suggested to be involved in X chromosome pairing and the Xpr could autonomously drive 
Xic-trans interactions even as an ectopic single-copy transgene. Furthermore, introduction 
of  an Xpr transgene in male ES cells was strongly selected against suggesting a role in 
activation of  Xist [53].  Although Jpx, Ftx and Xpr have been implicated in trans-regulation, 
a recent study indicates no trans effects and only cis effects upon deletion of  Jpx, Ftx and 
Xpr [59]. Also recently, the long non-coding RNA, XistAR (Xist Activating RNA) has 
been described to activate Xist in cis and as required for XCI [72]. XistAR is encoded 
within exon 1 of  the mouse Xist gene and is transcribed antisense to Xist and exclusively 
from the Xi. When XistAR is selectively truncated, without affecting the overlapping 
Xist gene, XCI initiation as a result of  Xist induction is diminished by 90%.   
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The trans X-inactivation center  
Xist, Tsix and Xite play an important role in cis inactivation, but have been shown not 
to be required for in trans communication [43], as female cells lacking one functional 
Xist, Tsix and Xite allele, are still able to initiate XCI on the wild type X chromosome. 
This suggests involvement of  other factors in the counting and initiation process 
located outside this deleted region. The finding that these cells initiate XCI in contrast 
to XY males, and the observation that the XCI initiation frequency was much higher 
in XXXX tetraploid ES cells than XXXY ES cells suggested a model in which the 
probability to initiate XCI is proportional to the X chromosome:ploidy ratio. These 
observations also provided evidence for the presence of  an X-linked gene(s) encoding a 
trans-acting factor(s) that is involved in promoting XCI. Autosomally encoded inhibitors 
set the threshold for XCI to occur whereas the X-linked activators help to overcome 
this threshold. Female cells have two X chromosomes and thus double the amount of  
X-linked activators as compared to male cells with only one X chromosome. The two 
copies of  X-linked activator(s) in female cells can overcome the threshold to allow XCI 
to occur. Inactivation of  one X chromosome in females, results in cis inactivation of  the 
activator gene, thereby lowering the concentration of  X-linked activator in cis below the 
threshold required for XCI to occur and similar to male cells. Because of  the stochasticity 
of  the process a female cell can also initiate XCI on both X chromosomes. Accumulation 
of  Xist on both X chromosomes leads to reactivation of  the X chromosomes because a 
specific level of  XCI-activator activity may be required for sustained expression of  Xist 
and maintenance of  the Xi [59]. In addition, in a cell with two active X chromosomes 
are blocked in differentiation, extending the time frame where XCI can be initiated. 
The balance between activators and inhibitors of  XCI determines the probability to 
initiate XCI and the feedback through inactivation of  XCI activator genes in cis prevents 
inactivation of  both X chromosomes in most female cells. 
 
The trans X-inactivation center: XCI inhibitors   
The pluripotency factors Nanog, Rex1, Klf4, Oct4, c-Myc and Sox2, germline factor 
Prdm14 [73-75] as well as factors like Ctcf  and YY1 [76, 77] have been reported to 
inhibit the XCI process directly by repressing Xist, activating Tsix, or indirectly by 
repressing activators of  XCI by binding of  different combinations of  these factors at 
different loci. NANOG, REX1, OCT4, SOX2 and PRDM14 have been implicated in 
Xist repression and OCT4, SOX2, REX1, c-MYC, KLF4 as well as CTCT and YY1 in 
Tsix activation. Rex1 and other XCI inhibitors, including Nanog, Sox2, Oct4, are central 
factors in the pluripotency network, which link XCI to loss of  pluripotency (Figure 
3A). Recently, the MOF-associated complexes [78], involved in dosage-compensation in 
Drosophila, and chromatin organizers Satb1 and Satb2 [79] have also been associated with 
a possible role in inhibiting XCI, but this involvement needs to be further elucidated. 
 
The trans X-inactivation center: XCI activators   
Autosomally encoded XCI inhibitors or autosomally encoded Xist-activators such as 
YY1 [80] will be equally expressed in male and female cells and can therefore not be 
the determining factors in the counting process in initiation of  XCI (Figure 3B). In 
contrast, X-encoded XCI activators will be differentially expressed between male and 
female cells. Activators of  XCI promote Xist expression, either directly or indirectly 
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by repression of  Tsix. Recently, Rnf12, Xpr, Jpx and Ftx, have been reported as XCI 
activators (Figure 3A), and interestingly they are all located in close proximity to Xist, 
which may facilitate a rapid feedback mechanism. Introduction of  additional copies 
of  mouse or human Rnf12 in ES cells increased the probability to initiate XCI, which 
resulted in XCI on the single X chromosome in male cells and in a high percentage of  
female cells on both X chromosomes. These studies supported a dose-dependent role 
for RNF12 in the activation of  XCI. Rnf12 is essential for XCI, as Rnf12+/- and Rnf12-/- 
differentiated ESCs showed reduced XCI, with the latter having almost no XCI initiation 
at all, although the genetic background may influence the phenotype, as another study 
showed a less severe phenotype in vivo [81].  Unlike Rnf12 transgenic male ES cell lines, 
male cell lines with Ftx, Jpx and Xpr transgenes did not show XCI induction. Female 
cells lacking the region containing Jpx, Ftx, and Rnf12 showed further affected XCI 
as compared to a deletion of  Rnf12 alone, whereas a deletion of  Jpx or Ftx alone did 
not appear to have affected XCI [59]. This indicates that Jpx and Ftx might only work 
alongside Rnf12 in activating Xist expression. Moreover, it appears that the function 
of  Jpx and Ftx is mostly if  not exclusively in cis, as only when introducing Rnf12 back 
into these cells as a randomly integrated transgene, the phenotype was rescued and 
a combination of  Rnf12, Jpx, and Ftx transgenes did not have additional effects on 
XCI [59]. These findings argue against a role in trans activation of  Xist, and could be 
explained by a different role for these genes in initiation of  XCI in cis. For instance 
through co-activation or another unidentified mechanism. Thus, only Rnf12 has been 
described as an activator of  XCI shown to activate XCI in trans [82, 83]. The presence 
of  female Rnf12+/- cells that did initiate XCI also indicated that one or more additional 
X-encoded XCI-activators are involved in initiation of  XCI [51] (Figure 3B). 
1
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Figure 3:  A) Molecular coupling of  XCI to loss of  pluripotency. Mainly pluripotency factors are inhibiting 
Xist expression and thus XCI initiation. Loss of  pluripotency, thus loss of  inhibiting factors repressing Xist 
in addition to activation of  Xist through Rnf12, Jpx, Ftx, Xpr, XistAR, Yy1 and other yet to be identified 
activator(s) would lead to initiation of  XCI. B) Factors affecting threshold for XCI initiation (adapted 
from Barakat et al, 2014 [59]).  Xist activators (light green shaded area) and XCI inhibitors (blue line) set 
the threshold for XCI to occur, whereas X-linked activators (dark green shaded area), present in double 
the amount in females (green line), allow females with two X chromosomes to overcome the threshold. 
Males (grey line) with one X chromosome will not overcome the threshold and will not initiate XCI. When 
one X chromosome, along with the X-linked activators is silenced in female cells, they will decrease to 
levels similar to males underneath the threshold and will not initiate XCI on the other X chromosome. 
Normal situation (left) in which females initiate XCI, because females have double the amount of  X-linked 
activators to overcome the threshold for XCI to occur, whereas males do not. In Rnf12+/- females (right), 
a reduced initiation of  XCI is observed. Since XCI is not completely abolished, this would point to the 
presence of  other remaining, yet unidentified XCI activator(s).
Rnf12 and Rex1: a balance controlling XCI
Rnf12 has been identified as a potent XCI-activator [83]. Rnf12 encodes an E3 ubiquitin-
ligase that activates Xist indirectly by targeting its repressor REX1 for proteasomal 
degradation [84]. REX1 is a transcription factor and pluripotency factor maintaining 
the pluripotent state in ES cells by suppression of  genes involved in differentiation, 
which again links loss of  pluripotency to XCI [85, 86]. REX1 mediated repression of  
XCI as mentioned before is two-way as it activates Tsix and represses Xist, the latter 
most likely by competing for binding sites with its ortholog and Xist activator YY1 
[80]. In male ES cells addition of  one copy of  Rnf12 or removal of  one copy of  Rex1 
results in ectopic XCI [84]. REX1 binding sites were found in Xist and Tsix regulatory 
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regions and over-expression of  REX1 led to inhibition of  Xist expression. Genetic 
studies and reporter studies indicate that the prime regulatory target of  REX1 is Xist, 
although previous studies indicated a role for REX1 in transcription elongation of  
Tsix [87]. The mechanism proposed is therefore that REX1 represses Xist possibly 
partially mediated through Tsix, and sets the threshold for XCI to occur along with 
other XCI inhibitors. Male cells have only one copy of  Rnf12, and degradation of  REX1 
by RNF12 will not be sufficient to allow the threshold to drop below the level required 
for initiation of  XCI to occur. Female cells on the other hand have two copies of  
Rnf12 and upon differentiation Rnf12 will be upregulated and RNF12 will target REX1 
for degradation relieving the repression of  Xist and promoting XCI by activating Xist. 
Auto-ubiquitination of  RNF12 facilitates its high turnover, which together with its 
location in close proximity to Xist ensures that, in most cells, only one X chromosome 
will be inactivated as the RNF12 dose will decrease below the threshold. Inactivation 
of  the XCI-activators lowers their nuclear concentration, which lowers the probability 
of  the remaining X chromosome to initiate XCI, nevertheless by chance some cells 
will upregulate Xist on both X chromosomes [83, 84]. A recent study in an XX ES 
cell line, analyzing the effect of  heterozygous deletion of  both  Xist and Rnf12 on the 
same chromosome, indicated a severe XCI defect [59]. Loss of  XCI was attributed to 
exclusive initiation of  XCI on the wild type X chromosome, leading to Rnf12 null cells 
with  upregulated REX1, which blocks continued expression of  Xist, underscoring the 
robustness of  the feedback mechanisms involved in XCI. The role of  RNF12 and 
REX1 in XCI is a nice example of  the regulation of  XCI by interplay between its 
inhibitors and activators. 
 Establishment of  XCI: locking and spreading of  Xist along the Xi
Initiation of  XCI leads to cis spreading of  Xist coating the 150Mb mouse X chromosome 
in order to silence it. How exactly Xist RNA spreads and coats the entire X chromosome 
is not completely understood. From previous studies we know that as Xist RNA spreads 
along the X chromosome, the basic transcriptional machinery becomes depleted and 
euchromatic marks such as histone 3 lysine 4 di-and tri- methylation (H3K4me2/me3) 
and histone H3 and histone H4 acetylation  (H3/H4 Ac) are lost [45, 46, 88]. After 
the loss of  euchromatic marks, repressive marks accumulate such as histone 3 lysine 9 
di-methylation (H3K9me2) [46, 47] and Polycomb complex 1 and 2 (PRC1 and PRC2) 
are recruited [89-92] catalyzing the monoubiquitylation of  lysine 119 of  histone H2A 
(H2A119ub) [91] and histone 3 lysine 27 tri-methylation (H3K27me3) [47], macroH2A 
is incorporated [93, 94] and finally CpG island methylation accumulates [95, 96], 
altogether contributing to the silencing process. 
Loading of  Xist RNA onto the X chromosome in cis
For Xist RNA to carry out its function, it needs to be loaded onto the X chromosome 
it is transcribed from to allow further spreading along the X in cis. How exactly this 
is achieved in such a tight manner, especially considering it is not affecting the other 
genetically identical X chromosome in trans, has been a long standing question in the 
field. It was proposed that Xist RNA might act trough a nucleation center, with high 
affinity binding sites for Xist RNA in close proximity to the Xic, facilitating spread 
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along the Xi in cis to other binding sites along the X chromosome [97, 98]. Recently, has 
been suggested that Xist RNA is tethered to the nucleation center on the Xi by YY1 
to subsequently allow its further spreading in cis.  YY1 is a bivalent protein, capable of  
binding both DNA and RNA. In XCI, YY1 binds Xist exon 1 via a trio of  binding sites 
near conserved repeat F of  Xist exon 1 and in turn repeat C and potentially repeat B of  
Xist RNA makes direct contact with YY1 [99]. Conversely, an earlier study generated 
a mutated Xist cDNA transgene, which happened to lack these YY1 binding sites, and 
found that spreading and silencing was not affected [100]. This study did indicate that 
regions mediating Xist RNA localization were scattered throughout Xist and were found 
to be functionally redundant. Therefore, it cannot be excluded that the presence of  other 
low-affinity binding sites were bound by YY1 serving as a new nucleation center near 
the transgene to allow YY1 to tether Xist RNA to the X chromosome. Along with being 
tethered to the nucleation center to allow spreading in cis, the RNA and DNA binding 
matrix protein heterogenous nuclear protein U (hnRNPU; also known as SAF-A) might 
also be an important factor locking Xist RNA on the Xi. hnRNPU was found enriched 
on the Xi [101, 102] and depletion of  hnRNPU results in detachment of  Xist RNA 
from the Xi, diffusion of  Xist RNA away from the Xi, and ES cells lacking hnRNPU 
fail to form an Xi [103]. HnRNPU recruitment is Xist dependent, but independent on 
gene silencing, as hnRNPU was still recruited to the Xi by an Xist lacking the A-repeat 
[104], indicating its involvement in locking Xist to the Xi, but not in silencing of  the Xi. 
 
Xist RNA functioning exclusively in cis
Xist RNA was allegedly non-diffusible and also unstable when not bound to the Xi and 
could therefore only act in cis [100, 105-107]. Interestingly, in the study by Jeon and Lee 
[99] and Hasegawa [108], Xist RNA appeared to diffuse. In the former study, transgenic 
Xist clouds also contained Xist particles from the cells own Xi clouds resulting in 
squelching of  the endogenous clouds. Xist RNA might therefore not be strictly cis-acting 
as was long believed and does remain stable when not bound to chromatin. In contrast, 
the active X chromosome (Xa) nor the male X chromosome have ever been shown to 
be enriched for Xist RNA from the Xi or from transgenic Xist particles [65, 100, 105-
107]. Also, previous work in which a tetraploid XXXX cell line was used with tagged 
Xist, showed exclusive Xist RNA spreading in cis in cells with two Xi’s [105]. For this 
experiments ES cells were differentiated to analyze the effects after XCI, whereas in the 
study describing diffusion of  Xist in trans, an inducible transgene was introduced de novo 
into post-XCI cells. In this way the transgene and autosome are not exposed to the usual 
developmental programming, which might explain the reported phenomenon of  trans 
diffusion [99]. In Drosophila melanogaster, dosage compensation on the X chromosome 
in males involves spreading of  Rox1/2 RNA, which is dependent on a balance between 
expression of  the roX RNA and the abundance of  MSL protein components [109-
111]. One could imagine that over-expression of  an Xist transgene might deplete the 
pool of  chromatin factors and hence facilitate spreading in trans. Taken together these 
observations postulate that Xist RNA is actually diffusible and stable, but this would 
never be observed in vivo as it is ‘locked’ into place by proteins including hnRNPU.  
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Xist spreading and LINE-1 repeats
Now that we have an idea on how Xist RNA is loaded onto the Xi and only attaches 
to the X chromosome it is transcribed from, we look further into how it actually 
spreads and completely coats a 150Mb chromosome with only a few escaping genes as 
exceptions. The long-standing hypothesis was that Xist RNA is able to spread through 
way stations on the X chromosome [112-114]. LINE-1 repeats were suggested to 
serve as way-stations for Xist RNA spreading considering they are enriched on the X 
chromosome over autosomes [113], their density was correlated with the low efficiency 
of  XCI spreading on autosomes [106, 115, 116] and escaping genes were found to 
be LINE-1 poor in human [117].  Recently, evidence is accumulating against this 
hypothesis. Inefficient spreading and silencing of  an autosome might be the result of  a 
lethal monosomy if  Xist RNA would silence an autosome. This is evident from efficient 
XIST RNA spreading and silencing of  one of  the trisomy 21 chromosomes of  a Down 
syndrome hiPS cell [118]. In addition three recent studies show that LINE-1 repeats 
were not enriched over input in a Xist CHART-seq [119], no significant relationship 
between Xist localization and LINE1 repeats was found using an RNA antisense 
purification (RAP) technology [120] and finally, when looking at a spatial relationship, 
LINE-1 dense regions were more frequently found exterior to H3K27me3 and Xist 
RNA domains [121]. Taken together, these observations point to a mechanism other 
than LINE-1 elements as way stations for spreading of  Xist RNA .
 Even though LINE-1 repeats might not be involved in the direct spreading 
of  Xist RNA, these repeats could still have other important roles in XCI [122]. Two 
classes of  LINEs do seem to function in XCI. The first are LINEs that are silenced 
upon Xist RNA coating, prior to silencing of  other X-linked genes. These LINEs are 
thought to facilitate assembly of  a heterochromatic nuclear compartment into which 
genes can be recruited and silenced. The other class of  LINEs are expressed on both X 
chromosomes prior to XCI. After differentiation, these LINEs are exclusively expressed 
from the Xi and silenced on the Xa, and thought to facilitate the spread of  silencing into 
regions on the X chromosome that are difficult to silence through the regular spreading 
mechanism, such as regions in close proximity to escaping genes. 
 
Models for spreading of  Xist RNA along the X chromosome  
If  Xist RNA does not spread by means of  LINE-1 way stations or other specific binding 
sites which could act as way stations, how does it spread along an entire X chromosome? 
High-resolution maps of  Xist binding on the X chromosome generated using allele-
specific CHART-seq, suggested a two-step model for spreading of  Xist [119]. In cells 
undergoing XCI, Xist RNA targets gene-rich domains first, and the remaining gene-poor 
domains thereafter [119, 120]. However it was found that gene density alone did not 
explain early Xist RNA localization patterns, as chromosome wide correlation between 
Xist localization and gene density was relatively modest and therefore a proximity 
transfer model was hypothesized instead [120]. In this model the spatial organization 
of  the X chromosome is instructive in Xist RNA targeting gene-rich regions in close 
proximity to the Xist locus first, and subsequently spreading further into gene-poor 
regions afterwards. This proximity hypothesis was validated in a male cell line with an 
inducible Xist transgene integrated into the Hprt locus (±50Mb proximal to Xist), where 
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Xist RNA localization strongly correlated with proximity contacts at the Hprt integration 
site but not with the endogenous Xist localization sites. This study also observed that 
most genes targeted by Xist RNA are not active in ES cells and targeting initially occurs 
independent of  the conserved A repeat of  Xist. After spreading to the inactive gene-
rich regions, Xist, now dependent on a functional A repeat, is able to spread and silence 
the active genes as well. Additionally, Marks et al [123] used high-resolution allele 
specific RNA-seq to study the dynamics of  gene silencing on the Xi. Genes proximal 
to the Xist were found to be silenced prior to distal genes and lowly expressed genes 
also showed faster XCI dynamics than highly expressed genes [123]. Furthermore, it 
was hypothesized that X-linked TADs might function as modular domain structures 
initially targeted by Xist RNA spreading, and that secondary spread of  XCI might occur 
within these TADs. These studies point to a stepwise model for the spreading of  Xist 
RNA and suggest LINE-1 repeats might be less important in Xist RNA spreading 
than anticipated. Xist RNA spreads to (inactive) gene-rich regions first, and spreading 
along the rest of  the chromosome follows from thereon. Whether it is independent 
of  sequence specificity  and most likely due to proximity transfer [120] or that TADs 
might be involved in Xist RNA spreading remain intriguing questions to be explored. 
 
Silencing the X, novel Xist interactors  
After Xist has spread along the X chromosome it needs to ensure silencing of  the 
genes coated by Xist RNA. One of  the most studied relationship between Xist and 
recruitment of  silencing complexes to silence chromosome-wide are Xist and PRC2. 
PRC2 is composed of  SUZ12, EED, RBBP4/7 and EZH2 of  which EZH2 convers 
histone methyltransferase activity, catalyzing tri-methylation of  histone H3 at lysine 27 
[124, 125]. Recruitment of  PRC2 to the Xi is dependent on Xist RNA [92] and to 
some extent on repeat A of  Xist [89, 126, 127]. Xist and PRC2 seem to be functionally 
tethered when observing Xist clouds at 20-nm resolution using STORM [128], and 
“identification of  Direct RNA interacting Proteins’’ (iDRiP) [129] identified PRC2 as 
an Xist interacting partner, suggesting direct recruitment of  PRC2 by Xist. However, 
significant spatial separation and no co-localization between PRC2 proteins and 
Xist RNA respectively was observed with 3D-SIM [130, 131], and PRC2 binding to 
Xist [132] was not confirmed in two other studies applying alternative technologies 
(RNA Antisense Purification-Mass Spectrometry (RAP-MS) and Comprehensive 
Identification of  RNA-binding Proteins by Mass Spectrometry (ChIRP-MS)) to identify 
Xist interacting proteins [133, 134]. Although this discrepancy might have resulted from 
application of  different techniques, averaging for whole populations as compared to 
single cells and using male versus female cells, these findings may indicate that PRC2 
recruitment is indirect. This could involve PRC2 mediated recruitment by JARID2 [135] 
and ATRX [136]. Loss of  Jarid2, normally interacting with Xist repeat B and F, results in 
inefficient recruitment of  PRC2 and loss of  H3K27me3 enrichment on the Xi, despite 
proper Xist RNA spreading [135]. Loss of  ATRX, which is enriched on the Xi, also 
leads to an XCI defect [136, 137]. ATRX promotes binding of  PRC2 to repeat A of  
Xist RNA by forming a ternary complex of  ATRX, PRC2 and Xist RNA [136]. Recent 
work also indicates that PRC1 mediated accumulation of  H2AK119ub is sufficient for 
PRC2 recruitment [138], and interestingly, components of  the PRC1 complex were 
detected in the two Xist-interactor screens  [132, 139]. These findings indicate that 
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PRC2 recruitment might be secondary following initial recruitment of  PRC1 by Xist, 
but also suggests that multiple mechanisms are involved tethering PRC2 to the X. 
 The RAP-MS, ChIRP and iDRiP identified many other interesting Xist RNA 
binding proteins [129, 132, 133]. Spen, was among the 9 proteins identified in all three 
studies, and its involvement in XCI was further confirmed in two independent studies 
applying forward genetic [140] and pooled shRNA [141] screens. Spen (also known as 
Sharp) is a novel silencing factor required for and recruited by Xist RNA to silence the 
Xi [132, 133, 140, 141]. Spen was initially identified as an RNA binding protein involved 
in the recruitment of  the SMRT/NcoR co-repressor complex [142]. Several Spen co-
factors were also identified in different screens including, HDAC3, SMRT and RBM15, 
and knockdown or knockout of  all of  these factors resulted in XCI phenotypes. Spen 
interacts with Xist via the A repeat [132, 140] in ESC but this interaction is intensified 
in differentiated cells [132]. The exact mechanism through which Spen acts in 
establishment of  the Xi is not clear, but most likely involves deposition of  histone 
deacetylase activity through recruitment of  HDAC3. Several studies indicate that active 
histone marks antagonize polycomb group complex targeting (reviewed in [143]), and 
therefore loss of  histone acytelation might pave the way for PRC1 and PRC2 to be able 
to catalyze H2A119ub and H3K27me3, further installing the silent state. Besides Spen 
and its interactors several more interesting Xist interacting proteins were identified with 
these screens. These include the m6A methyltransferase WTAP and HnrnpK, which are 
both required for XCI, and it will be worth looking into more detail at possible roles for 
these proteins in XCI.  A summary of  Xist binding proteins and the regulatory network 
at the Xic is shown in Figure 4.   
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Figure 4: A)The Xic and Xist binding proteins. Shown are different genes located within the Xic and 
the action sites of  the trans acting factors (top). Also indicated are the binding sites of  Xist regulatory 
and nucleation factors (DNA binders), and Xist RNA-binding proteins involved in establishment of  the 
Xi (RNA binders). B) Model of  the sequence of  events leading to silencing of  the X chromosome. Xist 
RNA interacts with SPEN and RBM15. SPEN recruits SMRT, resulting in recruitment and/or activation 
of  HDAC3 and deacetylation of  H3K27. This allows for PRC2 and PRC1 recruitment which respectively 
methylate H3K27 and ubiquitylate H2AK119. Eventually,macroH2A is recruited to the X, together with 
the DNA methylation machinery.  Figure adapted from [144] and [145]. 
Barr body formation  
The final stage in establishment of  the Xi is the formation of  the Barr body [20], but 
how and when exactly during XCI this chromatin compaction towards a Barr body 
occurs was still unknown because of  limiting resolution with the standard microscopy 
techniques.  Now using 3D-SIM and STORM with better resolution, the structural and 
spatial arrangement of  the Barr body in the nucleus can be observed in greater detail. 
Xist RNA is organized as distinct foci distributed throughout the Barr body with less 
than 100 foci, each consisting of  about 3 (up to 10) transcripts Xist RNA [128, 131]. 
The Barr body maintains principle ultra-structural features of  a general chromosome 
territory (CT) architecture, only in the Barr body the active nuclear compartment (ANC) 
appears to be collapsed and preferential localization of  Xist RNA foci was observed 
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within and at boundaries of  these collapsed ANC channels [131]. The nuclear matrix 
protein hnRNP U/SAF-A [101, 108] was enriched within the Barr body and found in 
close spatial proximity to Xist RNA [131]. Multimer formation of  hnRNP U/SAF-A, 
triggered by Xist RNA, could create a scaffold that helps maintain the integrity of  the 
Barr body structure [131]. Interestingly, hnRNP U/SAF-A was identified in all three 
RAP-MS, ChIRP and iDRiP screens as interaction partner of  Xist, in support of  a 
crucial role for this protein in XCI [129, 132, 133]. In addition, RAP-MS, and iDRiP also 
identified Lamin-B receptor [129, 133], which might play a role in tethering the Barr 
body near the nuclear periphery. 
Time resolved 3D-SIM on differentiating ESC revealed initial spreading of  Xist RNA 
foci around day 3 of  differentiation into a de-condensed chromatin environment, by day 
4 focal Xist RNA spreading and RNA PolII exclusion was observed, but no evidence for 
chromatin compaction. Distinct global compaction of  a Xist RNA defined Xi territory 
towards a Barr body was evident at day 5. Exclusion of  RNA PolII and removal of  
active marks could result in silenced genes quickly undergoing chromatin condensation 
at this stage. Distinctive marking of  the Barr body was observed in most cells after day 
7 and a higher level of  chromatin compaction in the Barr body was observed at day 
9 and might represent a stable stage of  chromatin arrangement in the Xi mediated by 
late stage repressive signatures such as DNA methylation. One interesting observation 
worth mentioning is that autosomal Barr body formation, obtained by inducible Xist 
transgenes [65], clearly differ from the female Xi and resemble more active chromatin 
up to day 10 of  differentiation [131] potentially explaining discrepancies in different 
studies. 
 Taken together, studies on the establishment of  the Xi are rapidly unravelling 
how Xist is loaded onto the X chromosome, how it spreads along the Xi in cis and how 
it manages to silence chromosome-wide and finally form a highly condensed Barr body. 
Using the proteins found in the unbiased proteomic screens in functional analysis can 
help identify the missing players in the establishment of  the Xi. 
Maintenance of  XCI  
Once the Xi has been established and a Barr body is formed, the Xi is maintained 
in an inactive state and clonally propagated throughout cell divisions. Even though 
maintenance of  the Xi seems to be very stringent and maintained throughout cell 
divisions, escaping genes seems to vary between tissues [146]  which could indicate 
tissue specific maintenance. Genes escaping XCI include genes in the pseudo-autosomal 
regions (PAR) and individual genes escaping XCI called escapers, with or without a Y 
homolog. Genes in the PAR, the region homologous to the Y chromosome, escape XCI 
but are not differentially expressed between the sexes as males also have two copies of  
genes located in this region.  Escapers that have a Y homolog are also present in two 
copies in both males and females. It is only the escapers without a functional Y homolog 
which are differentially expressed between the sexes, thus absolute equalization of  gene 
dosage between the sexes is not the case [7]. 
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The maintenance phase is the least studied phase of  the rXCI process and therefore 
a lot still remains to be explored. In a study using MEFs harboring a GFP transgene 
on the X chromosome and exposing these cells to a mouse shRNA library, 
factors involved in maintenance of  the Xi could be identified as a result of  GFP 
reactivation [147]. 32 proteins involved in maintenance of  the Xi were identified 
in this study, of  which only DNMT1 was also identified in one of  the three Xist 
interactor screens [129]. One of  these studies involving the identification of  Xist-
interactors also tested the effects of  knockdown of  specific genes, revealing a role 
for cohesion factors and topoisomerase in maintenance of  the Xi. These findings 
might indicate that different factors act in establishment and maintenance of  the 
Xi, but might also reflect differences in the technical setup. It will clearly be worth 
looking into more detail at to unravel the unknowns of  this last phase of  rXCI.   
 
XCI in different species: choosing the right model   
XCI occurs in all therian mammals, thus marsupials and eutherians. Even though the 
end result of  XCI, dosage compensation by inactivating one X chromosome in female 
cells,  is the same, two major differences between these two clades are evident: marsupial 
XCI involves genomic imprinting, always inactivating the paternal X chromosome (Xp), 
whereas XCI in eutherians is mostly random with respect to parental origin of  the 
X chromosome, only showing iXCI in extraembryonic tissues in mouse [148, 149], 
rat [150], common voles [151] and cow [152]. In addition, marsupial XCI involves a 
lncRNA Rsx [153], whereas eutherian XCI involves the lncRNA Xist. Rsx and Xist are 
non-homologous and have a different origin but share several common features. Both 
lncRNAs are large, repeat-rich, spliced and polyadenylated non-coding RNAs only 
expressed in female cells. Also, both contain a high GC content and are highly enriched 
in tandem repeats which are biased towards the 5’end [153]. Furthermore, Xist and 
Rsx are exclusively transcribed from and coat the Xi resulting in formation of  distinct 
RNA clouds which can be visualized by RNA-FISH. Marsupial XCI and eutherian XCI 
have evolved separately, which explains the differences between the two forms of  XCI, 
even though both forms achieve inactivation of  one X chromosome in female cells. 
Nevertheless, it seems that there are differences in XCI, especially regarding timing and 
escaping genes across eutherians as well. 
 Most eutherian studies show rXCI in the embryo and adult or somatic tissues 
and Xist is conserved between them, yet some differences in initiation, form of  XCI in 
extraembryonic tissues and the actual process of  XCI have been reported for different 
eutherian species. Therefore, one of  the major debates in the field is whether the mouse 
is a good model to study XCI as it appears that not everything can be extrapolated 
to other species as well. So far,  as mentioned before, iXCI has only been reported 
in mouse, rat, common voles, cow and some contradicting reports in human as well 
[154-158]. Other species such as rabbit [159], horse [160], mule [160], monkey [161] 
show rXCI in their extra embryonic tissues. In addition, it seems that the mouse is the 
only species which has an Xist gene with a completely overlapping Tsix gene, whereas 
it is truncated before reaching the Xist promoter in other species [162]. Other major 
differences are the timing of  XCI initiation and silencing. Some of  these differences in 
timing are a result of  differences in development of  the embryo of  different species. In 
mouse female embryos Xist is upregulated and spreads to inactivate the X chromosome 
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directly, whereas in human and monkey female embryos, XIST can be detected around 
the blastocyst stage on both X chromosome without signs of  gene silencing. In culture 
there are even more differences and hES and hIPS can be found in different states with 
respect to XCI [163]. Most of  these and other discrepancies between mouse/human 
XCI and other species seems to lie in the ability to obtain pluripotent cells and maintain 
them in the naïve state when analyzing them in culture. 
 Mouse embryonic stem (ES) cells are the most frequent used ex vivo model 
system for XCI studies as these pluripotent stem cells are derived from the ICM and 
initiate random XCI upon differentiation in female cells but not in male cells [18]. 
Ultimately, we need to consider: are mice really recapitulating human XCI? So far, 
studies of  XCI in mouse have been very important in translation to X-linked diseases. 
In addition ES cells can be genetically manipulated and subsequently used to generate 
genetically manipulated mice. Mice are therefore the main model organism used for 
XCI, as XCI can be studied both in vitro and in vivo [19]. In contrast, XCI in early 
human development has not been studied as intensively because of  ethical and other 
restrictions in culture. Thus while mouse ES cells can recapitulate XCI regulation in 
vitro, XCI in hES and hiPS cells shows variations and switches from one state to the 
other in culture, making it much more difficult to study the XCI process, requiring more 
knowledge about human XCI in vivo. 
 In summary, mouse XCI seems to be more complete, having least escaping 
genes and a very tightly regulated XCI in place as compared to other eutherian species. 
Understanding the main differences in XCI between species and the different degrees 
of  silencing resulting from these differences can help us understand silencing and 
skewing which can be used to target specific human diseases in the future.
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Aim and scope of  this thesis  
In mammals, males are the heterogametic sex having an X chromosome and a Y chromosome 
whereas females have two X chromosomes. Despite originating from an ancient homologous 
autosomal pair, the X and Y chromosome now differ greatly in size and gene content after ~180 
MY of  evolution. The X chromosome retained over 1000 genes, whereas the Y chromosome 
degenerated over time and only contains about a hundred genes mainly involved in male 
spermatogenesis. Females have two X chromosomes and thus double the amount of  X-encoded 
genes as compared to males which creates an imbalance of  X-encoded genes between males 
and females. Mammals achieve dosage compensation of  this imbalance of  X-encoded genes by 
inactivating one of  the two X chromosomes in female cells by a process called X chromosome 
inactivation (XCI). XCI is a stochastic process in which each X chromosome has an equal 
probability to be inactivated. Even though XCI is stochastic, it is a tightly regulated process to 
obtain one active X chromosome per diploid genome. Regulation of  XCI is achieved by the 
X inactivation center (Xic), located on the X chromosome, which harbors all the necessary 
elements for XCI to occur. These elements are regulated by XCI activators and inhibitors.  
The aim of  this thesis is to gain more insight into the molecular mechanism of  XCI. Specifically, 
how XCI is regulated by  activators and inhibitors of  XCI, which regions of  the X chromosome 
are involved in this process and whether imprinted XCI is different from random XCI  with 
respect to the inactivated X (Xi).
XCI is regulated by X-encoded activators and autosomally encoded inhibitors. The only 
described trans-activator so far is the E3 ubiquitin ligase Rnf12. RNF12 was shown to target 
the XCI inhibitor REX1 for proteasomal degradation. RNF12 mediated degradation of  REX1 
highlights the interplay between XCI activators and XCI inhibitors to determine whether Xist 
is upregulated and if  XCI is initiated or not. In Chapter 2, different aspects of  the RNF12 
mediated ubiquitin pathway involved in XCI are explored. These aspects include involvement 
of  the X-encoded E1 activating enzyme UBA1, whether specific lysines are indispensable for 
the proteasomal degradation of  REX1 as well as determining whether a close homologue of  
RNF12, RNF6, might be involved in XCI. In Chapter 3, we focus on the dynamics of  the 
key players in XCI, Xist and Tsix. Xist and Tsix  are two overlapping antisense transcribed non 
coding RNAs. Xist RNA coats and spreads along the entire X chromosome recruiting chromatin 
remodeling complexes to silence the X chromosome in cis whereas Tsix transcription and/or the 
produced Tsix RNA represses Xist. Using reporter cell lines we studied the dynamics of  Xist and 
Tsix independently. In Chapter 4, we set out to identify the region(s) involved in activation of  
XCI, containing novel X-encoded XCI activator(s). In this chapter a large mega base deletion 
was generated to narrow down the region(s) of  interest. In Chapter 5, we explored the Xi 
epigenetic landscape, examining Xi specific chromatin marks in cell types representing different 
embryonic lineages and developmental stages of  the mouse embryo. We compared different 
cell types displaying imprinted and random XCI to identify lineage specific markers that could 
explain the difference between these two forms of  XCI. In Chapter 6, we discuss the main 
findings of  the described chapters taking into consideration related work in the XCI field and 
possible future directions to continue this work. In Addendum A, an overview is given on 
candidate genes explored to search for the remaining XCI activators which were found not to 
be involved in activation XCI. 
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Abstract 
X chromosome inactivation (XCI) in female mammals is a dosage compensation mechanism 
to equalize X encoded gene dosage of  XX females to XY males. Initiation of  XCI is a tightly 
regulated process directed by autosomally encoded inhibitors and X encoded activators of  
XCI. The XCI activator and E3 ubiquitin ligase, RNF12, activates XCI through proteasomal 
degradation of  one of  the XCI inhibitors, REX1. Here we have studied the ubiquitin pathway in 
context of  XCI in more detail.  We show that two copies of  the X encoded E1 activating enzyme, 
UBA1, are necessary for proper initiation of  XCI and is a novel XCI activator. In addition, we 
show that the RNF12 mediated downregulation of  REX1 is robust, involving multiple ubiquitin 
targets and XCI still proceeds in the absence of  these targets. Finally, we show that the E3 
ubiquitin ligase Rnf6, an autosomal close homologue of  Rnf12 that is equally expressed in male 
and female cells, acts as an Xist activator most likely through degradation of  REX1. 
Introduction  
X chromosome inactivation (XCI) is required for proper dosage compensation of  X encoded 
genes between mammalian XX females and XY males, leading to near complete inactivation 
of  one of  the two X chromosomes in female cells. XCI can be divided into three main phases: 
initiation, establishment and maintenance of  the inactive X chromosome (Xi) [1]. Initiation 
of  XCI is the crucial phase, regulated by activators and inhibitors of  XCI,  determining the 
number of  X chromosomes in a nucleus and directing initiation of  XCI. Inhibitors of  XCI 
are autosomally encoded, acting as denominators, setting up the threshold for XCI to occur. In 
contrast, XCI activators are X encoded, acting as numerators,  expressed at twice the level in 
female as compared to male cells and therefore trigger female specific initiation of  XCI. Several 
XCI inhibitors have been identified, mainly consisting of  pluripotency factors, clearly linking 
XCI initiation to loss of  pluripotency [2-5]. The E3 ubiquitin ligase Rnf12 has been identified as 
a potent trans activator of  XCI [6]. RNF12 is important for XCI as Rnf12-/- cells fail to initiate 
XCI, but represents not the sole XCI activator, as Rnf12+/- cells, though delayed, still undergo 
XCI which is never observed in male cells.  
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2 In XCI, RNF12 targets the XCI inhibitor and pluripotency factor REX1 for proteasomal degradation [7, 8]. This pathway starts with ATP-dependent activation of  ubiquitin by the E1 
activating enzyme and transfer to an E2 enzyme to be recruited by the ring finger of  an E3 
ubiquitin ligase. Bridging of  the active ubiquitin charged E2 and the substrate protein results 
in ubiquitination of  the target protein, and repetitive recruitment of  the E2 results in poly-
ubiquitination and subsequent degradation of  substrates [9-11]. The E1 activating enzyme is 
indispensable for proteasomal degradation and deletion of  Uba1 in C. elegans is lethal [12-14]. In 
vertebrates, two E1s exist, Uba1 and Uba6, however Uba1 appears to be the main activator of  
most E2s [9, 15-17]. Interestingly, Uba1 is located on the X chromosome and dose dependent 
degradation of  target proteins might therefore be affected by different expression levels of  
Uba1 in male and female ES cells. In mice, Uba1 is inactivated upon XCI [18], and might be 
involved as an upstream activator in a ubiquitin mediated cascade to up-regulate Xist, through 
dose dependent RNF12 mediated downregulation of  REX1, or other ubiquitin related pathways.
Rnf12 is a member of  the RING finger family, consisting of  over 100 members. Sequence 
comparison by principal component analysis (Figure 1A) of  members of  the RNF family 
showed highest homology of  Rnf12 to Rnf6, clustering together yet secluded from the 
clustering of  the rest of  the members of  this gene family. The sequence homology of  different 
functional domains of  these proteins is very high ranging in the order of  70% [19], and 
although Rnf6 is autosomally encoded and equally expressed in male and female cells, this E3 
ubiquitin ligase might attribute to the turnover of  REX1, lowering the threshold for initiation 
of  XCI.  To address this and explore the role for of  the ubiquitin pathway in activation of  
XCI, we first studied the specificity of  RNF12 mediated targeting of  REX1 by examining 
the effects of  modifying the substrate on ubiquitination and degradation. In subsequent 
genetic ablation experiments we studied the dose dependent role of   Uba1 and Rnf6 in XCI. 
Our studies underscore the impact of  the ubiquitin pathway on the regulation of  XCI. 
Experimental procedures 
BACs, plasmids and antibodies  
The BAC covering Rnf6 (CHORI) used in this study was RP24-304C5. Recombination between 
the BAC and an ori-less recombination vector to introduce a kanamycin/neomycin resistance 
cassette, allowing selection in ES cells, into the BAC backbone was performed according to 
Barakat et al (2015) [20]. Plasmids used in the REX1 and RNF12 ubiquitination experiments 
were REX1-mCherry, Rex1-FLAG-V5, RNF12-EGFP and RNF12-FLAG [8]. Rnf6 cDNA 
was cloned into the pEGFP-N1 vector (Clonetech) to obtain an RNF6-EGFP expression 
vector. The pSpCas9(BB)-2A-Puro (PX459) (Addgene plasmid # 48139) was used to insert the 
CRISPR guide RNAs [21]. Antibodies used were recognizing REX1 (Abcam), RNF12 (Abnova), 
β-Actin (Sigma), V5 (Invitrogen) and Ub (Enzo). The secondary antibodies were α-Mouse 
IgG-peroxidase (Sigma) for RNF12 and Ub, and α-Rabbit IgG-peroxidase (Sigma) for REX1. 
 
 
Cell lines  
Cell lines, culture media and culture conditions for ESC culture and differentiation were described 
previously [7, 22]. BACs (linearized) and CRISPR vectors were introduced in hybrid wildtype 
F1 129sv/CAST [23] male or female ES cells by electroporation in a 0.2cm electroporation 
cuvette (BioRad) at 118kV, 1200μF and ∞Ω in a Gene Pulser Xcell Electroporation System 
(BioRad). After 24 hours of  recovery, ES cells were grown on ES medium containing neomycin 
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2(270μg/ml) or puromycin (1ug/ml) for seven days or 24 hours for BACs or CRISPR vectors respectively.  
 
Xist RNA Fluorescent in situ hybridization  
Procedure, probe labeling and antibodies have been described previously [7, 22]. 
 
RNA isolation from ES cells and cDNA synthesis  
TRIzol® (Invitrogen) was added to the cells and RNA was isolated according to manufacturer’s 
instructions. RNA samples were diluted to contain 2μg RNA in 10μl. Before cDNA synthesis, 
1μl DNase (Invitrogen) was added to the RNA samples, for 30 minutes at 37oC to remove any 
contaminating genomic DNA. The DNase was inactivated at 65oC for 10 minutes. 1μl Random 
Hexamers (Applied BioSystems) and 1μl dNTP mix (Invitrogen) was added and incubated at 
65oC for 5 minutes and subsequently cooled on ice for 1 minute. 4μl 5x First Strand Buffer, 2μl 
0.1M DTT and 1μl RNaseOUT (Invitrogen) were then added to the samples and incubated 
at 25oC for 2 minutes before adding 1μl SuperscriptII Reverse transcriptase (Invitrogen). The 
samples were then incubated at 25oC for 10 minutes followed by 50 minutes at 42oC and finally, 
15 minutes at 70oC.
Rnf6-EGFP fusion protein  
Primers were designed flanking Rnf6 cDNA with XhoI and KpnI sites, leaving the ATG (start site) 
intact but removing the Stop-codon: Fw 5’ CTCGAGATGGATCCGTCTAGATCTAGATCA 
3’ and Rv 5’ CGGTACCCCACTGCTTGTGGCTCCGAATTC 3’. This was then cloned into 
TOPO by Zero Blunt® TOPO® PCR Cloning (Invitrogen) and sequenced with MF-20i and 
MR-Invitrogen primers. Using the XhoI and KpnI sites Rnf6 was cloned into the pEGFP-N1 
vector with T4 DNA ligase (Roche). Rnf12-EGFP and Rex1-mCherry were described previously 
[8].
Transient transfection of  HEK293 cells  
HEK293 cells were co-transfected with Rnf6 (-EGFP or FLAG) and Rex1 (-mCherry or 
FLAG-V5) [8] to determine the degree of  ubiquitination and degradation of  REX1 by RNF6. 
As a control, RNF12 (-EGFP or FLAG) [8] was used. Rnf6/12 and Rex1 were transfected in 
the ratio 3:1 when using EGFP/mCherry and 1:1 when using the pCAG-FLAG-V5 vectors 
respectively. Polyethylenimine (Polysciences) was used to transfect the HEK293 cells. For the 
EGFP/mCherry transfection, cells were grown on round cover slips treated with poly D-lysine 
in a 12-well plate until ~80% confluent. After 24 hours, the cells were fixed with 4% PFA for 
20 minutes at room temperature, washed 3 times in PBS, incubated for 20 minutes in 0.1% 
triton and washed 3 times in PBS before mounting with VECTASHIELD® Mounting Medium 
containing 4’, 6-diamidino-2-phenylindole (DAPI). Images were acquired using a fluorescence 
microscope (Axioplan2; Carl Zeiss). The transfection with Flag-Rnf6/Rnf12 and Flag-V5-Rex1 
was done in a similar way as described above, but in a 10 cm dish per transfection. After 48 
hours, nuclear proteins were isolated.
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2 Nuclear protein isolation  For nuclear protein isolation a confluent 10 cm dish of  cells was used. The cells were scraped 
into 1 ml cold PBS containing protease inhibitor (Complete, EDTA-free, Protease Inhibitor 
Cocktail Tablets (Roche)) and kept on ice. The cells were spun down for 10 seconds at 4oC and 
resuspended in 400μl cold buffer A (10mM Hepes 7.6, 1.5mM MgCl2, 10mM KCl, 1xPI, 0.5mM 
DTT and 15μM MG132) and subsequently incubated on ice for 10 minutes. The cells were 
vortexed for 10 seconds and briefly spun down again at 4oC. The supernatant fraction containing 
the cytoplasmic proteins was discarded and the pellet was resuspended in 150μl Buffer C (20mM 
Hepes 7.6, 1.5mM MgCl2, 25% glycerol, 420mM NaCl, 0.2mM EDTA, 1xPI, 0.5mM DTT and 
15μM MG132) and incubated on ice for 20 minutes. After centrifugation at 13200 rpm for 2 
minutes at 4oC, the DNA binding proteins were obtained in the supernatant fraction. 
Western blot  
Samples for western blots were diluted with 2xLaemmli Buffer to obtain 180μg protein in 
60μl. The samples were boiled at 99oC for 5 minutes. The SDS-PAGE gel consisted of  a 5% 
stacking gel and a 10% running gel and was run in electrophoresis buffer (25mM Tris (pH8.3), 
192mM glycine, 0.1%SDS from BioRad) in a Biorad cell. After electrophoresis, the proteins 
were transferred onto a nitrocellulose membrane by blotting for 45 minutes at 200mA in blot 
buffer (25mM Tris (pH8.3), 192mM glycine (BioRad) and 20% Methanol) in a Trans-Blot SD 
semi-dry electrophoretic transfer cell (BioRad). Blocking of  non-specific sites was done for 
30 minutes in 3% Milk (or 1% BSA for Ubiquitin)/1xTBS/0.1%Tween. After blocking, the 
primary antibody was added overnight at 4oC. Primary antibodies used in this study: α-Rnf12 
(1:3000), α-Rex1 (1:3000), α-Actin-HRP (1:50000), α-Ubiquitin (1000). Secondary HRP labeled 
antibodies (all diluted 1:5000) used in this study: α-Mouse (Rnf12, Ubiquitin) and α-Rabbit 
(Rex1). The membrane was exposed to ECL Western Blotting detecting reagents in a ratio of  
1:1 (GE Healthcare) for 1 minute and exposed to light-sensitive film (Kodak or GE Healthcare) 
and developed.
Site-directed mutagenesis  
The QuickChange site-directed mutagenesis kit (Invitrogen) was used to introduce single point 
mutations. Rex1 cDNA [8] was used as template and two overlapping primers (Table 1) containing 
the desired mutations were used to generate a mutated plasmid containing staggered nicks. The 
PCR product was treated with DpnI, which is specific for methylated and hemi methylated DNA and 
therefore digests only the template DNA. The desired mutated plasmid was then transformed into 
XL1-Blue super competent cells by a heat shock for 45 seconds at 42oC. When correct mutations 
were confirmed, the Rex1 mutant sequences were cloned into a pCAG-Flag-V5 vector [8]. 
Table 1: Primers for site-directed mutagenesis, creating point mutations changing lysine into arginines in REX1. Point 
mutations are underlined in the sequence. 
Fw: 5’-3’and Rv: 3’-5’ Mutation
CGACAGACTGACCCTAAGGCAAGACGAGGCAAGGC K33 A
GGAGTACATGACAAGGGGGACGAGGCAAGAGAGGAGAGAGAGGTC
K126, K129, 
K132 A
CACGGAGAGAGCTCGAGACTAAGGCGACATTTTCTGGTG K213, K215 A
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2V5 Immunoprecipitation  The nuclear proteins were diluted 1:1 with buffer C-0 (20mM Hepes (pH 7.6), 20% glycerol, 
1.5mM MgCl2, 0.2mM EDTA, 1xPI, 0.5mM DTT, 15μM MG132). Precipitates caused by dilution 
were removed by centrifugation at maximum rpm for 5 minutes after which the supernatant was 
transferred to non-stick tubes containing 15μl washed α-V5 agarose beads (Sigma). The beads 
with nuclear proteins were rotated at 4oC for 90 minutes and then washed four times with buffer 
C-150 (20mM Hepes (pH 7.6), 10% glycerol, 150mM KCl, 1.5mM Mgcl2, 0.2mM EDTA, 0.02% 
NP40, 1xPI, 0.5mM DTT, 15μM MG132). 2x Laemmli buffer was added to the beads, mixed 
and boiled for 4 minutes at 99oC. The samples were then centrifuged for 1 minute at 3000 rpm 
and transferred to a new tube and checked by immunoblotting on an 8% polyacrylamide gel.
Deletions with the CRISPR/Cas9 system  
CRISPR guides were designed by using the CRISPR design tool (http://crispr.mit.edu/). The 
designed CRISPR guide oligos with 5’- CACC and 3’- CAAA overhangs (Table 2) were cloned 
into the pX459 CRISPR vector (Addgene) containing a U6 RNA polymerase II promoter. The 
CRISPR guides were inserted into the pSpCas9 (BB)-2A-Puro (PX459) plasmid (Addgene) [21] 
by a simultaneous digestion-ligation reaction [24]. First, the pX459 vector was digested with BbsI 
(NEB) to allow the replacement of  the restriction sites with direct insertion of  the annealed oligo 
guides. This was then directly used to transform heat competent bacteria. A combination of  two 
guides (beginning and end) was used in each targeting and each targeting was first screened as a 
pool to ensure the deletion is present, followed by single clone screens (Table 3). 
Table 2: Oligo’s for CRISPR guides for deletion of  Rnf12, Rnf6 and Uba1.  5’- CACC and 3’- CAAA overhangs are 
indicated in bold and the preferred G as a starting nucleotide is underlined. 
Gene Location Guide 
Rnf12 Intron 2 Fw: 5’ CACCGAAAGCGCTGTACAAAAAGTT 3’
Rv: 5’AAACAACTTTTTGTACAGCGCTTTC3’
3’UTR Fw:  5’ CACCGGAACAAGTACTCTAAACTA 3’
Rv: 5’ AAACTAGTTTAGAGTACTTGTTCC 3’
Rnf6 Exon1 Fw: 5’CACCG TGCAAATAGAACCCGATCTA 3’
Rv: 5’AAAC TAGATCGGGTTCTATTTGCA C3’
Exon5 Fw: 5’CACCG AGTCGGGGGCCTCGATTAAC 3’
Rv: 5’AAAC GTTAATCGAGGCCCCCGACT C3’
Uba1 Exon1 Fw: 5’CACCG TTGCGCGGAGCTCGGAAGCG 3’
Rv: 5’AAAC CGCTTCCGAGCTCCGCGCAA C3’
Exon27 Fw: 5’CACCG TATAGCTGGAGTAGCCCATT 3’
Rv: 5’AAAC AATGGGCTACTCCAGCTATA C3’
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2 Table 3: Primers  for detection wildtype allele, deletion and allele check of  Rnf12, Rnf6 and Uba1
Wildtype allele PCR over deletion Allele check
Rnf12 CTGCAGTGAATCCTCCTTGA CTGCAGTGAATCCTCCTTGA GCTCACAACCATCCATAACG
AGCAAACTTGGTTGGGAAAC TGAACAAATTGTGTGCATGG TCTATCCCCTCTGCCATTGTT
Bstx1 digest on 129 allele
Rnf6 GGCTGCATCTCCATTACTCA GGCCATTGCTTTGATTCTCT CTTCCCAGAGTTGCAAATGA
GGCCATTGCTTTGATTCTCT GGAAGGGTCATTTGGTGAGT CTGAGGGGGTAGAGCAGAAG
EcoRV digest on CAS allele
Uba1 GAGGCGCAGAAGTAGAGAGAA CCCCTCTATTCAGGCGTCTA TCTCCTTCACAGCTCCTTGA
AAAATTCTGCCCTCCAACAG CCCTTCAGACCCACCATTAC TGATTAAGAGCACCGACTGC
EcoNI digest on 129 allele
Results  
RNF12 mediated degradation of  REX1: Redundancy in preferentially ubiquitinated lysines  
To obtain more insight into the mechanism of  RNF12-mediated degradation of  REX1, mass 
spectrometric analysis was performed to identify the ubiquitinated sites within REX1 in female 
ES cells. An in vitro ubiquitination study identified five peptides derived from REX1 with the 
diglycine signature corresponding to putative lysine acceptor sites for ubiquitin linkage. These 
five peptides corresponded to ubiquitination of  K33, K129, K132, K213 and K215 of  REX1 
[25]. To determine whether these sites are indispensable for the degradation of  REX1, the five 
lysines identified, including one additional lysine (K126) in close proximity to two ubiquitinated 
lysines, were mutated into arginines by site-directed mutagenesis. We replaced lysines into 
arginines as these amino acids are most similar; ionizable basic amino acids with a net positive 
charge in the pH ranges found in the cell. Different Rex1 mutant expression vectors were 
generated with point mutations at different positions within REX1 (Figure 1B). The generated 
Rex1 mutant vectors were subsequently transiently co-transfected with RNF12 in HEK293 cells. 
Nuclear proteins were analyzed by western blot for REX1 protein levels in the absence (no 
ubiquitination) and presence of  RNF12 (ubiquitination). Despite equal amounts of  expression 
vectors transfected in HEK cells, all mutated REX1 proteins showed reduced expression levels 
in the absence of  RNF12, possibly related to protein miss-folding and destabilization (Figure 1C 
and 1D lower panel). Co-transfection of  Rnf12 with Rex1 single, double and triple mutations still 
let to degradation of  REX1, highlighting redundancy in the degradation pathway. We therefore 
generated REX1 expression vectors with five or six mutated lysines. These REX1 mutants 
4 and 5 displayed near similar REX1 protein levels in the presence and absence of  RNF12, 
suggesting that these mutants are less prone to degradation by RNF12. To determine the degree 
of  ubiquitination of  REX1 mutant 4 and 5, IP followed by immuno-detection of  ubiquitinated 
REX1 was performed. This analysis indicated the presence of  an intense smear corresponding 
to poly-ubiquitinated mutant REX1, indicating activity of  RNF12 towards mutant REX1 (Figure 
3C). However,  levels of  REX1 poly-ubiquitination were reduced for mutants 4 and 5 compared 
to wild type in the presence of  RNF12, suggesting that the new targets for poly-ubiquitination 
were less efficiently  recognized by the proteasome.
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2Figure 1: A) Rnf12 and Rnf6 cluster together and away from the rest of  the RNF family in a Principal 
component analysis. A spatial representation of  the similarities of  the sequences of  the RNF gene 
family. The sequences are displayed as points in ‘similarity space’ and similar sequences tend to 
lie near each other in this space. B) Five different Rex1 mutants (V5 REX1 mut1-5) were created by 
site directed mutagenesis. Green shaded areas represent the zinc finger domains. The five identified 
lysines are indicated with a * and the additional lysine mutated in their close proximity is shown in red. 
C) Western blot with nuclear proteins of  transient co-transfections of  V5 REX1 mut1-3. Levels of  
REX1 and RNF12 were detected in the different transfected samples and actin was used as a loading 
control. D) Western blot (lower panels) and IP (upper panel) with nuclear proteins of  transient co-
transfections of  combinations of  RNF12 and V5 REX1 mut4 and mut5 expression vectors. Levels of  
REX1 and RNF12 were detected in the different transfected samples and actin was used as a loading 
control in the western blot (lower panel). The IP was performed with an anti-V5 antibody followed by 
immuno-detection with an anti-ubiquitin antibody to determine the degree of  ubiquitination of  the 
different REX1 mutants by RNF12 as compared to wild type REX1 (upper panel).  
 
Loss of  Uba1 in Rnf12+/- cells affects XCI  
Rnf12 expression levels play an important role in XCI upon ES cell differentiation. Nevertheless, 
the presence of  female ES cells inducing XCI in a Rnf12+/- heterozygous background indicates 
that more XCI activators are involved. The main E1 activating enzyme in mammals, Uba1, is 
X-encoded and might represent a putative XCI activator increasing the rate of  ubiquitination by 
boosting the levels of  activated E1 in female cells.  To test whether Uba1 acts as an activator of  
XCI, we aimed to generate Rnf12+/-:Uba1+/- heterozygous knockout female ES cells, using the 
CRISPR/Cas9 technology. First, Rnf12 was removed from one allele in female F1 Cast:129/Sv 
ES cells. These hybrid ES cells have 1 SNP in every 100bp facilitating identification of  properly 
targeted clones and allele specific follow up of   phenotypes. Rnf12 was targeted to the 129/Sv 
allele using two guides recognizing intron 2 and the 3’UTR of  Rnf12,  generating a deletion of  
approximately 18.5kb, removing the complete open reading frame of  Rnf12 (Supplementary 
Figure 1A-C). This new Rnf12+/- ES cell line recapitulated the reported XCI phenotype observed 
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2 in differentiated Rnf12
+/-(neo) ES cells which contain a neomycin resistance cassette in exon 5 [6] 
(Supplementary Figure 1 D and E), showing a reduction in cells initiating XCI and skewing 
of  XCI towards the mutated allele  (Supplementary Figure 1E) [26]. We next designed guide 
RNAs recognizing exon1 and exon27 of  Uba1 forcing an approximate 24kb deletion (Figure 
2A). Two heterozygous clones were obtained (Supplementary Figure 2B and C) and analyzed 
for an effect on XCI by differentiating these cells up to 8 days followed by Xist-RNA FISH 
to determine the percentage of  cells with Xist clouds. Xist expression was also determined by 
qPCR at different time points, up to 8 days, of  differentiation.  Both clones still formed Xist 
clouds after differentiation in a similar percentage of  cells as compared to Rnf12+/- cells (Figure 
2D). Nevertheless, analysis of  Xist expression at day 0, 2, 4, 6 and 8 of  differentiation, indicated 
that Xist expression was significantly affected at days 6 and 8 and did not reach wildtype Xist 
expression levels as observed in the Rnf12+/- cells  (Figure 2E). To exclude a relation between 
delayed differentiation and reduced Xist expression in these two clones, expression levels of  
pluripotency factors Rex1, Nanog and Oct4 expression was analyzed over 8 days of  differentiation 
and displayed normal differentiation (Figure 2 F,G, H). The results suggest that Uba1 is indeed 
involved in activation of  XCI providing more robust initiation of  XCI by boosting Xist 
expression, rather than inducing XCI in a higher number of  cells.  
Figure 2: A) Representation of  Uba1 deletion guides and primers. B)PCR spanning the deleted region 
of  Uba1. Two clones (89 and 186) show the deletion not detected in control 129/Sv:Cast cells (top). PCR 
spanning DXMit44 length polymorphism marker. Both clones show the presence of  both Cast and 129 
allele as seen in the wildtype (129/Cast) cells representing the presence of  two X chromosomes (bottom). 
C) Allele specific PCR  of  Uba1 allele identifying targeted allele; 129/Sv for clone 89  and Cast for clone 
186 . D) Percentage of  cells with Xist clouds at day 0,2,4,6 and 8 of  differentiation in F121 (wildtype; 
n=298 d0; n= 256 d2; n=241 d4; n=206 d6; n= 272 d8) Rnf12+/- cells (n= 223 d0; n= 251 d2; n=241 d4; 
n=233 d6; n=218 d8) and two Rnf12+/- :Uba1+/- clones (clone 89: n= 226 d0; n= 232 d2; n=250 d4; n= 
206 d6 n=260 d8; clone 186: n= 266 d0; n= 264 d2;  n=208 d4; n=202 d6; n= 259 d8). E) Relative Xist 
expression normalized to β-actin at day 0,2,4,6 and 8 of  differentiation of  F121 (wildtype) Rnf12+/- cells and 
two Rnf12+/- :Uba1+/- clones. Error bars represent standard deviation (Comparison of   Rnf12+/- :Uba1+/- vs 
Rnf12+/- t test, * p<0.05, ** p<0.001). F) Relative Rex1 expression normalized to β-actin at day 0,2,4,6 and 
8 of  differentiation of  F121 (wildtype) Rnf12+/- cells and two Rnf12+/- :Uba1+/- clones. Error bars represent 
standard deviation (Comparison of   Rnf12+/- :Uba1+/- vs Rnf12+/- t test, * p<0.05, ** p<0.001). G)As in F but 
now for Nanog (G) and Oct4 (H).
 
RNF6 can target REX1 for proteasomal degradation  
The prominent role of  Rnf12 and Uba1 in XCI, highlights the importance of  the ubiquitin 
pathway in initiation of  XCI. Interestingly, Rnf6 is a close homologue of  Rnf12, and is expressed 
in ES cells. Although RNF6 is autosomally encoded, it might still contribute to the turnover of  
REX1 or other RNF12 target proteins in the activation of  XCI. To investigate this, we generated 
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2a Rnf6-EGFP fusion expression construct and tested whether REX1 could act as a substrate of  RNF6. Expression vectors encoding RNF6-EGFP and RNF12-EGFP were co-transfected with 
REX1-mCherry fusion proteins in HEK293 cells that do not endogenously express any of  these 
proteins. REX1-mCherry alone transfections revealed bright red cells, whereas co-transfection 
of  RNF12-EGFP with REX1-mCherry, only resulted in EGFP positive cells (Figure 3A). In 
contrast co-transfection of  RNF6-EGFP with REX1-mCherry resulted in EGFP positive cells 
that also showed dimmed expression of  mCherry (Figure 3A). This finding suggested that RNF6 
could also target REX1 for degradation, but also indicated that RNF12 was more efficient. To 
further analyze and support this observation, transfections were performed in HEK293 cells 
using combinations of  a tagged expression vector encoding V5-REX1 and expression vectors 
encoding untagged RNF12/RNF6. Nuclear extracts were isolated from cells that were either 
treated or not treated with the proteasome inhibitor MG132, followed by immuno-precipitation 
of  REX1 with anti-V5 agarose beads, and detection with anti-V5 and anti-ubiquitin to visualize 
poly-ubiquitinated REX1. We found that in the absence of  MG132 REX1 levels are reduced in 
the presence of  RNF12 and RNF6, although the effect is less pronounced for RNF6 (Figure 
3B, left bottom panels). Immunoprecipitation of  REX1 and detection with an anti-ubiquitin 
antibody also indicated poly-ubiquitinated REX1 in the presence of  RNF12 and RNF6, but 
confirmed that the activity of  RNF6 was less pronounced compared to RNF12 (Figure 3B, right 
panels). These results indicate that Rnf6 might be involved in XCI by lowering the threshold set 
by REX1. To test this hypothesis, we introduced extra copies of  Rnf6 in male 1.3 ES cells using 
BACs. Our previous studies have shown that introduction of  additional copies of Rnf12 resulted 
in ectopic XCI in transgenic male and female cells [6]. Also in our Rnf6 transgenic male cells 
ectopic Xist clouds were observed, which were never observed in male control cells (Figure 3C). 
Nevertheless, the percentage of  cells with Xist clouds was very low, with most clones showing 
between 1% and only one clone 2.4% of  cells with Xist clouds (Figure 3D). This percentage 
of  Xist clouds did not correlate with the copy number, and Xist qPCR analysis indicated no 
significant increase in Xist expression, reflecting that ectopic XCI was limited to a small number 
of  cells. 
 
Loss of  Rnf6 in female Rnf12+/- cells leads to further affected XCI  
Although the level of  Xist induction was very low in male Rnf6 transgenic ES cells, the presence 
of  a small number of  ectopic  Xist clouds and in vitro ubiquitination of  XCI inhibitor REX1 by 
RNF6, suggested a role for Rnf6 in XCI initiation. To test whether Rnf6 is indeed involved in 
XCI, we deleted Rnf6 from in Rnf12+/- cells using the CRISPR/Cas9 technology. Rnf6, located 
on chromosome 5, was deleted using two guides recognizing exon1 and exon5, resulting in 
an approximate deletion of  10kb (Figure 3E). We obtained one Rnf12+/-:Rnf6+/- clone with a 
heterozygous deletion of  Rnf6 and one Rnf12+/-:Rnf6-/- clone with a homozygous deletion of  
Rnf6  (Figure 3 F, G). To test the effect of  these deletions on XCI, wildtype, Rnf12+/-,  Rnf12+/-
:Rnf6+/- and Rnf12+/-:Rnf6-/- ES cells were differentiated up to 6 days, and analyzed by Xist-
RNA FISH to determine the percentage of  cells with Xist clouds. We foundreduced Xist cloud 
formation after 4 and 6 days of  differentiation (Figure 3H) and Xist qPCR analysis indicated that 
cells with a deletion of  Rnf6 displayed affected XCI. In addition, lower levels of  Xist expression 
did not recover after day 6 of  differentiation, as found for Rnf12+/- cells (Figure 3I). These results 
indicate that Rnf6 facilitates in activation of  Xist, likely through the degradation of  REX1 and 
possibly by affecting other targets in XCI. 
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Figure 3: A) Transient transfections of  (from top to bottom) REX1-mCherry, co-transfection of  RNF12-
EGFP with REX1-mCherry and co-transfection of  RNF6-EGFP with REX1-mCherry. From left to right, 
mCherry, EGFP, DAPI and a merge of  the different transfected cells. B) Immuno-detection (lower panel) 
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2and immunoprecipitation with nuclear protein extracts of  transfection of  combinations of  expression vectors V5-REX1, RNF12 and RNF6 (RNF12 antibody weakly detects RNF6 (74kD), RNF12 (66kD)). 
Cells were either not treated (left) or treated with MG132 (right). C) Xist RNA FISH on male 1.3 wildtype 
cells and three male clones with overexpression of  Rnf6. Wildtype cell show only pinpoints, whereas 
the three clones show ectopic Xist cloud formation in a small percentage of  cells. D) The three Rnf6 
transgenic clones of  (C) with corresponding percentage of  cells showing ectopic Xist cloud formation E) 
Representation of  Rnf6 deletion: guides and primers. F) PCR spanning the deleted region of  Rnf6 (left) 
and the wildtype Rnf6 (right) revealing a heterozygous clone (#50) and a knockout clone (#198) which 
is negative on both alleles for all PCR amplifications in the deleted region.  G) Digestion of  SNP PCR 
in figure 3F with EcoRV indicates the deletion of  clone #50 on the 129/Sv allele of  chromosome 5. H) 
Percentage of  cells showing Xist clouds. I) Relative Xist expression normalized to β-actin at day 0, day 2, 
day 4, day 6 and day 8 of  differentiation of  F121 (wildtype) Rnf12+/-, Rnf12+/-:Rnf6+/-, Rnf12+/-:Rnf6-/- cells. 
Error bars represent standard deviation (Comparison of  clones vs Rnf12+/- t test, * p<0.05, ** p<0.001). 
 
Discussion and conclusion  
In XCI, RNF12 targets REX1 for proteasomal degradation [8]. RNF12 is X-encoded, facilitating 
female specific Xist activation by dose dependent down regulationof  REX1, which acts as a 
repressor of  Xist. Mass spectrometry analysis identified five of  the 26 lysines within REX1 as targets 
for ubiquitination: K33, K129, K132, K213 and K215 respectively [8]. To determine whether 
these specific lysines were indispensable for degradation of  REX1, combinations of  lysines were 
mutated into arginines. In a study applying a similar approach, the specific lysines important for 
degradation of  p53 were determined [28]. For p53 it was found that C-terminal lysine residues 
were the main sites of  ubiquitin ligation and crucial for targeting p53 for proteasomal degradation. 
Mutating these sites to arginines resulted in a mutant p53 which was resistant to Mdm2 induced 
degradation and refractory to Mdm2-mediated ubiquitination [28]. This requirement of  specific 
lysines for proteasomal degradation was also apparent for NF-κB and IκBα [28]. For RNF12 
we found that only when most lysines were mutated this resulted in a reduction of  REX1 
ubiquitination, nevertheless ubiquitination still occurred, suggesting redundancy in targeted 
lysines in the degradation of  REX1. Redundant action in ubiquitination has also been reported 
before for other proteins [29-32] and would make the RNF12/REX1 pathway more robust.    
To further  investigate the role of  the ubiquitin pathway in XCI we studied the effects of  mutating 
the main ubiquitin activation enzyme Uba1 on XCI. Uba1 is located on the X chromosome 
and dose dependent break down of  REX1 might be further augmented by increased levels of  
UBA1 in female as compared to male cells. Our studies indeed showed a further reduction in 
XCI in differentiating Rnf12+/-:Uba1+/- ES cells when compared to Rnf12+/- cells. This effect was 
more prominent at later stages of  differentiation not affecting the percentage of  Xist clouds 
but impacting at the Xist expression level. This finding suggests that Uba1 facilitates robust 
expression of  Xist in a dose dependent manner, and demonstrates that Uba1 is an activator of  
XCI. Whether dose dependent levels of  UBA1 are important for the action of  RNF12 or other 
E3 ubiquitin ligases in XCI, requires further investigation. Similar to Rnf12, Uba1 is silenced 
upon XCI in mouse and the mouse Y homolog, UbaY, only has male-specific functions [27], 
providing an important feedback mechanism to block XCI of  all X chromosomes present [18].
Both Rnf12 and its close homologue Rnf6 are ubiquitously expressed during mouse embryogenesis 
[19]. To test whether these proteins had overlapping functions in XCI we performed co-
transfection studies in HEK293 cells. These experiments indicated that REX1 is a much better 
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2 target for RNF12 than RNF6 in proteasomal degradation, but also indicate that RNF6 is able to target REX1 for ubiquitination. Nevertheless, the impact of  RNF6 on the degradation of  REX1 
appears less prominent compared to RNF12, which might be related to differences in expression 
levels, target specificity and nuclear localization. RNF6 is mainly present in the cytoplasm 
whereas RNF12 is located to the nucleus. This seems to be determined by differences in NLS, 
showing most of  the sequence convergence between the two E3 ubiquitin ligases, showing only 
20% homology in this region [19]. Replacement of  these NLSs even resulted in nuclear RNF6 
and cytoplasmic RNF12 [19]. Although addition of  Rnf6 transgenes to male cells did show little 
effect with respect to Xist expression and XCI, knockout of  one or both copies of  Rnf6 in a 
heterozygous Rnf12 background had a clear impact on XCI.  In contrast to RNF12, RNF6 is not 
X-encoded, and is equally expressed in male and female cells, and hence cannot be considered an 
XCI activator. Interestingly, Rnf6 dosage appears not to affect XCI as we observed a similar XCI 
phenotype in heterozygous and knockout Rnf6 cells. Nevertheless, Rnf6 could stimulate the XCI 
process by lowering the threshold for XCI (in male and female cells) through degradation of  
REX1 and potential other targets. A similar mode of  action has been proposed for YY1, which 
competes for binding sites with REX1 to lower the threshold for Xist activation [33]. 
Taken together, these results identify UBA1 as a novel XCI activator, and RNF6 
as an Xist activator. We propose a model of  an activation cascade in which the E1 activating 
enzyme UBA1 together with RNF12 and RNF6 target REX1 and potential other targets for 
proteasomal degradation (Figure 4). Increased expression of  X-encoded Uba1, and Rnf12 in 
female cells facilitates female exclusive initiation of  XCI, and proper feedback once the inactive 
X chromosome is established (Figure 4). As XCI was not completely abolished in Rnf12+/-
:Uba1+/- cells our results also indicate that additional putative X-encoded XCI activators are 
present, most likely acting through otherpathways.
 
    
Figure 4: Model of  the activation cascade involving the E1 activating enzyme UBA1, which allows 
ubiquitination of  the target protein, REX1 and other potential targets, by  the E3 ubiquitin ligases RNF12 
and RNF6 resulting in proteasomal degradation of  REX1. Reduced levels of  REX1 relieve repression of 
Xist activating upregulation of Xist and initiation of  XCI. 
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Supplementary Figures
Supplementary Figure 1: A) The Rnf12 gene showing guide RNAs and PCR primers used. A heterozygous 
deletion of  Rnf12 results in skewing of  XCI towards the mutated allele.  B) Deletion of  Rnf12 in F121 (129/
Cas) female ES cells. Top left: PCR spanning the deletion (∆Rnf12). Top right: wildtype Rnf12 allele (Wt 
Rnf12). Bottom: Sequencing showing the deletion of  18.5 kb by CRISPR/Cas9 fusion of  Rnf12 exon1 
and Rnf12 intron 3 by NHEJ. C) PCR of  a region containing a SNP to determine targeted allele for the 
two clones; first clone deletion on the 129/Sv allele, second clone deletion on the Cast allele. D) Q-PCR 
analyzing Rnf12 expression in F121 (dark blue) and Rnf12+/- cells (deletion on the 129/Sv allele) (light blue) 
differentiated for 0, 2, 4, 6 and 8 days. E) qPCR analyzing Xist expression in F121 (dark green) and Rnf12+/- 
cells (deletion on the 129/Sv allele) (light green) differentiated for 0, 2, 4, 6 and 8 days (left) and an allele 
specific quantification of  Xist from the 129 (dark blue) and CAS (light blue) allele in F121 and Rnf12+/- cells 
(deletion on the 129/Sv allele). 
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2Supplementary Figure 2: Xist RNA FISH on day 4 and 6 differentiated wildtype, Rnf12+/- and Rnf12+/- 
:Uba1+/- cells. The right panel merge shows nuclei with Xist clouds (white arrows) and Xist/Tsix pinpoints 
(red arrows). 
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Supplementary Figure 3: Xist RNA FISH day 4 and 6 differentiated wildtype, Rnf12+/- and Rnf12+/- 
:Rnf6+/- cells. The right panel merge shows nuclei with Xist clouds (white arrows) and Xist/Tsix pinpoints 
(red arrows).
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Chapter 3
Xist and Tsix transcription dynamics is regu-
lated by the X-to-autosome ratio 
and
 semi-stable transcriptional states
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Abstract 
In female mammals, X chromosome inactivation (XCI) is a key process in the control of  gene 
dosage compensation between X-linked genes and autosomes. Xist and Tsix, two overlapping 
antisense transcribed noncoding genes, are central elements of  the X inactivation center (Xic) 
regulating XCI. Xist up-regulation results in coating of  the entire X chromosome by Xist RNA 
in cis, whereas Tsix transcription acts as a negative regulator of  Xist. Here, we generated Xist and 
Tsix reporter mouse embryonic stem (ES) cell lines, to study the genetic and dynamic regulation 
of  these genes upon differentiation. Our results revealed mutually antagonistic roles for Tsix on 
Xist  and vice versa, and indicate the presence of  semi-stable transcriptional states of  the Xic 
predicting the outcome of  XCI. These transcriptional states are instructed by the X to autosome 
ratio, directed by regulators of  XCI, and can be modulated by tissue culture conditions. 
 
Introduction  
Early during mammalian development one of  the two X chromosomes in female cells is 
transcriptionally inactivated. This X chromosome inactivation (XCI) process is initiated early 
during development, and is then clonally propagated through a near infinite number of  cell 
divisions. Two X-linked non-coding genes, Xist and Tsix play a key role in the regulation of  XCI 
in mouse. Xist expression is up-regulated on the future inactive X chromosome (Xi) (1, 2), and 
cis-spreading of  Xist leads to recruitment of  chromatin remodelling complexes that render the 
X inactive (3, 4). Tsix is transcribed anti-sense to Xist and fully overlaps with Xist (5). Tsix 
transcription and/or the produced Tsix RNA are involved in repression of  Xist which includes 
Tsix mediated chromatin changes at the Xist promoter (6-9).  
 Xist and Tsix are key components of  the Xic, the master switch locus that is regulated 
by XCI-activators and inhibitors of  XCI. XCI-activators either activate Xist and/or repress Tsix, 
whereas XCI-inhibitors are involved in repression  of  Xist and/or the activation of  Tsix. In 
recent years several XCI-inhibitors have been described, including the pluripotency factors 
NANOG, SOX2, OCT4, REX1, and PRDM14, which provide a direct link between cell 
differentiation and initiation of  XCI (10-13). These factors, and other ubiquitously expressed 
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3XCI-inhibitors including CTCF (14, 15), repress initiation of  XCI through binding to multiple 
gene regulatory elements of  Xist and Tsix. Genetic studies indicate that several of  these elements 
might fulfil redundant roles in the regulation of  XCI (16-18).   
 The X-linked gene Rnf12 encodes a potent XCI-activator, as overexpression of  Rnf12 
results in ectopic initiation of  XCI in differentiating transgenic embryonic stem cells (ESCs) 
(19). The encoded protein RNF12 is an E3 ubiquitin ligase, which targets the XCI-inhibitor 
REX1 for degradation (20). Degradation of  REX1 by RNF12 is dose dependent and two-fold 
expression of  RNF12 in female cells prior to XCI is important for female specific initiation of  
this process. ChIP-seq studies indicated REX1 binding in both Xist and Tsix regulatory regions. 
REX1 mediated repression of  Xist involves indirect mechanisms including activation of  Tsix, as 
well as direct regulation of  Xist by a competition mechanism, where REX1 and YY1 compete 
for shared binding sites in the F repeat region in Xist exon 1 (21).  
 Rnf12 knockout studies revealed a reduction of  XCI in differentiating female Rnf12+/- 
ES cells, and a near loss in XCI initiation in Rnf12-/- ES cells (16). However, remained initiation 
of  XCI in a subpopulation of  Rnf12+/- cells also indicates the presence of  additional XCI 
activators, as XCI is not initiated in male cells. This is supported by in vivo studies revealing that 
mice with a conditional deletion of  Rnf12 in the developing epiblast are born alive (22).  Jpx and 
Ftx have been described as putative XCI-activators (15, 23, 24). Both genes are located in a 
region 10-100kb distal to Xist, and knockout studies indicated that both genes are involved in 
Xist activation. Although transgene studies implicated Jpx as a trans-activator of  Xist, recent 
studies involving a knockout of  a region from Xite up to the Xpr region did not reveal a trans 
effect, suggesting that the predominant function of  Ftx and Jpx in XCI is the cis-activation of  
Xist (25).   
 Interestingly, examination of  the higher order chromatin structure revealed Xist and 
Tsix to be located in two distinct neighboring topological associated domains (TADs) (26, 27). 
Positive regulators of  Xist, including Jpx and Ftx are located in the same TAD. Similarly, the Tsix 
positive regulators Xite, Tsx and Linx are located in the Tsix TAD, suggesting that these two 
TADs represent the minimal X inactivation center covering all cis-regulatory elements, which are 
regulated by trans-acting XCI-activators and –inhibitors (27-29).  During development or ES cell 
differentiation the XCI-activator concentration in female cells will be two fold higher compared 
to male cells, which is sufficient to direct female exclusive initiation of  XCI. Stochastic initiation 
of  XCI and rapid feedback mechanisms, including the shutdown of  Tsix, Rnf12 and other XCI-
activators in cis, direct a highly efficient XCI process, facilitated by the requirement of  loss of  
pluripotency for initiation of  XCI (30).  
 The overlapping gene bodies of  Xist and Tsix and the mutually antagonistic roles of  
these two genes hamper clear insights in the regulatory mechanisms that govern Xist and Tsix 
transcription. To be able to study the independent pathways directing Xist and Tsix transcription 
we have generated Xist and Tsix reporter alleles, with fluorescent reporters replacing the first 
exon of  Xist and/or Tsix. Our studies indicate antagonistic roles for both Xist and Tsix, and 
show that RNF12 and REX1 regulate XCI through both repression of  Tsix and activation of  
Xist. Live cell imaging confirms a reciprocal correlation of  Xist and Tsix transcription, but also 
reveals that their regulation is not strictly concerted and rather stable in time. Interestingly, loss 
of  an X chromosome severely affects the dynamics of  both Xist and Tsix expression, and results 
in two different cell populations with semi-stable transcriptional states, absent in female ES cells. 
This indicates a regulatory role for the X:A ratio, regarding the nuclear concentration of  
X-encoded trans-acting factors. Similar semi-stable transcriptional states are observed  in female 
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3ES cells grown in medium supplemented with MEK and GSK3 inhibitors, displaying distinct 
XCI characteristics upon ES cell differentiation. Our findings suggest that XCI-activators are 
required to install a uniform transcriptional state of  the Xic that allows proper up-regulation of  
Xist upon ES cell differentiation.   
 
Results  
Antagonistic roles for Xist and Tsix  
X chromosome inactivation (XCI) is orchestrated by Xist and Tsix, two non-coding RNA genes 
with antagonistic roles. Xist is essential for XCI to occur in cis (31, 32), while Tsix  is a negative 
regulator of  XCI (6, 33). Analysis of  the regulation of  Xist and Tsix, and their relationship 
during the onset of  XCI is hampered by the architecture of  the locus. Tsix entirely overlaps with 
Xist, is transcribed in antisense direction, and manipulation of  one of  the two genes always 
affects the antisense partner. To be able to follow and manipulate the activity of  the Xist and Tsix 
promoters independently, we generated a series of  reporter lines in murine ES cells (Fig. 1a). 
Exploiting BAC-mediated homologous recombination in polymorphic female 129/Sv-Cast/Ei 
ES cells (34), exons 1 of  Xist and Tsix, located on the Cast/Eij X chromosome, were replaced 
with EGFP and mCherry coding sequences, respectively (Supplementary Fig. 1 and Supplementary 
Fig.2a-c). Expression of  the reporters was thus controlled by  the endogenous promoters of  
these two non-coding genes (Fig. 1b). Wild type female 129/Sv-Cast/Ei ES cells show preferential 
inactivation of  the 129/Sv X chromosome in 70% of  the cells, attributed to SNPs in regulatory 
elements that affect the regulation of  Xist and Tsix throughout the ESC differentiation process. 
We found that the alleles behaved as full Xist/Tsix knockouts, resulting in complete skewing of  
XCI, because splice donor sites at the 3’-end of  the targeted exons were removed and polyA 
signals downstream of  the reporters terminated transcription (Supplementary Fig. 1 and 
Supplementary Fig. 2a-c). By successive rounds of  targeting followed by cre-mediated removal 
of  selection markers three ES cell lines were obtained: i) Xist promoter-EGFP knock-in (Xist-
GFP) , ii) Tsix promoter-mCherry knock-in (Tsix-CHERRY) and iii) double knock-in on the 
same allele with Xist promoter-EGFP and Tsix promoter-mCherry (Xist-GFP/Tsix-CHERRY). 
Differentiation of  these lines and expression of  Xist and Tsix on the remaining wild-type 129/
Sv allele was unperturbed (Supplementary Fig. 3a). Xist-GFP/Tsix-CHERRY cells displayed 
similar kinetics of  Xist cloud formation as wild type cells, albeit with slightly reduced percentages 
as - probably due to stochastic initiation- expected from a full Xist knockout (Supplementary Fig. 
3b). FACS analysis of  EGFP and mCherry expression for all three ES cell lines showed faithful 
recapitulation of  the behaviour of  wild-type Xist and Tsix during the first days of  differentiation 
(Fig 2a), which was not delayed by a half-life for EGFP and mCherry  that ranged in the order 
of  11-14 hours (Supplementary Fig. 3c).   As expected, comparison of  Xist-GFP/Tsix-CHERRY 
ES cells, which allows independent tracking of   Xist/Tsix, with  Xist-GFP  ES cells shows EGFP 
de-repression in undifferentiated cells when Tsix is deleted in cis (Fig.2b). Comparison of  Xist-
GFP/Tsix-CHERRY with Tsix-CHERRY revealed delayed down-regulation of  the mCherry 
reporter in the double knockin cell line (Fig. 2c), indicating a role for Xist in silencing Tsix. The 
delay in mCherry down-regulation cannot be attributed to differences in mCherry expression/
Tsix promoter activity between the Xi (in Tsix-CHERRY line) and the Xa (in Xist-GFP/Tsix-
CHERRY line), suggesting that Tsix down-regulation on the future Xa is compromised upon ES 
cell differentiation in the absence of  Xist (Supplementary Fig.3a). To verify that this effect is not 
due to the deletion of  any DNA elements involved in the repression of  Tsix in Tsix-CHERRY, 
we performed  two-colour RNA FISH to distinguish between Xist and Tsix transcripts in 
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3differentiating ES cells. Three independent Xist deletion lines, Xist-GFP, Xist1lox and ptet-Xist, 
harbouring an insertion of  a doxycycline inducible promoter replacing the 
endogenous  Xist promoter ((35)  and A. Loda, unpublished), show persisting Tsix transcription 
from Xa compared to wild-type cells (Fig. 2d-e). Taken together, these results show that Xist and 
Tsix display antagonistic roles, directly influencing the expression level of  each other on the Xa 
during the early phases of  ES cell differentiation. It also highlights the need to investigate the 
dynamics of  their early genetic regulation on the uncoupled allele in Xist-GFP/Tsix-CHERRY.
 
 
 
Figure 1: Generation of  the reporter alleles.(a) Map of  the Xist/Tsix locus showing design 
of  the reporter cell lines. (b) Exemplary pictures of  undifferentiated and differentiated cells. 
 
Dynamics of  regulation of  the Xic by live cell imaging   
To further analyze the dynamics of  Xist and Tsix regulation, we performed live cell imaging 
of  differentiating Xist-GFP/Tsix-CHERRY cells for extended periods of  time by confocal 
microscopy (Fig. 3a). The integrated EGFP and mCherry fluorescence intensities (FI) of  
entire single cells were measured, resulting in semi-oscillating patterns due to accumulation of  
fluorescent reporters followed by dilution upon cell division (Fig. 3b).  For each cell cycle, the 
slope of  the linear regression of  integrated FI over time gives an estimate of  the activity of  the 
Xist and Tsix promoters. Binning cell cycles with low, medium and high increase in EGFP FI 
into groups and comparing the corresponding values for mCherry confirms a concerted anti-
correlated regulation independent of  antisense transcription, with EGFP being up-regulated 
before down-regulation of  mCherry (Fig. 3c). Next, we set a threshold for mean EGFP FI 
to estimate at which point EGFP FI rises above background noise. Low values for the slope 
of  mCherry before, and high values after Xist activation argue that, in spite of  concomitant 
anti-correlated  regulation, Xist and Tsix are independently and stochastically regulated 
(Supplementary Fig. 4a). 
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Figure 2: Xist and Tsix Reporter Lines Reveal Antagonistic Roles for Xist and Tsix. (a) Histograms 
of  EGFP (green) and mCherry (red) FI distribution as determined by FACS analysis. Days 0 through 
9 of  differentiation are depicted for Xist-GFP, Tsix-CHERRY and Xist-GFP/Tsix-CHERRY. (b and c) 
Histograms of  EGFP (b) and mCherry (c) FI distribution as determined by FACS analysis. Black outlines 
represent single knockin cell lines Xist-GFP undifferentiated (b) and Tsix-CHERRY at day four of  
differentiation (c). Solid colors represent FI distributions for Xist-GFP/Tsix-CHERRY. (d) Quantification 
of  two-color RNA FISH detecting Xist and Tsix transcripts at different time points of  differentiation. The 
proportion of  cells with an Xist cloud, identifying the Xi, and a Tsix pinpoint from the Xa, is shown. Dark 
blue bars represent wild type female ES cells, green bar Xist-GFP line and light blue bars two independent 
Xist deletion lines. Top right panel shows exon-intron structure of  Xist, grey bars indicate the deleted 
region of  the respective deletion line. Error bars indicate 95% confidence interval, n > 150 for all time 
points and cell lines, asterisks indicate P < 0.05 (*) or P < 0.1(**) by two-proportion z-test. (e) Xist/Tsix 
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3two-colour RNA-FISH of  wild type and Xist-GFP cells. Green probe detects Xist and Tsix, red probe 
detects only Tsix. 
Xi is identified by presence of  Xist cloud, Tsix transcription from Xa by presence of  separate two-color 
pinpoint in the same nucleus.         
 To unravel the relationship between activation of  Xist and Tsix and establishment of  
the Xi we introduced a mTagBFP2-Ezh2 fusion gene into Xist-GFP/Tsix-CHERRY ES cells 
(Supplementary Fig 4b-c). Since we were not able to continually follow high numbers of  cells 
until an Xi domain appeared, we instead scored cells at different time points of  differentiation 
(Fig. 3d). The results show that high GFP levels almost never concur with an EZH2/Xi domain. 
RNA FISH analysis on day 2 differentiated FACS sorted EGFP low, intermediate, high, and very 
high cells, however, demonstrated that both Xist promoters become activated and that EGFP 
up-regulation and XCI initiation correlate (Fig. 3e). At day 3 the EGFPhigh and EGFPveryhigh FACS 
sorted fractions of  cells contained less Xist clouds than the EGFPintermediate fraction. This suggests 
that EGFPhigh and EGFPveryhigh cells down-regulate EGFP before Xist clouds become detectable, 
but also indicates the presence of  a sub-population of  cells that strongly and consistently activate 
Xist-GFP without up-regulation of  Xist on the wild-type X chromosome.  
Live cell imaging also enabled us to follow single cells through mitosis and monitor the 
fate of  daughter cells through successive rounds of  cell division. Plotting the slope of  EGFP/
mCherry FI for each generation confirms the previously described anti-correlation of  Xist 
and Tsix activity for each given cell (Fig. 3f). Moreover, daughter cells display strikingly similar 
patterns of  Xist and Tsix promoter activities, indicating that they generally follow the same fate. 
This implies that switches of  Xist and Tsix activity occur rarely or slowly and that once a certain 
transcriptional state is established it is stably transmitted through cell division and relatively 
resistant to changes or reversal. Taken together, live cell imaging and fate mapping suggest 
that on an uncoupled allele, Xist and Tsix are antagonistically regulated in a developmentally 
concerted manner, even though up- and down-regulation of  both genes per se are independent 
and probably stochastic. 
   
 
Figure 3: Time-Lapse Imaging of  Live Cells. (a) Exemplary pictures of   Xist-GFP/Tsix-CHERRY 
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3cells (top panels) and Xist-GFP/Tsix-CHERRY+Ezh2-Flag cells (bottom panels) taken at different time 
points of  differentiation during time-lapse imaging. Scale bar is 5 µm. (b) Whole cell integrated FI values of  
EGFP (green) and mCherry (red) plotted over time for several exemplary cells during time-lapse imaging. 
(c) Linear regression of  FI over time for each cell cycle was performed. Slope of  linear regression as a 
proxy for promoter activity is plotted. Values for EGFP FI are binned into low (lowest tercile), medium 
(intermediate tercile) and high (highest tercile), and the corresponding values for mCherry are plotted right 
next to it. (d) Quantification of  presence of  mTagBFP2-Ezh2 focus/ Xi domain and/or high levels of  
EGFP at different time points of  differentiation in Xist-GFP/Tsix-CHERRY+ mTagBFP2-Ezh2 cells. 
Error bars indicate 95% confidence interval, n =162 for 48 hours, n = 215 for 60 hours and n = 277 for 72 
hours. (e) Day two and three differentiating Xist-GFP/Tsix-CHERRY cells were FACS-sorted into EGFP 
low, intermediate, high and very high fractions. Graphs show quantification of  Xist RNA FISH in these 
fractions. The number on top of  each fraction represents their relative abundance within the population 
before sorting. Error bars indicate 95% confidence interval, n > 250 for all time points and fractions. (f) 
Pedigree of  an exemplary cell followed through four cell divisions. In top panel, slope of  linear regression 
as described in (c) is shown for EGFP FI. In lower panel, slope of  linear regression is shown for mCherry. 
Same colored dots represent the same cell, thus values for EGFP in top panel and mCherry in lower panel. 
Arrows connecting dots indicate mother cell to daughter cell relationship. Asterisks in (d) and (e) indicate 
P < 0.05 (*) as calculated by chi-square test.
Effects of  activators and inhibitors on XCI  
RNF12 functions as a trans-activator of  XCI (19) by targeting REX1, a repressor of  XCI, for proteasomal 
degradation (20).  Previous work has indicated that REX1 might have a dual role in the activation 
of  XCI by activating Tsix and repressing Xist (12, 16, 20). To dissect  this XCI regulatory 
network and determine the role of  these factors  in the regulation of  Xist and Tsix in ES cell 
lines harboring  uncoupled Xist/Tsix alleles , we introduced Rnf12 and Rex1 transgenes into 
the three knock-in cell lines. Clones chosen for analysis consistently over-expressed Rnf12 
and Rex1 two- to three-fold as compared to wild-type cells (Supplementary Fig. 5a). FACS 
analysis  of  differentiating Xist-GFP/Tsix-CHERRY ES cells showed that Rnf12 and Rex1 
transgenes had a clear effect on the EGFP and mCherry reporters (Fig. 4a, b). REX1 strongly 
repressed the Xist and activated the Tsix promoter. Conversely, Rnf12 overexpression resulted 
in increased activation of  EGFP and reduced mCherry expression . This was also evident from 
quantitative analysis of  RNA levels by qPCR. In the Xist-GFP/Tsix-CHERRY line, both Xist 
and EGFP were up-regulated by an Rnf12 transgene and down-regulated by a Rex1 transgene, 
while the opposite effect was observed for Tsix and mCherry (Supplementary Fig. 5b). Since 
we monitored the uncoupled allele in a comparatively well-preserved genomic context, we can 
exclude any indirect effects due to interference from the corresponding antisense partner. In 
the presence of  the antisense partner, in the single knock-in Xist-GFP and Tsix-CHERRY 
lines, we observed that the effect of  Rnf12 and Rex1 overexpression was strongly attenuated 
(Supplementary Fig. 5b). This finding indicates that antisense transcription or the antisense 
transcript represses transcription of  the Xist  and Tsix promoter located on the opposite strand, 
and that a balanced allele might be necessary for proper integration of  regulatory signals. 
 The major difference between female cells that undergo XCI and male cells that do not 
is the X:A ratio. To better investigate the effects of  changes in this X:A ratio on Xist and Tsix 
expression,  we screened Xist-GFP/Tsix-CHERRY for subclones that had lost the wild-type 129 
X chromosome by using an X-linked RFLP (Supplementary Fig. 5c). These XO lines showed 
a stable karyotype (Supplementary Fig. 5d), but comparison of  these XO lines (XGTC-XO), 
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3with the XX Xist-GFP/Tsix-CHERRY double knock in ES cell line indicated that the dynamics 
of  both GFP and mCherry expression during ES cell differentiation was severely affected by 
loss of  the wild type X chromosome (Fig.4c top panel, and 4d). In addition, the XO cells are 
present in two distinct mCherry-high and mCherry-low populations. This bimodal mCherry 
distribution was also observed for the XY Tsix-CHERRY only knock-in cells (Fig. 4c, bottom 
panel), indicating that the dynamics of  these states is affected by the X:A ratio.
To test whether these effects are solely related to the Rnf12 copy number we generated 
three independent XX Xist-GFP/Tsix-CHERRY Rnf12+/- heterozygous knockout cell lines 
where Rnf12 was mutated on the 129/Sv allele (Supplementary Fig. 5e,g,h). Examination of  
these ES cell lines during differentiation, shows a severe reduction in upregulation of  the 
Xist-GFP reporter allele (Supplementary Fig. 5i). However, the two sub-populations found 
in undifferentiated XGTC-XO, and Tsix-Cherry only ES cells are absent in Xist-GFP/Tsix-
CHERRY Rnf12+/- cells (Fig. 4e), which show a similar FACS profile compared to Rex1 
transgenic Xist-GFP/Tsix-CHERRY cells.  A decrease in Rnf12 levels, therefore, does not 
explain the reduced mCherry expression level throughout ES cell differentiation observed in 
XGTC-XO ES cells. In addition, comparison of  Tsix RNA expression levels in male and female 
ES cell lines by qPCR analysis confirmed that lower levels of  Tsix RNA are present in male ES 
cells (Supplementary Fig. 5f). These findings indicate that more X-encoded factors are involved 
in the regulation of  XCI, and that the X:A ratio also directs the dose dependent activation of  
Tsix. 
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3Figure 4: Impact of  the RNF12-REX1 regulatory network on Xic regulation. (a) Contour plots of  
FACS analysis showing EGFP and mCherry FI at different time points of  differentiation for Xist-GFP/
Tsix-CHERRY (XX), Xist-GFP/Tsix-CHERRY+ Rex1 (+Rex1) and  Xist-GFP/Tsix-CHERRY+Rnf12 
(+Rnf12). For all experiments 100.000 cells were analyzed per time point. Starting from outermost contour, 
lines represent 7.5%, 22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events (logarithmic scale). (b) Same as 
in (a), but mean FI for EGFP and mCherry is plotted (linear scale). (c) Contour plots of  FACS analysis 
showing EGFP and mCherry FI at different time points of  differentiation for the XGTC-XO (top panels) 
and XY Tsix-CHERRY (bottom panels) lines. Starting from outermost contour, lines represent 7.5%, 
22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events logarithmic scale). (d) Same as in (c), but mean FI for 
EGFP and mCherry is plotted for the XGTC-XO line (linear scale). (e) Contour plots of  FACS analysis 
showing EGFP and mCherry FI in undifferentiated Xist-GFP/Tsix-CHERRY (XX) cells and for clones 2, 
3, 43 of  Xist-GFP/Tsix-CHERRY Rnf12+/- ES cell lines. Starting from outermost contour, lines represent 
7.5%, 22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events logarithmic scale).
Semi-stable transcriptional states of  the Xic predict outcome of  XCI  
The striking bimodal mCherry distribution of  XGTC-XO ES cells indicates that in similar 
proportions of  cells the Tsix promoter is either on or off. These two states switch, if  at all, 
very slowly. This is evident from the presence of  two distinct populations considering the half-
life of  mCherry, and the fact that recovery of  the mixed population of  mCherry positive and 
negative cells after FACS-sorting of  one of  the populations does not occur within two weeks 
(Fig. 5a). Moreover, seeding cells at a low density results in homogeneous colonies of  either 
mCherry negative or positive cells (Fig. 5b). Also differentiation of  sorted mCherry positive and 
negative XGTC-XO ES cells did not lead to an increase in switching between states (Fig. 5a). 
 Staining for the differentiation marker CD31 and alkaline phosphatase activity, specific 
for undifferentiated embryonic stem cells, did not reveal differences in cell differentiation 
between the different cell populations (Supplementary Fig. 6a). Also, bisulfite sequencing analysis 
of  the Tsix promoter did not reveal differences between the mCherry high and low populations 
(Supplementary Fig. 6b). To find the basis of  the difference between the two populations, RNA 
sequencing was performed on FACS-sorted mCherry positive and negative XGTC-XO cells. 
This analysis indicated that both populations have highly similar expression profiles (Pearson 
correlation coefficient (Pearson) r=0.9832; Supplementary Fig. 6c), and confirmed that expression 
of  the pluripotency factors was indifferent between the two cell populations (Pearson r=0.999). 
Interestingly, close examination of  expression levels of  genes located in the Xic indicated several 
genes for which the expression level correlated or anti-correlated with Tsix-promoter driven 
mCherry expression (Pearson r=0.83, Fig. 5c). These differences were most prominent for genes 
located within the Tsix TAD (Pearson r=0.34), and suggest that the on-off  switch of  the Tsix 
promoter is based on distinct epigenetic states and/or the spatial conformation of  the Xic. 
 Interestingly, in 2i+LIF conditions, that force ES cells to adopt a more naïve state, 
the two distinct XY Tsix-mCherry and XGTC-XO ES cell populations became uniform (Fig 
5d, and data not shown), suggesting that tissue culture conditions have a severe impact on 
the transcriptional states of  the Xic. Indeed, Xist qPCR analysis of  wild type 129/Sv-Cast/Eij 
female ES cells indicates that Xist is more repressed in 2i versus serum+LIF conditions, but that 
during ES cell differentiation up-regulation of  Xist, and skewing of  XCI are indifferent between 
the two culture conditions (Supplementary Fig. 6d-e). Nevertheless, the 2i+LIF conditions did 
impact on the transcriptional states of  the Xic in female Xist-GFP/Tsix-CHERRY cells now 
displaying two separable mCherry populations, absent in serum+LIF growth conditions (Fig. 
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36a). Again, after sorting mCherry low and high cells, recovery of  the mixed population of  cells 
did not occur in 2i+LIF or differentiation conditions in a time frame of  two weeks (Fig. 6a). 
Intriguingly, the mCherry low population activates the Xist promoter-driven EGFP reporter 
much more strongly than the mCherry high population (Fig. 6a). This suggests that the potential 
to initiate XCI is determined by the state of  the Xic already before differentiation. Xist RNA 
FISH performed on day 2 of  differentiation on these cells moreover indicates that the mutant 
and wild-type allele co-exist with a high probability in the same state, because cells from the 
mCherry low population showed higher percentages of  cloud formation  (Fig. 6b).  We also 
transferred the Xist-GFP/Tsix-CHERRY ES cells to serum+LIF to trigger a “primed” state 
(36).  After 14 days culturing in this serum+LIF condition mCherry levels stay mostly stable, 
and preferential up-regulation of  the Xist-GFP in the mCherry-medium cells is still observed 
(Fig. 6d). Similar to our findings with XGTC-XO ES cells, RNA sequencing of  undifferentiated 
mCherry-low and -high Xist-GFP/Tsix-CHERRY ES cells, revealed marked differences between 
the two cell populations, of  genes located within the Xist and Tsix TADs (Fig. 6e). Allele specific 
expression analysis of  Rnf12 showed increased Rnf12 expression in mCherry low cells but no 
preference for expression from the 129/Sv or Cast/Eij alleles, indicating that transcriptional 
states are synchronized between the wild type and reporter alleles (Fig. 6c). Stabilization of  
these transcriptional states might be accomplished by feedforward and feedback loops involving 
Rnf12 and Rex1. To test this we analysed wild type and Rex1 and Rnf12 transgenic Xist-GFP/
Tsix-CHERRY ES cells cultured in 2i+LIF. FACS analysis revealed that Rex1 over-expression 
forces cells to adopt the mCherry-high state whereas Rnf12 does the opposite, indicating that 
different transcriptional states are stabilized in trans by trans-acting factors (Fig. 6f,g). These 
findings argue that the on-off  switch of  the Tsix promoter is based on distinct epigenetic 
states and/or the spatial conformation of  the Xic and also explains the observed Xist promoter 
activation on both alleles in the mCherry low population by increased levels of  RNF12 (Fig. 
6b,c). Our findings highlight the presence of  differential epigenetic states, affected by extrinsic 
and intrinsic factors, capable of  providing  stable on-off  switches for genes involved in XCI. 
 
Figure 5: Two Stable States of  the Xic in XO cells. (a) Contour plots of  FACS analysis showing 
EGFP and mCherry FI for XGTC-XO line. Top panel depicts original population with bimodal mCherry 
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3distribution, underneath the sorted mCherry low and high populations (as indicated by red bounding box 
and arrows) are shown directly after the sort, 14 days after the sort and upon differentiation. Starting from 
outermost contour, lines represent 7.5%, 22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events. (b) XGTC-
XO ES cell clones after single cell plating. (c) Expression levels of  genes located in the Xic as determined 
by RNA sequencing of  XGTC-XO mCherry low and high populations. Top indicates location of  genes 
along the X chromosome, bars show log2(FPKM mCherry low/FPKM mCherry high). (d) Contour plots 
of  FACS analysis showing EGFP and mCherry FI for the XY Tsix-CHERRY ES line grown in serum+LIF 
(top panels, as shown in Fig. 4C) and 2i+LIF (bottom panels) conditions, prior to and at different timepoints 
after differentiation.
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Two Stable States of  the Xic Predict XCI Potential in XX cells. (a) Contour plots of  FACS 
analysis showing EGFP and mCherry FI for the Xist-GFP/Tsix-CHERRY ES cell line grown in 2i+LIF. 
Top panel depicts original population with bimodal mCherry distribution, underneath the sorted mCherry 
low and high populations (as indicated by red bounding box and arrows) are shown directly after the sort, 14 
days after the sort and upon differentiation. Starting from outermost contour, lines represent 7.5%, 22.5%, 
37.5%, 52.5%, 67.5%, 82.5% of  total events. (b) Quantification of  Xist RNA FISH in female Xist-GFP/
Tsix-CHERRY cellas at day two of  differentiation after sorting mCherry low and high populations. Error 
bars indicate 95% confidence interval, n=313 for mCherry low and n=305 for mCherry high populations. 
Asterisk indicates P < 0.05 by two-proportion z-test. (c) Allele specific RNA expression analysis by RNA 
sequencing. Shown is the FPKM value and allele specific expression ratio (129/Sv:green, Cast:shaded). 
(d) Contour plots of  2i+LIF mCherry high and low Xist-GFP/Tsix-CHERRY ES cell populations 14 
days after change from 2i+LIF to serum+LIF conditions (top panels), and two days later after start of  
differentiation. (e) Expression levels of  genes located in the Xic as determined by RNA sequencing of  
Xist-GFP/Tsix-CHERRY mCherry low and high populations. Top indicates location of  genes along 
the X chromosome, bars show log2(FPKM mCherry low/FPKM mCherry high). (f) Contour plots of  
FACS analysis showing EGFP and mCherry FI at different time points of  differentiation for Xist-GFP/
Tsix-CHERRY (XX), Xist-GFP/Tsix-CHERRY+ Rex1 (+Rex1) and  Xist-GFP/Tsix-CHERRY+Rnf12 
(+Rnf12) ES cells grown in 2i+LIF conditions. Starting from outermost contour, lines represent 7.5%, 
22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events. (g) Same as in (F), but mean FI for EGFP and 
mCherry is plotted. 
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Discussion  
In mouse Xist and Tsix represent the key cis-regulatory players in proper execution of  XCI. This 
sense-antisense transcribed gene couple fulfils antagonistic roles in the regulation of  XCI, with 
the action of  Tsix restricted locally as a negative regulator of  Xist, whereas Xist acts over large 
distances silencing genes along the X chromosome. Our study confirms the repressive role of  
Tsix on Xist expression, although this effect appears most pronounced in undifferentiated ES 
cells. Xist upregulation is often  interpreted to be the consequence of  mono-allelic Tsix 
downregulation (33, 37). Interestingly, our study indicates that Xist acts locally facilitating the 
shutdown of  Tsix, not only on the Xi but also on the future Xa, as we observed sustained Tsix 
expression comparing three different Xist knockout ES cell lines with wild type cells during ES 
cell differentiation. These findings indicate that Xist and Tsix are in a constant interplay, silencing 
of  Tsix involves Xist dependent and independent mechanisms. Although this effect is likely 
mediated through Xist RNA instructed local recruitment of  chromatin remodeling complexes, 
we cannot exclude a transcriptional interference mechanism to be involved. 
 Live cell imaging of  XX cells harboring Xist/Tsix fluorescent reporters indicated that 
also in the absence of  sense-antisense overlapping transcription expression of  Xist and Tsix is 
anti-correlated. Nevertheless, this anti-correlation is not strict, and we find Xist up-regulation 
prior to Tsix down-regulation and vice versa. This suggests a mechanism of  stochastic expression 
of  both genes, where initiation of  Xist expression is increased during differentiation until a level 
is reached which is sufficient to spread in cis, leading to Tsix silencing thereby providing a feed 
forward loop facilitating further Xist transcription initiation, accumulation and spreading. 
 The present live cell imaging studies indicate that regulation of  Xist and Tsix is rather 
stable in time and that Xist and Tsix expression in daughter cells preferably adopt the same fate. 
This might be related to Xic locus intrinsic factors or to stable expression profiles of  regulators 
of  XCI. The studies involving XGTC-XO reporter cells grown in serum+LIF conditions and 
XX Xist-GFP/Tsix-CHERRY reporter cells cultured in 2i supplemented medium indicate that 
genes located within the Xist and Tsix TADs adopt different transcriptional fates, favoring 
expression of  a subset of  genes. These distinct transcriptional fates might represent semi-stable 
states of  higher order chromatin structure that can be propagated through many cell divisions, 
and are different from reported X chromosome wide cohesion differences (38).  A recently 
developed polymer model predicted such different states of  higher order chromatin structure 
(39). These transcriptional states are maintained independent of  Tsix promoter methylation 
(Supplementary Fig. 6b), and are likely independent of  DNA methylation in general, which is 
nearly absent in 2i conditions (40). Switching between the different transcriptional states rarely 
occurs, but is more frequently observed upon ES cell differentiation, which might be related to 
the reported increased chromatin dynamics during the early stage of  ES cell differentiation (37), 
possibly provoked by changes in regulators of  the XCI process. In serum+LIF conditions no 
distinct sub-populations of  XX ES cells are observed suggesting that switching between states 
happens at a much higher frequency, with a shifted equilibrium constant or that all cells adopt 
one and the same transcriptional state. Increased mobility of  the Xic has also been reported 
during early ES cell differentiation and might reflect switching of  transcriptional states described 
in this study (37). This does not necessarily mean that different transcriptional states as 
represented by the Tsix-mCherry-low and -high subpopulations are intrinsically stable. Rather, 
we favour a scenario in which chromatin conformation is fluctuating but exists preferentially in 
one or the other conformation (Fig. 7a). Our differentiation studies indicate that this 
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3transcriptional state in XX ES cells under serum conditions responds more homogeneously to 
differentiation cues than ES cells grown in 2i conditions. Nevertheless, also in serum+LIF 
differentiated ES cells we observe cells that do not accumulate a PRC2 domain on the Xi, and 
continue to express the Xist-GFP reporter at high levels suggesting that these cells are locked in 
an epigenetic state that does not allow initiation of  XCI on the wild type X chromosome. The 
results obtained with the 2i cells indicate that these transcriptional states can even predict the 
responsiveness of  the Xic to XCI regulators prior to the initiation of  this process, and that many 
cells do not initiate XCI at all.  As Tsix-mCherry levels in  serum+LIF are equal to the Tsix-
mCherry high subpopulation in 2i conditions that is more refractory to XCI initiation, this 
indicates that different transcriptional states exist that cannot be fully separated by Tsix levels 
only.  
 Interestingly, the present RNA-FISH studies on sorted 2i populations indicate cross 
talk between the Xic’s with respect to this responsiveness, revealing significantly more cells 
initiating XCI on the wild type X in Tsix-mCherry low than high cells. This difference appears 
to be related to differences in the expression level of  activators and inhibitors of  XCI, coordinated 
with the transcriptional state of  the Xic. A switch to a transcriptional state with a higher Rnf12 
transcription level on one allele will result in increased RNF12 mediated turnover of  REX1 and 
Xist activation. In general, several pluripotency factors act as repressors of  Rnf12 (13, 42), and 
also reduced REX1 levels may therefore facilitate switching to a transcriptional state with higher 
Rnf12 expression on the second X chromosome, providing a feed forward loop fixing in the 
transcriptional state (Fig 7b,c). Our results might explain previous results obtained with 
differentiating ES cells grown in 2i conditions, showing a high number of  cells initiating XCI on 
both X chromosomes (43), and indicate that the 2i culture conditions are suboptimal for studying 
the XCI process.   
 The reporter lines generated for this study nicely recapitulate XCI. Nevertheless, RNA 
and protein stability, and differences in detection levels, clearly affect the our measurements. In 
our studies we removed exon 1 completely, as a previous attempt to generate a Xist-EGFP 
reporter allele failed because remaining Xist sequences prevented nuclear export of  the RNA 
(Sado et al Mol Cell 2005). Removal of  regulatory sequences and introduction of  the reporters 
themselves might therefore have impacted on the regulation of  Xist and Tsix. Previous work has 
implicated RNF12 in the regulation of  random XCI by activation of  Xist and repression of  Tsix. 
ChIP analysis indicated two prominent REX1 binding peaks in both the Xist and Tsix intragenic 
regulatory elements. REX1 mediated repression of  Xist involves competition of  REX1 and YY1 
binding for the same binding sites in the F-repeat region of  Xist, YY1 being an activator of  Xist 
expression (21). Despite the removal of  this F-repeat region from our reporter allele, we still find 
clear effects of  Rnf12 and Rex1 over-expression on Xist regulation, indicating a role for alternative 
binding sites, such as found in the Xist promoter, or indirect mechanisms to be instructive in Xist 
regulation. Our findings are supported by previous studies also showing an effect of  changes in 
Rnf12 expression on luciferase reporters linked to the minimal Xist promoter (16, 20). Although 
our results suggest a prominent role for the RNF12-REX1 axis in the regulation of  XCI, the 
effects on Xist and Tsix transcription where much more prominent in the absence of  overlapping 
transcription, indicating that activation of  XCI requires a very balanced cis- and trans-acting 
environment for proper regulation. In addition, the severely reduced dynamics of  Xist-GFP and 
Tsix-mCherry expression in XO reporter cell lines during ES cell differentiation, also indicates 
that more X-linked factors are involved in the regulation of  XCI. Interestingly, these factors also 
boost Tsix expression, which might be a requirement for proper execution of  a mutual exclusive 
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3XCI process, providing a stable binary switch. XCI-activators therefore seem to act at two 
different levels, first by bringing the Xic to a transcriptional state that allows proper execution of  
XCI, and second by providing sufficient Xist promoter activity through direct and indirect 
mechanisms.
 
 
Figure 7: Model for dynamics of  Xic transcriptional states (a) The Xic can adopt two distinct 
transcriptional states. State 1 is permissive whereas state 2 is refractive to Xist up-regulation upon 
differentiation. (b) In serum+LIF conditions female XX ES cells show rapid switching between 
different states, whereas in 2i+LIF conditions state switching dynamics is reduced leading two 
synchronization of  states. Rex and Rnf12 overexpression forces cells to adopt one single transcriptional 
state. (c) The relative quantity of  alleles adopting distinct combinations of  transcriptional states.  
 
Methods  
Plasmids and Antibodies  
Plasmids used for generation of  transgenic cell lines were pCAG-Rex1-Flag, pCAG-Rnf12-
Flag (20) and pCAG-mTagBFP2-Ezh2-Flag. The coding sequence of  mTagBFP2 was inserted 
N-terminally to the EZH2 coding sequence amplified from mouse cDNA and cloned into 
pCAG-Flag to give pCAG-mTagBFP2-Ezh2-Flag. Antibodies used were against Flag-M2 
(Sigma), REX1 (Abcam and Santa Cruz), RNF12 (Abnova), H3K27me3 (Diagenode) and 
CD31-FITC (BD Biosciences).
Cell Lines  
Standard ES cell culture conditions included serum+LIF, and both ES cell and  differentiation 
conditions have been described (Barakat et al., 2011a). 2i+LIF conditions were: DMEM 
supplemented with 100 U/ml penicillin/streptomycin, 20% KnockOut Serum Replacement 
(Gibco), 0.1mM NEAA, 0.1mM 2-mercaptoethanol, 5000 U/ml LIF, 1µM MEK inhibitor 
PD0325901 (Stemgent) and 3M GSK3 inhibitor CH99021 (Stemgent). Transgenic ES cell lines 
were generated using wild-type female line F1 2-1 (129/Sv-Cast/Ei) and wild-type male line 
J1 (129/Sv). The BAC targeting strategy was used as has been described (34). In short, the 
Xist knockin was created as follows: an EGFP/neomycin-resistance-cassette flanked by lox sites 
was targeted by homologous recombination in bacteria to a BAC (34). 5’and 3’targeting arms 
were amplified from a BAC using primers 1 + 2 and 5 + 6, respectively. With the modified 
BAC wild-type ES cells were targeted, and the resistance cassette was removed by transient Cre 
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3transfection, resulting in ES cell line Xist-GFP. A Xist ScrFI RFLP with primers 4 + 20 was 
used to screen drug-resistant clones for correct recombination events. The Tsix knockin was 
created as follows: a mCherry/neomycin-resistance-cassette flanked by lox sites was targeted 
by homologous recombination in bacteria to a BAC. 5’and 3’targeting arms were amplified 
from BAC using primers 25 + 27 and 29 + 30, respectively. With the modified BAC wild-type 
or Xist-GFP ES cells were targeted, and resistance cassettes were removed by transient Cre 
transfection, resulting in cell lines Tsix-CHERRY or Xist-GFP/Tsix-CHERRY, respectively. A 
Tsix PCR length polymorphism with primers 36 + 41 was used to screen drug-resistant clones 
for correct recombination events. Rex1, Rnf12 and mTagBFP2-Ezh2 transgenes were introduced 
by electroporation (Bio-Rad Gene Pulser Xcell) and subsequent puromycin selection. Over-
expression of  transgenes was verified by western blotting and qRT-PCR. The XGTC-XO ES cell 
line was generated by subcloning Xist-GFP/Tsix-CHERRY via single cell sorting on a FACSAria 
III platform. Single cell-derived subclones were screened for loss of  the wild type X chromosome 
by an Pf1MI RFLP located in the X-linked gene Atrx using primers 68 + 69.   
 
FACS Analysis and Cell Sorting  
Single cell suspensions were prepared by TE treatment for 7 minutes at 370C. Duplets were 
excluded by appropriate gating and dead/dying cells by Hoechst 33258 straining (1 µg/
ml, Molecular Probes). Relative fluorescence intensities were determined for EGFP and 
mCherry. Cell analysis was performed on LSRFortessa and cell sorting on FACSAria III 
(BD Biosciences) with FacsDiva software. Statistical Analysis was performed in FlowJo.  
 
Expression Analysis  
RNA was isolated using Trizol reagent (Invitrogen) using manufacturer’s instructions. DNAse 
I treatment was performed to remove genomic DNA, and cDNA was prepared using 
random hexamers and SuperScriptII (Invitrogen). Quantitative RT-PCR was performed on 
a CFX384 Real-Time PCR Detection System (Biorad) using Fast SYBR Green Master Mix 
(Applied Biosystems) and primers described in Table S1. Results were normalized to Actin, 
using the ∆CT method and mostly represented as fold-change versus day 0 of  differentiation. 
 
Live Cell Imaging and Image Analysis  
Cells were preplated to remove feeders and differentiation was initiated 12 hours prior to start of  
imaging.Cells were seeded at low density (104 cells/well) in a 6-well glass bottom dish (MatTek 
P06G-1.5-20-F) coated with human plasma fibronectin (Millipore). Imaging was performed on a 
Leica SP5 AOBS at 370C and 5% CO2 using adaptive focus control to keep cells in focus during 
the entire experiment. Pictures were taken every 20 minutes for a total of  68 hours. Tiled images 
were acquired and automatically stitched to record a large field of  view at sufficient resolution 
to resolve subcellular structures and follow cells over time. Average projection of  Z-stack was 
generated in Fiji (version 1.45b) and background corrected integrated fluorescence intensities 
for EGFP and mCherry were measured for single cells over the entire time frame that a given cell 
was clearly discriminable. Based on recorded values, linear regression by least squares method 
was performed to calculate the straight line that best fits the data. The slope of  this function 
with fluorescence intensity being dependent on time was used as a proxy for Xist or Tsix 
promoter activity. Threshold for Xist activation was calculated by using 3.29 standard deviations 
(corresponding to 99.9% within confidence interval) of  mean EGFP FI values measured in cells 
within the first six hours of  time-lapse experiment.
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3 Fluorescent In Situ Hybridization and Immunofluorescence  For Xist/Tsix RNA-FISH and immunofluorescence stainings cells were grown on or 
absorbed to poly-lysinated coverslips. For RNA-FISH, cells were fixed for 10 minutes with 4% 
paraformaldehyde (PFA)-PBS at room temperature, washed with 70% EtOH, permeabilized 
4 minutes with 0.2% pepsin at 37°C and post-fixed with 4% PFA-PBS for 5 minutes at room 
temperature. Coverslips were washed twice with PBS and dehydrated in a gradient of  70%, 90%, 
and 100% EtOH. Nick-labeled DNA probes (digoxigenin for Xist/Tsix probe, biotin for Tsix 
probe) were dissolved in hybridization mixture (50% formamide, 2XSSC (1XSSC: 0.15 M NaCl, 
0.015 M sodium citrate), 50 mM phosphate buffer (pH 7.0), 10% dextran sulfate) and 100 ng/
µl mouse Cot DNA to a final concentration of  1 ng/µl. Probe was denatured for 5 min, pre-
hybridized for 45 min at 37°C, and coverslips were incubated overnight in a humid chamber at 
37°C. After hybridization, coverslips were washed once in 2XSSC, three times in 50% formamide-
2X SSC, both at 37°C and twice in TST (0.1 M Tris, 0.15 M NaCl, 0.05% Tween 20) at room 
temperature. Blocking was done in BSA-TST for 30 minutes at room temperature. Detection 
was done by subsequent steps of  incubation with anti-digoxigenin (Boehringer) and two FITC-
labeled antibodies for Xist/Tsix RNA detection or anti-biotin (Roche) and two rhodamine-labeled 
antibodies for Tsix RNA detection in blocking buffer for 30 min at room temperature. Coverslips 
were washed twice with TST between detection steps and once finally with TS (0.1 M Tris, 0.15 M 
NaCl). Dehydrated coverslips were mounted with ProLong Gold Antifade with DAPI (Molecular 
Probes). For immunofluorescence, cells were fixed for 10 minutes at room temperature in 4% 
PFA-PBS followed by three washes in PBS and permeabilization in 0.25% Triton-X100-PBS. 
Blocking was done in blocking solution (0.5% BSA, 1% Tween20 in PBS) for 1 hour at room 
temperature. All antibody incubation steps were done for 1 hour at room temperature in blocking 
solution, followed by three washes in blocking solution. Primary antibodies were used at the 
following concentrations: anti-Flag-M2(1:1000), anti-H3K27me3 (1:500). Secondary antibodies 
used were conjugated to Alexa Fluor 488 or Alexa Fluor 546 (Molecular Probes; 1:500).  
 
RNA sequencing  
RNA samples were collected two days after FACS sorting different populations of  
undifferentiated ES cells, prepared with the Truseq RNA kit, sequenced according to 
the Illumina TruSeq v3 protocol on the HiSeq2000 with a single read 43 bp and 7bp 
index and mapped against the mouse mm10/GRCm38 reference genome using Tophat 
(version 2.0.10). Gene expression values were called using Cufflinks (version 2.1.1).  
 
Statistical Methods  
Confidence interval of  95% was calculated as:   to   ,  to with n for the number of  cells counted 
and p for the percentage of  Xist clouds scored. Standard deviation was calculated as: , with x 
for the sample mean and n for sample size. Linear regression was performed using the least 
squares method. Pearson product-moment correlation coefficient was calculated as: ,with x and 
y for values of  paired data. Single-factor analysis of  variance (ANOVA) using the F-distribution 
was used to test the null hypothesis that all of  three or more groups of  samples belong to 
populations with the same mean values. To test if  the observed frequencies for three or more 
groups are equal to the expected frequencies, the chi-square test of  independence was calculated 
by:  , with Oij being the observed and Eij the expected frequencies. The two-proportion z-test 
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3was calculated by: , with n for the number of  cells analyzed, and  and  corresponding to the 
proportion and average proportion, respectively.
Supplementary figures and table:  
 
 
Supplementary Figure 1. Targeting strategy. (a) Targeting scheme for generation of  Xist-GFP, Tsix-
CHERRY and Xist-GFP/Tsix-CHERRY murine ES cell lines. BAC name, location and relative size are 
indicated on top of  panel. Lower part of  panel depicts mCherry and EGFP (pmCherry-C1 and pEGFP-C1, 
both Clontech) targeting cassettes, exon-intron structure of  Tsix (grey) and Xist (black), and position 
of  genotyping (black arrowheads) and phenotyping (red arrowheads) primers. Primer numbers as in 
description in Supplementary Table 1. Polymorphisms used for screening of  correctly targeted clones are a 
length polymorphism (LP) in the DXPas34 region and an ScrFI restriction fragment length polymorphism 
(RFLP) in exon 1 of  Xist. (b) Precise location of  deleted Xist/Tsix sequences. Dots represent flanking 
sequences, dashes indicate location of  the deletion. The exact coordinates of  Mus musculus genome assembly 
GRCm38 are indicated for the last non-deleted bases.
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Supplementary Figure 2: Targeting of  Cell Lines. (a) Targeting of  EGFP to the Xist locus in female 
wild-type 129/Sv-Cast/Ei ES cell line. Left panel shows PCR amplification and ScrFI RFLP digest of  PCR 
product to identify clones with a correctly targeted Cast/Ei Xist allele. Correct targeting of  EGFP-cassette 
to Cast/Ei allele results in loss of  Cast/Ei-specific restriction products, as shown for clone 2. Arrows on 
left indicate size of  PCR product and size of  ScrFI restriction fragments. J1 is a 129/Sv control, F121 the 
polymorphic 129/Sv-Cast/Ei mother cell line. Center panel shows PCR amplification and Pf1MI digest 
of  an X-linked PCR product from the Atrx gene to verify presence of  two X chromosomes. Arrows on 
left indicate size of  PCR product and size of  Pf1MI restriction fragments. J1 is a 129/Sv control, F121 
the polymorphic 129/Sv-Cast/Ei mother cell line. For example, clones 16 and 35 had lost the Cast X 
chromosome. Right Panel shows PCR on cDNA over an Xist length polymorphism, demonstrating that in 
clone 2 only 129/Sv Xist is expressed upon differentiation (lower Cast band represents transcription read 
through only detectable in undifferentiated samples). Arrows on left indicate size of  129/Sv and Cast/Ei 
PCR products. (b) Targeting of  mCherry to the Tsix locus in female wild-type 129/Sv-Cast/Ei ES cell line. 
Left panel shows PCR amplification of  an Tsix length polymorphis on genomic DNA to identify clones 
with a correctly targeted Cast/Ei Tsix allele. Correct targeting of  mCherry-cassette to Cast/Ei allele results 
in loss of  Cast/Ei-specific band, as shown for clone 13. Arrows on left indicate size of  PCR product for 
129/Sv and Cast/Ei alleles. J1 is a 129/Sv control, 1239 is a Cast/Ei control and F121 is the polymorphic 
129/Sv-Cast/Ei mother cell line. Center panel shows PCR amplification and Pf1MI digest on Atrx as in 
(A). Right panel shows PCR on cDNA over an Xist length polymorphism, demonstrating that in clone 13 
Xist skewing is reversed and Xist is primarily expressed from Cas/Ei allele. (c) Targeting of  mCherry to the 
Tsix locus in Xist-GFP ES cell line. Left and center panel as in (b), showing correct targeting in clone 2∆23.
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3Supplementary Figure 3: Behavior of  Wild Type and Mutant Alleles of  Xist and Tsix. (a) Expression 
analysis of  Xist, Tsix, EGFP, mCherry expression levels at different time points of  differentiation by 
quantitative RT-PCR. Quantification is depicted as fold change as compared to undifferentiated cells. Of  
note, in wild type cells Xist and Tsix levels arise from both the future Xa and Xi; in Xist-GFP Xist arises from 
future Xi, Tsix from both future Xa and Xi and EGFP from future Xa; in Tsix-CHERRY Xist arises from 
both future Xa and Xi, Tsix from future Xa and mCherrry from future Xi; in Xist-GFP/Tsix-CHERRY 
Xist and Tsix arise from future Xi, while EGFP and mCherry arise from future Xa. Error bars represent 
SD of  two or three independent experiments. (b) Quantification of  Xist RNA FISH in differentiating wild 
type and Xist-GFP/Tsix-CHERRY cells. Error bars indicate 95% confidence interval, n = 100 for day 0, n 
= 350 for day 3 and 6, n = 150 for day 10. (c) Determination of  half-life of  EGFP and mCherry reporter 
proteins by cycloheximide chase and FACS analysis of  mean FI values for EGFP and mCherry. Xist-GFP 
and Tsix-CHERRY cells were treated with 100µg/ml cycloheximide (Sigma) to stop protein synthesis and 
decay of  fluorescent proteins was monitored over time. Values were fitted to a first order decay function to 
estimate the degradation rate constant k and half-life was calculated as: t1/2=ln(2)/k. Asterisks indicate P 
< 0.05 (*) or P < 0.1(**) by single-factor analysis of  variance (a) or two-proportion z-test (b).
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Supplementary Figure 4: Life cell imaging of  reporter lines. (a) Linear regression of  FI over time for 
each cell cycle was performed. Slope of  linear regression as a proxy for promoter activity is plotted. Bins 
are chosen according to time point of  Xist promoter activation. Threshold for Xist activation was set at 
3.29 SDs (corresponding to 99.9% within confidence interval) of  background mean EGFP FI measured 
within the first six hours of  time-lapse experiment. Bins as depicted in cartoon on top of  panel were 
chosen as follows: The exact cell cycle in which EGFP FI threshold is reached (exact), one cell cycle before 
or after threshold is reached (-1,+1) and all cell cycles before or after threshold is reached (all before, all 
after). (b) Immunofluorescence staining for H3K27me3 and Flag in Xist-GFP/Tsix-CHERRY line at day 
3 of  differentiation. White arrowheads indicate Xi domain as identified by H3K27me3 and Ezh2-Flag 
staining. (c) Quantification of  Xist-GFP/Tsix-CHERRY cells showing transient enrichment of  Ezh2-Flag 
on the Xi during differentiation determined by direct detection of  fluorescence. Two different transgenic 
clones are shown. Error bars indicate 95% confidence interval, n > 150 for all time points showing Xi 
domains, n=100 for all time points without Xi domains. Asterisks indicate P < 0.05 (*) or P < 0.1(**) by 
two-proportion z-test.
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3Supplementary Figure 5: Generation and analysis of  Rnf12 and Rex1 transgenic and mutant and 
XO ES cell lines. (a) Expression analysis of  Rnf12 and Rex1 at different time points of  differentiation by 
quantitative RT-PCR. Xist-GFP, Tsix-CHERRY and Xist-GFP/Tsix-CHERRY lines plus the corresponding 
Rnf12 and Rex1 transgenic lines are shown. Quantification is depicted as fold change as compared to 
undifferentiated cells without Rnf12 or Rex1 transgenes. Error bars represent SD of  two independent 
experiments. (b) Expression analysis of  Xist, Tsix, EGFP, mCherry expression levels at different time 
points of  differentiation by quantitative RT-PCR. Xist-GFP, Tsix-CHERRY and Xist-GFP/Tsix-CHERRY 
lines plus the corresponding Rnf12 and Rex1 transgenic lines are shown. Quantification is depicted as fold 
change as compared to undifferentiated cells without Rnf12 or Rex1 transgenes. Error bars represent SD 
of  two independent experiments, asterisks indicate P < 0.05 (*) or P < 0.1(**) by single-factor analysis of  
variance for RNF12/REX1 transgenic cell lines and their respective mother cell lines. (c) Screen to identify 
loss of  wild type X chromosome in subclones of  Xist-GFP/Tsix-CHERRY by utilizing an X-linked RFLP. 
PCR amplification and Pf1MI digest of  an X-linked PCR product from the Atrx gene is shown. Arrows 
on left indicate size of  PCR product and size of  Pf1MI restriction fragments. F121 is the polymorphic 
129/Sv-Cast/Ei mother cell line, Cast is pure Cast/Ei control. Four of  384 clones showed loss of  an X 
chromosome including clone 76 which lost the wild type 129/Sv X chromosome. (d) Karyotype analysis of  
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3XGTC-XO ES cells prior to FACS analysis. (e) Xist, Tsix and Rnf12 q-PCR expression analysis comparing 
day 3 differentiated control and three experimental Rnf12+/- ES cell lines. Asterisks indicate P < 0.05 (*) 
by Student’s t-Test. (f) Targeting of  Rnf12 in the Xist-GFP/Tsix-CHERRY ES cell line. Shown is PCR 
amplification of  an RFLP on genomic DNA to identify clones with a correctly targeted Rnf12 allele. 
Correct targeting results in loss of  the 129/Sv allele. Arrows on left indicate size of  PCR product for 129/
Sv and Cast/Ei alleles. Shown are  129/Sv-Cast/Ei (F1), 129/Sv (129) and Cast/Eij (cas) controls, and 
the starting Xist-GFP/Tsix-CHERRY (dki) and Rnf12+/- ES cell lines. (g) PCR amplification of  DXMit65 
length polymorphism on genomic DNA, to confirm presence of  two X chromosomes. (h) Contour plots 
of  FACS analysis showing EGFP and mCherry FI for the Xist-GFP/Tsix-CHERRY control and three 
Rnf12+/- ES cell lines at different time points of  differentiation. Starting from outermost contour, lines 
represent 7.5%, 22.5%, 37.5%, 52.5%, 67.5%, 82.5% of  total events. (i) Expression analysis of  Tsix at 
different time points of  differentiation by quantitative RT-PCR. Wild type female XX and male XY cell 
lines are shown. Quantification is depicted as fold change as compared to undifferentiated female cells.
  
Supplementary Figure 6: RNA expression analysis of  XGTC-XO, mCherry low and high 
subpopulations. (a) FACS analysis of  mCherry levels and pluripotency marker CD31 in XY Tsix-
CHERRY (XY) and XGTC-XO (XO). Percentage of  CD31+ cells is shown for mCherry low and high 
populations, indicating that there is no difference in pluripotent state between the mCherry low and 
high populations. (b) Bisulfite sequencing analysis of  the Tsix major promoter region in XO mCherry 
low and high populations (empty and filled circles depict unmethylated and methylated CpG sequences 
respectively). (c) RNA sequencing of  XGTC-XO mCherry low and high populations. FPKM values 
for all genes are plotted, red dots are pluripotency factors, blue dots genes located in the Xic. From 
top to bottom zoom in is depicted as indicated on axes. Pearson correlation coefficient r=0.9832. (d) 
Xist qPCR expression analysis at different time points during ES cell differentiation of  wild type 129/
Sv:Cast ES cells cultured in serum+LIF and 2i conditions. (e) Allele specific expression analysis of  Xist 
during ES cell differentiation indicates skewing of  Xist expression throughout the XCI process.   
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3Supplementary Table 1. Primers used in this study as listed in the Materials and Methods section.
# SEQUENCE DESCRIPTION
1 AGGTACCTCCCAAGGTATGGAGTCACC Forward primer 5’ targeting arm for Xist
2 TACCGGTAGGAGAGAAACCACGGAAGAA Reverse primer 5’ targeting arm for Xist
5 TAGTACTCAATGGCTTGACCCAGACTT Forward primer 3’ targeting arm for Xist
6 TAGTACTGTGCCAGAAGAGGGAGTCAG Reverse primer 3’ targeting arm for Xist;
Reverse primer ScrFI RFLP in Xist
20 GCTGGTTCGTCTATCTTGTGG Forward primer ScrFI RFLP in Xist
25 CTTTGGTCTCTGGGTTTCCA Forward primer 5’ targeting arm for Tsix
27 TACCGGTAGCTGGCTATCACGCTCTTC Reverse primer 5’ targeting arm for Tsix
29 GAGGGCAGATGCCTAAAGTG Forward primer 3’ targeting arm for Tsix
30 CGCAGGCATTTTACCTTCAT Reverse primer 3’ targeting arm for Tsix
36 AGTGCAGCGCTTGTGTCA Forward primer Tsix length polymorphism, 
for DNA
41 TATTACCCACGCCAGGCTTA Reverse primer Tsix length polymorphism, for 
DNA
68 TCCCCAATTA AAGGTGTTGA Forward primer Pf1MI RFLP in Atrx
69 AATTCACGTTCTCCTCTTTCACT Reverse primer Pf1MI RFLP in Atrx
106 AGGGCATCGACTTCAAGGAG Forward primer EGFP expression
107 CACCTTGATGCCGTTCTTCTG Reverse primer EGFP expression
108 CCCGTAATGCAGAAGAAGACC Forward primer mCherry expression
109 CTTCAGCCTCTGCTTGATCTC Reverse primer mCherry expression
137 GTGATGGAAGAAGAGCGTGA Forward primer Tsix expression 
138 GCTGCTTGGCAATCACTTTA Reverse primer Tsix expression
157 AACCCTAAGGCCAACCGTGAAAAG Forward primer Actb expression 
158 CATGGCTGGGGTGTTGAAGGTCTC Reverse primer Actb expression
159 GGATCCTGCTTGAACTACTGC Forward primer Xist expression 
160 CAGGCAATCCTT CTTCTTGAG Reverse primer Xist expression
1445 ACTGGGTCTTCAGCGTGA Forward primer Xist length polymorphism 
exon 6-7, for RNA
1446 GCAACAACGAATTAGACAACAC Reverse primer Xist length polymorphism 
exon 6-7, for RNA
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Chapter 4
Mega base deletion of  the X chromosome
Finding a needle in a haystack
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Abstract 
Inactivation of  one of  the two X chromosomes in female eutherian cells is necessary to 
compensate for the X-encoded genes between XX females and XY males. X chromosome 
inactivation (XCI) is a tightly regulated process orchestrated by inhibitors and activators of  XCI. 
XCI inhibitors set the threshold for XCI to occur whereas XCI activators, which are X-encoded, 
facilitate female specific initiation of  XCI. XCI inhibitors have been well described, whereas 
Rnf12 and Uba1 have been identified as X-encoded activators. Although Rnf12 and Uba1 are 
important for XCI, remained initiation of  XCI in Rnf12+/-:Uba1+/- female ES cells indicate that 
more factors are at play. Here we generated a 50Mb deletion of  the X chromosome, telomeric to 
Xist, pinpointing a region containing novel activator(s) of  XCI. 
Introduction  
X chromosome inactivation (XCI) is a mechanism equalizing gene dosage of  X-encoded 
genes between eutherian male and female cells by near complete silencing of  one of  the two 
X chromosomes in female somatic cells. Female specific initiation of  XCI is achieved by an 
interplay between activators and inhibitors of  XCI directing mono-allelic upregulation of  
the lncRNA Xist, when two X chromosomes are present in a diploid nucleus. XCI is a tightly 
regulated process ensuring one active X chromosome per diploid genome [1]. Xist spreads along 
the X chromosome in cis, recruiting different chromatin remodeling complexes to silence the X 
chromosome [2, 3]. XCI involves a plethora of  epigenetic changes, such as DNA methylation, 
to ensure inactivation of  the X chromosome and maintenance of  the inactive X (Xi) throughout 
cell divisions. Even though maintenance of  the Xi seems to be very stringent, some genes escape 
XCI.  Genes escaping XCI include genes in the pseudo-autosomal regions (PAR) and individual 
genes escaping XCI, some of  them with others without a Y homolog [4]. Genes in the PAR, the 
region homologous to the Y chromosome, and genes escaping XCI with a Y homolog are not 
differentially expressed between the sexes as males also have two copies of  genes located in this 
region.  In contrast, escapers without a functional Y homolog, most of  them evolutionary recently 
added genes, are differentially expressed between sexes, thus hindering absolute equalization of  
gene dosage between the sexes by a dosage compensation mechanism which developed much 
earlier in evolution of  the sex chromosomes [5]. 
 All factors regulating XCI are located in the X inactivation center (Xic), which can be 
further defined into a cis-Xic and trans-Xic [6]. The cis-Xic comprises all cis-regulatory elements 
in XCI affecting Xist expression directly or indirectly. These elements include Tsix [7-9] and 
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4Xite, which repress Xist, as well as Jpx, Ftx and Xpr, involved in activation of  Xist in cis [10-13]. 
The trans-Xic comprises several elements and genes located on the X chromosome and on 
autosomes acting in trans to direct XCI by establishing the X chromosome number. Autosomally 
encoded XCI inhibitors repress Xist by increasing the threshold for XCI initiation. Female specific 
initiation is triggered by X-encoded activators of  XCI, differentially expressed between male 
and female cells acting as dose dependent numerators. Several pluripotency factors, including 
PRDM14, SOX2, OCT4, NANOG and REX1 have been identified as XCI inhibitors, repressing 
XCI the early embryo and in embryonic stem cells (ESC), linking XCI to loss of  pluripotency 
[14-17]. As female ESC differentiate, loss of  this inhibitory activity and twofold expression of  
XCI activators leads to female exclusive XCI initiation. Xist RNA spreads and silences one of  the 
X chromosomes, consequently silencing the X-encoded activators in cis, resulting in a feedback 
mechanism preventing the remaining X chromosome from being inactivated.
 Two X-encoded XCI activators, Rnf12 [18-20] and Uba1 [Maduro 2016, Chapter 2], 
have been described. Rnf12 and Uba1 have been shown to be important for female specific XCI, 
and Rnf12+/-:Uba1+/- compound heterozygous female ES cells display even more affected XCI as 
compared to Rnf12+/- female ES cells. However, some residual Xist upregulation is still observed 
in Rnf12+/-:Uba1+/- ES cells, not observed in male cells [20]. This suggests that Rnf12 and Uba1 
are not the only X-encoded activators involved in determination of  the X chromosome number 
and initiation of  XCI. 
 The advances in CRISPR/Cas9 genome engineering has not only allowed the possibility 
of  generating small insertions/deletions, but also the ability to introduce mega base deletions/
insertions [21-23]. Here we set out to identify a candidate region containing X-encoded 
activator(s) by generating a large deletion using CRISPR/Cas9 technology and identify a 50Mb 
region telomeric to Xist involved in initiation of  XCI, indicating the presence of  at least one 
activator located in this region. 
Experimental procedures 
Plasmids  
The pSpCas9(BB)-2A-Puro vector (PX459) (Addgene plasmid # 48139) was used to insert 
the CRISPR guide RNAs [24].         
 
Cell lines  
Cell lines, culture media and culture conditions for ESC culture and differentiation were described 
previously [18, 25]. CRISPR vectors were introduced in hybrid female F1 (129/Cast) mouse embryonic 
stem cells by electroporation. Cells were electroporated in a 0.2cm electroporation cuvette (BioRad) 
at 118kV, 1200μF and ∞Ω in a Gene Pulser Xcell Electroporation System (BioRad). After 24 hours 
of  recovery, cells were grown on ES medium containing puromycin (1ug/ml) for 36 hours.   
Deletions with the CRISPR/Cas9 system  
CRISPR guides were designed by using the CRISPR design tool (http://crispr.mit.edu/). 
The designed CRISPR guide oligos with 5’- CACC and 3’- CAAA overhangs (Table1) were 
cloned into the pX459 CRISPR vector (Addgene) [24] by a simultaneous digestion-ligation 
reaction [26]. First, the pX459 vector was digested with BbsI (NEB) to allow the replacement 
of  the restriction sites with direct insertion of  the annealed oligo guides. Combinations of  
two guides (beginning and end) were used in each targeting and first screened as a pool to 
ensure the deletion to be present (Table 2), followed by single clone screens (Table 2 and 3). 
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4Xist RNA Fluorescent in situ hybridization  
Procedure, probe labelling and antibodies have been described previously [18, 25]. 
RNA isolation from ES cells and cDNA synthesis  
TRIzol® (Invitrogen) was added to each sample and RNA was isolated according to 
manufacturer’s instructions. RNA samples were diluted to contain 2μg RNA in 10μl. Before 
cDNA synthesis, DNase (Invitrogen) was added to the RNA samples, for 30 minutes at 370C, 
to remove any contaminating genomic DNA. DNase was inactivated at 650C for 10 minutes. 
Random Hexamers (Applied BioSystems) and dNTP mix (Invitrogen) were added and incubated 
at 650C for 5 minutes and subsequently cooled on ice for 1 minute. 5x First Strand Buffer, 0.1M 
DTT and RNaseOUT (Invitrogen) were then added to the samples and incubated at 250C for 2 
minutes before adding SuperscriptII Reverse transcriptase (Invitrogen). Samples were incubated 
at 250C for 10 minutes followed by 50 minutes at 420C and finally, 15 minutes at 700C. 
 
Table 1: Oligo’s for CRISPR guides for deletion of  C77370-Klf8.  5’- CACC and 3’- CAAA overhangs are indicated in 
bold and the preferred G as a starting nucleotide is underlined. 
Gene Guide oligo
C77370 Fw: 5’ CACCGTTATCTGGCCTAACAGTACC 3’
Rv: 5’ AAACGGTACTGTTAGGCCAGATAAC 3’
Klf8 Fw: 5’ CACCGTTGCAGGGGACTGTACCCCC 3’
Rv: 5’ AAACGGGGGTACAGTCCCCTGCAAC 3’
Table 2: Primers  for detection wildtype allele, deletion and allele check of  the deletion of  C77370-Klf8 and C77370-Klhl4
Wildtype allele 5’-3’ PCR over deletion 5’- 3’
∆C77370-Klf8 Fw: TTGTTTCCTTGGTCTTGCTG Fw: TTGTTTCCTTGGTCTTGCTG
Rv: GATCCGTCTGCCTCTTTCTC Rv: GGGGGAAAAGAGAGTGATGA
Table 3: DXMit primers 
Location on X 
chromosome (cM) Sequence 5’-3’
Size  
(bp)
DXMit55 3.31 Fw: CTGCTTCCAGAATATTATCACTACTCC Cast: 115
Rv: AAAACATCCATTTATGTTAACACACA 129: 141
DXMit75 30.84 Fw: ACCCTAGCCGGTTACTATCTCC Cast: 144
Rv: TCTCTCTCATTCCCCCCC 129: 104
DXMit44 38.38 Fw: TCTAAAAGCATGCCAAATTGG Cast: 230
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4Rv: TTCCTATCGCTCAGGTTTTTG 129: 184
DXMit65 47.86 Fw: ATATTAAGGGAGGTAACAAAGACCC Cast: 176
Rv: GGTTTCTGTGATTGCTATAGGACA 129: 144
DXMit197 68.46 Fw: TGTTCTATATTGCTTTGTTAGGTTTTG Cast: 160
Rv: GCAAAAAAGAAACCAACCCA 129: 122
DXMit121 73.95 Fw:  CCTTTAAACATTGTGATTAGTGATGG Cast: 104
Rv: CCTAATTTTGAACAGTATCAGTTTTCA 129: 150
DXMit184 78.70 Fw: GTCTGGATTTGGGTTCTAAATATTT Cast: 184
Rv: AAGCACATACACACATACGTTCTC 129: 150
Results  
Candidate region for XCI activators  
XCI is initiated in female cells when the concentration of  X-encoded activators is sufficient to 
overcome the threshold set by the XCI-inhibitors. The E3 ubiquitin ligase, Rnf12 [10, 18, 20], and 
the E1 activating enzyme, Uba1 [Maduro, Chapter 2], have been identified as important factors 
in activating XCI and female cells heterozygous for both genes display significantly affected 
XCI. However, slight upregulation of  Xist expression was still observed in Rnf12+/-:Uba1+/- cells, 
whereas male ES cells do not show this level of  Xist upregulation or the presence of  Xist clouds 
throughout differentiation. This observation suggests that there are other X-encoded activators 
involved in activation of  XCI that differentiate these cells from male cells. Previous candidate 
gene approaches to find X-linked activators of  XCI have proven laborious and precarious. We 
therefore decided to proceed with generating a large X chromosomal deletion of  a candidate 
region using CRISPR/Cas9 technology. 
 XCI evolved early in evolution of  mammalian sex chromosomes as a dosage 
compensation mechanism of  X encoded genes. Therefore, XCI activators are expected 
to be located within an X conserved region (XCR), orthologous to chicken chromosome 4, 
representing the ancient X chromosome [27]. In addition, proper negative feedback of  XCI 
activators is required to prevent both X chromosomes from being inactivated. Such a feedback 
mechanism would require XCI activators to be subject to XCI and silenced in early stages of  
XCI. Considering these points, a 50Mb candidate region telomeric to the cis-Xic locus was 
chosen as this region is part of  the XCR, is most conserved in gene content between human 
and mouse [28], contains regions with genes which are methylated at early stages of  XCI, and 
contains few escaping genes (Figure 1).   
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Figure 1: A) Comparison of  human (left) and mouse (right) X chromosomes. Blue = X conserved region 
(XCR) corresponding to regions on the mammalian X chromosome that are found on chicken orthologous 
autosome 4 and the marsupial X chromosome; white = X added region (XAR) corresponding to regions 
on the mammalian X chromosome found on chicken orthologous autosome 1 added after divergence of  
eutherians and marsupials.  The black dashed region (from AR to Col4a5) is conserved in gene content 
between human and mouse and only contains a 600kb inverted region around Xist (grey) [28].  The red 
region on mouse chromosome X depicts the 50Mb region studied herein (from C77370 to Klf8). Uba1, 
identified as an XCI activator (Chapter 2) is also depicted on the mouse X chromosome. B) Blocks of  
10Mb with number of  differentially methylated regions (2 kb flanking gene promoter), determined in cells 
at day 8 of  differentiation (the DMR blocks are not corrected for gene number).  C) XCI escape genes 
found in different studies in varying tissues ([29]=patski cells; [30]=NPCs; [31]=throphoblast cells; [32] = 
NPCs; [33]= neural stem cells; [34]= brain; [35]= brain; [36]= primary fibroblasts). 
 
A 50Mb deletion telomeric to Xist   
In order to determine whether the telomeric candidate region contained activators of  XCI, 
we generated a CRISPR/Cas9 mediated deletion of  this 50Mb region. The largest deletion 
reported so far was 30Mb, obtained with an efficiency of  ~1% [37], suggesting a strategy to 
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C77370 to Klf8, and used to target F1 hybrid Cast:129 Rnf12+Cast/-129 cells [described in Chapter 2] 
(Figure 2A). If  the deletion would encompass the most important factors involved in initiation 
of  XCI, this would result in abolished initiation of  XCI in these cells, mostly resembling male 
cells instead of  wildtype female cells with respect to Xist expression and Xist cloud formation 
upon differentiation. To ensure the designed CRISPR guides were recognizing the correct loci 
and ensure a 50Mb deletion was feasible, we first screened all targeted cells as a pool using PCR 
primers spanning the deleted region. The PCR across C77370 to Klf8, normally 50Mb apart, on 
the targeted pool showed correct targeting of  the guides, indicating fusion of  these loci by non-
homologous end joining (NHEJ) (Figure 2B). We therefore proceeded to pick 96 clones which 
were screened with the same primers flanking the deleted region (Figure 2B). We identified 1 
correct clone, containing the 50Mb deletion. The 50Mb deletion generated in the Rnf12+/- cells, 
now referred to as Rnf12+/-:Δ50Mb+/-, is heterozygous, and confirmed by sequencing (Figure 2B). 
Using DXMit marker primers along the X chromosome we could determine the targeted allele as 
well as the integrity of  the rest of  the X chromosome (Figure 2C) and the results clearly showed 
the presence of  only one allele in the deleted region whereas two alleles were detected for the 
remainder of  the X chromosome. The DXMit PCR products also showed that the deletion of  
C77370 to Klf8 is present on the Cast X chromosome, resulting in trans heterozygous Rnf12+/-
:Δ50Mb-/+ ES cells. Previous studies indicated that Rnf12+/- cells show preferential inactivation 
of  the mutated allele [10], which would lead to complete loss of  expression of  genes located in 
the deleted region which might be unfavorable for the cell resulting in selection towards skewing 
of  the Cast allele. However, as silencing is not expected to occur at the very early stages of  XCI 
we decided to analyze the combined effects of  these mutations on XCI initiation. 
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Figure 2: A) PCR of  the wildtype C77370 allele present in the wildtype, in the targeted clone 30 and 
in the targeted pool (top left figure). PCR analysis on the 50Mb deleted region present in the targeted 
clone 30 and in the targeted pool (top right figure). Bottom panel shows the sequenced PCR analysis 
on the deletion in clone 30. A) DXMit markers shown along the X chromosome (shaded red region 
represents the 50Mb deletion from C77370 to Klf8). DXMit65 and DXMit197 (red) are located inside 
the deletion. Wildtype 129/Sv:Cast/Eij ES cells reveal both 129/Sv (129) and Cast/Eij (cast) alleles 
for all DXMit markers tested, whereas for the Rnf12+/-:Δ50Mb-/+ cells only the 129 allele is detected 
inside the deleted region, indicating a targeted Cast allele and the presence of  two X chromosomes. 
Loss of  XCI in Rnf12+/-:Δ50Mb-/+ cells.  
To test the effect of  the 50Mb deletion on XCI, we performed Xist RNA FISH on day 4 and 8 
differentiated ES cells (Figure 3A, E-F). The results indicated severely affected XCI which was 
more affected than Rnf12+/- cells and did not recover after 8 days of  differentiation, as observed 
in Rnf12+/- cells. Loss of  XCI in  Rnf12+/-:50Mb-/+  cells was confirmed by Xist qPCR indicating 
severely reduced upregulation of  Xist expression (Figure 3B). Rnf12+/-:Δ50Mb-/+ cells showed 
very low Xist expression up to day 8 of  differentiation only reaching the level of  Xist expression 
obtained at day 2 of  differentiation of  wildtype cells. Previous work on Rnf12+/- cells indicated 
preferential skewing towards inactivation of  the mutated X chromosome, through failure to 
establish inactivation of  the wildtype X chromosome due to loss of  Rnf12 expression. In our 
trans-compound knockout ES cells, inactivation of  the X chromosome baring the deletion of  
Rnf12, as well as the X chromosome with the 50Mb deletion, will lead to dosage problems. 
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on our Rnf12+/-:Δ50Mb-/+ cells over 8 days of  differentiation as compared to wildtype cells and 
Rnf12+/- cells (Figure 3C). We find that skewing of  XCI in Rnf12+/- cells becomes eminent at 
day 6 of  differentiation and silencing also starts at this time point. In Rnf12+/-:Δ50Mb-/+ cells, 
Xist expression is reduced from both alleles prior to cell selection and can therefore only be 
attributed to an XCI initiation defect.
We also analyzed Tsix expression in wildtype female and male, Rnf12+/- and Rnf12+/-
:Δ50Mb-/+ cells and found that both Rnf12+/-:Δ50Mb-/+ and Rnf12+/- cells showed increased 
expression of  Tsix as compared to wildtype female and male cells (Figure 3D). To ensure the 
Rnf12+/-:Δ50Mb-/+ cells did differentiate properly, important for initiation of  XCI to occur, 
Oct4 (pluripotency marker) and Gata6 (endoderm marker) expression was determined by 
qPCR. This analysis indicated no reduction in Oct4 (Figure 3D) and but did show an increase 
in Gata6 expression (Figure 3D) throughout ES cell differentiation indicating that these cells 
did differentiate into endoderm. Tsix upregulation was not related to a potential block in ES 
cell differentiation, but is most likely the consequence of  loss of  one copy of  Rnf12, resulting 
in upregulation of  REX1, a known activator of  Tsix. Our findings therefore indicate that the 
deleted 50 Mb region covers genes or elements that play a crucial role in female specific initiation 
of  XCI. 
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Figure 3: A) Xist RNA FISH results depicting percentage of  cells with Xist clouds (dark blue) and 
Xist/Tsix pinpoints (light blue) at day 4 and day 8 of  differentiation in wildtype, Rnf12+/- and Rnf12+/-
:Δ50Mb-/+ cells. Rnf12+/-:Δ50Mb-/+ showed a reduced percentage of  cells with Xist clouds B) Relative Xist 
expression normalized to β-actin day 0, 2, 4, 6 and 8 of  differentiation in wildtype, Rnf12+/- and Rnf12+/-
:Δ50Mb-/+ cells (error bars indicate SEM and t-test is a comparison of  ∆50Mb cells to Rnf12+/- cells * p< 
0.05; ** p<0.0001). ∆50Mb  cells have significantly reduced Xist expression levels at day 6 and day 8 of  
differentiation.  C) Allele specific Xist RT-PCR (red = Cast; blue = 129) over 8 days of  differentiation in 
wildtype (Cast/129), Rnf12+/- and Rnf12+/-:Δ50Mb-/+ cells. D) QPCR analysis determining Tsix (left), Oct4 
(middle), and Gata6 (right) expression at different time points in differentiation for female cells (XX), 
male cells (XY), Rnf12+/- and the Rnf12+/-:Δ50Mb-/+ cells. E) Left: Xist RNA FISH on day 4 differnetiated 
wildtype, Rnf12+/- and Rnf12+/-:Δ50Mb-/+ cells (Xist= FITC; DNA=Dapi). Right panels show (Xist clouds= 
red arrows); Xist/Tsix pinpoints= white arrows). F) Xist RNA FISH on day 8 differentiated wildtype, 
Rnf12+/- and Rnf12+/-:Δ50Mb-/+ cells (Xist= FITC; DNA=Dapi). Right panels show (Xist clouds= red 
arrows); Xist/Tsix pinpoints= white arrows).
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Activators of  XCI play an important role in proper initiation of  XCI and mono-allelic 
upregulation of  Xist expression. Activators of  XCI need to be located on the X chromosome 
in order to be expressed at higher concentrations in female cells as compared to male cells 
allowing a female cell, but not a male cell, to overcome the threshold for XCI to occur. In 
addition, activators of  XCI have to be subject to XCI to prevent inactivation of  the second X 
chromosome once initiation on one X chromosome has started. So far, only Rnf12 and Uba1 
have been described as activators of  XCI, but the presence of  some remaining Xist expression 
and Xist cloud formation in differentiated heterozygous Rnf12+/:Uba1+/- ES cells indicates that 
other activators are involved in initiation of  XCI as well. Previous candidate gene approaches 
in an attempt to identify other activators of  XCI have proven laborious and although candidate 
genes are based on careful selection, activators of  XCI can still be falsely excluded. We have 
therefore deleted roughly one third of  the telomeric X chromosome as a starting point to be able 
to identify the region(s) on the X chromosome involved in activation of  XCI. The 50Mb deletion 
described here was generated in Rnf12+/- ES cells to detect additive effects of  the deletion on 
XCI. Analysis of  Rnf12+/-:Δ50Mb-/+ cells upon differentiation revealed a very low percentage of  
cells with Xist clouds and significantly reduced Xist expression, which did not recover after 8 
days of  differentiation. The very low levels of  Xist expression remaining and cloud formation 
in a low percentage of  cells, indicates the presence of  at least one more activator located outside 
the 50Mb region deleted in this study. As Uba1 is not included in the deletion, this residual Xist 
expression and Xist cloud formation might be forced by differential expression of  Uba1. In 
addition, the trans deletion of Rnf12 and 50Mb deletion might have impacted on the robustness 
of  XCI initiation and lack of  recovery. Previous studies examining Xist+/-:Rnf12+/- cis-compound 
knockout ES cells indicate that forced inactivation of  the remaining copy of  Rnf12 on the 
wildtype X chromosome, as might happen in our Rnf12+/-:Δ50Mb-/+ cells due to cell selection, 
leads to reduction of  Xist cloud formation [10]. This effect will likely be less pronounced as in 
our Rnf12+/-:Δ50Mb-/+ cells as it will be forced by loss of  expression of  genes in the deleted 
region and not Rnf12. In addition, we show that the Rnf12+/-:Δ50Mb-/+ cells show reduced Xist 
expression from both alleles prior to cell selection. Taken together, our results suggest that XCI 
is regulated by at least three XCI activators of  which one is located in the 50Mb deleted region 
of  C77370 to Klf8.
 We have narrowed down a region which must contain at least one activator of  XCI, 
however 50Mb is still a large region and contains 202 annotated genes. We analyzed each of  the 
202 genes for different characteristics such as their molecular function, biological processes they 
are involved in, cellular localization, pathways involved in, or escape of  XCI to obtain a list of  
candidate genes (Table 4). From this analysis, we obtained 7 candidate genes which are: subject 
to XCI, expressed in ES cells, are nuclear and silenced by DNA methylation in the early stages of  
XCI. The 7 genes which met all the requirements were: C77370, Bex4, Morf4l2, Trap1a, Nup62cl, 
Tsc22d3 and Nxt2 (Figure 4). C77370 is located closest to Rnf12 and the Xic (220kb) whereas the 
other 6 genes are located within 10Mb of  each other and about 30Mb away from the Xic (Figure 
4). Future targeted strategies removing individual genes in Rnf12+/- :Uba1+/- cells will need to be 
performed to establish a role in XCI next to other unbiased candidate strategies
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Figure 4: Selection of  candidate genes in the 50Mb deleted region. First, genes were selected which were 
subject to XCI. Of  these genes, genes were selected which were expressed in ESCs and were localized in 
the nucleus. And finally, we selected genes which were also silenced early in XCI as observed by DNA 
methylation. Seven genes met these criteria: C77370, Bex4, Morf4l2, Trap1a, Tsc22d3 and Nxt2. The location 
of  these genes relative to the Xic is depicted below. 
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Abstract 
In mouse, X-chromosome inactivation (XCI) can either be imprinted or random. Imprinted 
XCI (iXCI) is considered unstable and depending on Polycomb Repressive Complexes, whereas 
random XCI (rXCI) is classified as stable and depending on DNA methylation. Here we have 
systematically examined epigenetic modifications associated with the inactive X-chromosome 
(Xi) in Trophoblast Stem cells, eXtra-Embryonic Endoderm Cells, undifferentiated and 
differentiated Epiblast Stem Cells in order to understand intrinsic differences in epigenetic 
mechanisms involved in silencing of  the inactive X-chromosome in lineages presenting iXCI and 
rXCI. Whereas euchromatic histone modifications are predominantly lost from the Xi territory 
in all cell types, the accumulation of  heterochromatic modifications diverges in between the 
analysed cell lineages. Particularly, only the Xi of  multipotent Trophoblast (iXCI) and Epiblast 
stem cells (rXCI).display a visible accumulation of  Polycomb Repressive Complexes (PRCs), in 
contrast to the Xi in differentiated Epiblast Stem Cells and eXtra-embryonic Endoderm cells. 
Despite this, the histone modifications catalysed by PRCs; ubH2AK119 and H3K27me3, remain 
the best heterochromatic markers for the Xi in all assessed lineages. Heterochromatic chromatin 
modifications associated with the Xi are a reflection of  the epigenetic landscape of  the entire 
genome of  the assessed cell regardless whether XCI is imprinted or random. 
Introduction
Sex determination in mammals is determined by the presence of  the male sex determining 
gene SRY located on the Y-chromosome. Female mammals have two X-chromosomes, whereas 
males possess one X-chromosome and one Y-chromosome. This imbalance is compensated 
through inactivation of  one of  the two X-chromosomes in all female cells. The actual silencing 
of  the X chromosome in placental mammals is a highly dynamic and complex process. A crucial 
player in initiation of  silencing of  the X is the long non-coding RNA Xist [1, 2]. Xist RNA 
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recruits specific protein complexes, which trigger, a cascade of  epigenetic events resulting in 
the inactivation of  the Xist-expressing X-chromosome [3]. A widely used animal model to study 
X-inactivation (XCI) is the mouse. In the female mouse embryo, Xist starts to be expressed 
during early embryogenesis from the 2-cell stage onwards, leading to silencing in cis. This form 
of  XCI is referred as imprinted XCI (iXCI), as it exclusively leads to XCI of  the paternally 
derived X-chromosome. Whereas all developing extra-embryonic lineages maintain iXCI, 
lineages that will form the embryo proper characteristically erase iXCI and re-establish XCI in 
a random manner (rXCI) [4]. In vitro differentiation of  embryonic stem (ES) cells derived from 
the inner cell mass (ICM) has provided quite detailed information on the sequence of  epigenetic 
events assisting in the inactivation of  one of  the X-chromosomes in embryonic tissues [5-11]. In 
differentiating ES cells the first epigenetic event following the accumulation of  Xist is the loss of  
euchromatic marks such as methylation of  histone H3K4 and acetylation of  H3K9. Subsequently, 
characteristic repressive histone modifications like methylation of  H3K27, H3K9 and H4K20 and 
ubiquitination of  H2A can be detected on the Xi. XCI in extra-embryonic tissues is, in contrast 
to fully differentiated embryonic tissues, considered unstable [12-16]. In order to understand 
how and why XCI is stable or unstable and if  epigenetic events differ between rXCI and iXCI, 
a full characterization of  chromatin modifications in lineages of  differing origin is necessary. 
 In this study, we have systematically characterized histone modifications associated with 
the inactivated X-chromosome (Xi) in trophoblast stem (TS) cells, eXtra-embryonic Endoderm 
(XEN) cells, in vitro derived Epiblast Stem Cells (EpiLCs) and to mesoderm differentiated 
EpiLCsEpiLCs. The obtained data were completed with reported data of  chromatin modifications 
on the Xi in pre-implantation embryos (Table 1) and cell lineages directly derived from the 
pre- and early post-implantation embryo (Table 2). This study has generated a comprehensive 
overview of  the epigenetic landscape of  the Xi in different cell lineages presenting either iXCI 
or rXCI.
Table 1. Chromatin Marks associated with the Xi in pre-implantation embryos
Chromatin Marks Xi 4-cell 8-cell Morula Blastocyst
H3K27me3
Absent [17, 18] Present [17, 18] 
Absent [6]
Present [17, 18] 
Present [6]
H4K20me1
H3K9me2 Absent [17, 18] Absent [17, 18] Present [17, 18] 
ubH2A
PRC1
PRC2 Absent [17, 18]
Present [17, 18] 
Absent [6]
Present [17, 18] 
Present [6]
RNA 
Pol II exclusion Present [17, 18] Present [17, 18] Present [17, 18] Present [17, 18]
H3K4me2 
exclusion Absent [17, 18] Present [18]; Present [17, 18] Present [17, 18]
H3K9ac 
exclusion Absent [17, 18] Present [18] Present [17, 18] Present [17, 18]
H4ac 
exclusion Present [17, 18] Present [17, 18]
H4K16Ac 
exclusion
5
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Table 2. Chromatin Marks associated with the Xi cell lineages
Chromatin 
Marks Xi ES Differentiation MEF TS Cell
Trophoblast and 
differentiated 
TSC
XEN
H3K27me3 Transient [5-7] Absent [6] Present [5, 6, 19, 20]
Transient [5, 6]
Stable [14]
Present  [21]
Absent [19, 20]
H4K20me1 Transient [7] Present [19] Transient [14]
H3K9me2
Stable [7-10]
Absent
[7]
Stable [8]
Absent [7]
Minorly present 
[20] Minorly present [20]
ubH2A Transient [5] Present [5, 19] Transient [5]
Polycomb 
Repressive 
Complex 1
Transient [5] Present [5, 19] Transient [5]
Polycomb 
Repressive 
Complex 2
Transient [5-7] Absent [6] Present [5, 6, 19, 20, 22]
Transient (Ezh2 
and Eed1) 
[5, 6]
Stable (Eed1)
[14]
Absent [19, 20]
RNA 
Polymerase II 
exclusion
Stable [11]
Absent to 
partially present 
[14]
H3K4me2 
exclusion Stable [7-9] Present [8] Present [19, 20]
Minorly present 
[14] Present [20]
H3K9ac 
exclusion Stable [8, 9] Present [8] Present [20] Present [20]
H4ac exclusion Stable [8, 9, 23] Present [8] Present [19]
Absent to 
partially present 
[14]
H4K16Ac 
exclusion Stable [9] Absent [14]
H3Ac exclusion Present [19]
Results
Despite the wealth of  experiments, a complete and comprehensive overview of  all histone 
modifications associated with the Xi in cell types of  different embryonic lineages is lacking. 
We therefore generated TS, XEN, and ES cells from pre-implantation embryos with the same 
genomic back ground, and differentiated the ES cell lines into EpiLCsEpiLCs, that were further 
differentiated towards the mesodermal lineage using WNT3 and BMP4 ligands. For our studies 
we examined Xi and Xist associated histone modifications in TS and XEN cell lines, and in 
undifferentiated and differentiated EpiLCs with an embryonic origin. The obtained results were 
compared to available data in the literature (reviewed in Table 1 and 2).
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5Loss of  euchromatic marks on the Xi
Previous studies indicate that the first epigenetic changes observed on the Xist coated X are 
related to loss of  histone modifications, H3K4me2, H3K9ac, H4ac, H4K16ac and RNA 
polymerase II, all associated with active chromatin. To test whether these markers were depleted 
throughout our panel of  cell lines we performed RNA FISH for Xist RNA in combination with 
immunohistochemistry for these histone modifications on TS (Fig S1A), XEN cells (Fig S2A), 
EpiLCs (Fig  S3A) and differentiated EpiLCs (Fig S4A). To quantify the results, 53 to 354 cells 
were counted and the percentage of  cells displaying Xist clouds with and without co-localization 
of  lost euchromatic marks was determined (Fig 1 and 2). Although the detection varied per 
cell type, loss of  euchromatic marks is a feature that is present in a high percentage of  cells in 
all lineages, indicating that the loss of  euchromatic marks is detected in lineages that are both 
independent (differentiated EpiLCs) and fully dependent on Xist expression (TS and XEN) for 
maintenance of  XCI (Fig 3).
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Figure 1. Immuno-RNA FISH detecting H3K9Ac (Rhodamine red) and Xist (FITC) on TS cells, XEN 
cells, EpiLCs and differentiated EpiLCs (DAPI is DNA). 
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5Figure 2. Percentage of  cells accumulating either Xist alone or  showing Xist together with exclusion of  the 
euchomatic marks H3K4me2, H3K9ac, H4ac, H4K16ac, and RNAPolII. Statistical significance (p<0,05) 
shown in the Figure and tested via z-test for proportion independent groups.
Polycomb repressive complexes  
Silencing of  the X chromosome is thought to proceed via the recruitment of  polycomb 
repressive complexes (PRC) 1 and 2. While each complex consists of  several proteins, for our 
studies only RNF2/RING1B has been assessed from the PRC1 complex, and JARID2, EZH2 
and EED were evaluated as representative of  the PRC2 complex, using the same panel of  TS, 
XEN, EpiLC and differentiated EpiLC lines. RNA-immuno FISH was performed detecting 
Xist in combination with one of  the PRC complex members. The number of  cells counted 
per staining is displayed in Fig 4. As previously reported [5, 6, 19, 20], TS cell lines distinctly 
displayed accumulation of  PRC2 on the Xi (Fig S4A and S4B). Whereas PRC2 associated 
proteins to some extent also clearly accumulated on the Xi in undifferentiated EpiLCs, Xi 
associated accumulation of  JARID2, EZH2 and SUZI12 was not detected in XEN cells or in 
differentiated EpiLCs (Fig 5A, 5B, S1B, S2B, S3B and S4B). JARID2 did show accumulation in 
XEN cells, but the accumulation was not associated with Xist. PRC2 catalyses trimethylation 
of  lysine 27 on histone H3 (H3K27me3). Immuno-RNA-FISH analysis detecting H3K27me3 
and Xist confirms that accumulation of  this modification is present at the Xi in all cell types 
and indicates that even when the catalysing complex is below the detection limit, as found in 
XEN and differentiated EpiLC cells, its downstream modification is maintained (Fig 5A and 
5B). Nevertheless, the percentage of  XEN cells and differentiated EpiLC cells with Xist clouds 
together with H3K27me3 accumulation is reduced compared to the other cell lines (Fig 4). 
The percentage of  cells displaying an accumulation of  H3K27me3 in differentiated EpiLCs 
was much higher when only immunostaining was performed. This was observed in all cell 
types studied and must be related to the more stringent conditions used for Xist RNA-FISH. 
 RING1B-Xist immuno-RNA FISH indicated clear Xi associated accumulation of  
RING1B in TS but not XEN cells, whereas this analysis failed for EpiLCs and differentiated 
EpiLCs. For XEN cells, EpiLCs and differentiated EpiLCs we therefore performed double 
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immunohistochemistry of  RING1B and ubH2AK119, as ubH2AK119 as the catalytic product 
of  this enzyme is the best marker for the Xi in XEN, EpiLC and differentiated EpiLC (see data 
below). This approach indicated that there was no clear accumulation of  RING1B on the Xi in 
XEN cells, EpiLCs and differentiated EpiLCs; although sporadically an accumulation could be 
observed (Fig 6). UbH2AK119, however, could be observed in all analysed cell lineages (Fig 4, 6), 
again indicating that the detection of  Xi associated enzyme complexes is not a requirement for 
the maintained presence of  a corresponding chromatin modification. Similarly to H3K27me3, 
an immunostaining of  ubH2AK119 in differentiated EpiLCs detected a higher percentage of  
cells presenting the modification.
Figure 3.Percentage of  Xist positive cells showing exclusion of  euchromatic modifications at the Xi.
Figure 4. Percentage of  cells accumulating either Xist alone or Xist together with accumulated members 
of  the PRC1 and 2 complexes and their catalysed modifications ubH2AK119 and H3K27me3. Statistical 
significance (p<0,05) shown in the Figure and tested via z-test for proportion independent groups.
Accumulation of  other heterochromatic markers 
H3K9me2 and H4K20me1 are both histone modifications associated with the Xi but not as well 
characterized as H3K27me3 and ubH2AK119. Several lysine 9 histone H3 methyltransferases, 
euchromatic and heterochromatic, have been characterized but it is unclear which enzyme 
catalyzes this modification on the Xi. We found that H3K9me2 accumulation, associating with 
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5Xist clouds, could only be observed in XEN and TS cells, but was not as abundant as H3K27me3 
and ubH2AK119 (Fig 7A, 8, 9). Immuno-RNA FISH indicates that H4K20me1, likely catalysed 
by SET8/PR-Set7 [24, 25], is a better marker for the Xi than H3K9me2, and also accumulates to 
a minor extent in EpiLCs (Fig 7B, 8 and 9). In conclusion, we found that accumulation of  PRC1 
and PRC2 is very variable on the Xi, but that the modifications, ubH2A119 and H3K27me3, 
catalysed by these complexes are better Xi associated chromatin markers compared to H3K9me2 
and H4K20me1. 
Figure 5A. Immuno-RNA FISH detecting EZH2 or H3K27me3 (Rhodamine red) together with Xist 
(FITC) on TS cells and XEN cells (DAPI is DNA). 
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Figure 5B. Immuno-RNA FISH detecting EZH2 or H3K27me3 (Rhodamine red) together with Xist 
(FITC) on TS EpiLCs and differentiated EpiLCs (DAPI is DNA). 
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5Figure 6. Immuno-RNA FISH detecting ubH2AK119 (Rhodamine red) together with RING1B or Xist 
(FITC) on TS cells, XEN cells, EpiLCs and differentiated EpiLCs (DAPI is DNA). 
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Figure 7A. Immuno-RNA FISH detecting H3K9me2 (Rhodamine red) together with Xist (FITC) on TS 
cells, XEN cells, EpiLCs and differentiated EpiLCs (DAPI is DNA). 
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5Figure 7B. Immuno-RNA FISH detecting H4K20me1 (Rhodamine red) together with Xist (FITC) on TS 
cells, XEN cells, EpiLCs and differentiated EpiLCs (DAPI is DNA).
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Figure 8. Percentage of  cells accumulating either Xist alone or Xist together with accumulated histone 
modifications H4K20me1 and H3K9me2. Statistical significance (p<0,05) shown in the Figure and tested 
via z-test for proportion independent groups.
Figure 9. Percentage cells accumulating Xi associated heterochromatic modifications in Xist expressing 
cells.
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5Discussion
Random and imprinted XCI are respectively depicted as stable and unstable. Since silencing 
of  the X-chromosome relies on histone modifications, we tried to understand whether the 
stability of  XCI could be simply conveyed to the presence or absence of  histone modifications 
associated with the Xi. To address this question, reported chromatin modifications (Table 1 
and 2) associated with the Xi were assessed in all early cell lineages presenting either iXCI or 
rXCI. XEN and TS cells representing cell lineages with iXCI, whereas undifferentiated and 
differentiated EpiLC portrayed lineages with rXCI. This is the first study that provides a 
comprehensive overview of  such a wide range of  chromatin modifications associated with the 
Xi in different embryonic and extra-embryonic cell types with the same genetic background. 
 Upon ES cell differentiation, among the first epigenetic changes detectable after Xist 
accumulation are the loss of  euchromatic features including RNA polymerase II, H3K9Ac, 
H4Ac, H4K16Ac. Our study indicates that this loss of  euchromatic marks is a general 
characteristic of  the Xi in a large percentage of  cells in all lineages examined, and is central 
to the iXCI and rXCI processes. Recently, SPEN family members and co-factors have been 
identified as interactors of  Xist. SPEN mediated recruitment of  HDAC3 has been implicated 
in triggering histone deacetylation in differentiated ES cells [26-30]. Whether iXCI also 
involves SPEN mediated recruitment of  HDAC3, and if  H3K4 demethylases are actively 
recruited to the Xi to trigger the loss of  RNA polymerase II needs further investigation [31]. 
 The loss of  active histone marks observed during ES cell differentiation is soon followed 
by the accumulation of  histone modifications associated with facultative heterochromatin. In 
contrast to the absence of  euchromatic marks we found that these heterochromatic features 
associated with the Xi were very heterogenic (Fig.10). Although H3K27me3 could be detected 
in all cell types, the PRC2 subunits EZH2, SUZ12 and JARID2, catalysing this modification, 
were only present on the Xi in both TS cells and EpiLCs. Similarly, ubH2AK119 accumulation 
associated with the Xi, could be detected in all cell types, despite the absence of  Xi associated 
RING1B in XEN cells and undifferentiated and differentiated EpiLCs. The failure to detect 
PRC members in some tissues in spite of  the presence of  their catalysed histone modifications 
does not exclude accumulation of  the PRC complexes, which may be present under the 
technical detection level, or the tested proteins may be substituted with other paralogs such 
as EZH1 [32] and RING1A [33]. The results, however, imply that a visible accumulation 
of  PRC complexes on the Xi are merely an extrapolation of  the plasticity of  the genome 
of  EpiLCs (rXCI) and TS cells (iXCI) rather than whether XCI is random or imprinted. 
 XCI in extra-embryonic tissues is classified as unstable in contrast to XCI in embryonic 
lineages. This is highlighted by the fact that forced expression of  Tsix, a negative regulator of  Xist 
and leading to Xist downregulation, results in reactivation of  the Xi in extra-embryonic tissues 
[34]. Interestingly, also EpiLCs still have the capacity to initiate rXCI upon differentiation [35], a 
feature that is lost upon differentiation of  this cell type, highlighting the plasticity of  this cell type 
with respect to XCI. The presence of  such a meta-stable state of  XCI in these three cell types 
might be attributed to reduced levels of  CpG methylation. In trophoblast and XEN cells CpG 
methylation is reported to be very low in comparison to embryonic tissues [36, 37]. Interestingly, 
despite high expression levels of  Dnmts [36], the DNA methylation level of  CpG islands on 
the X-chromosome in female EpiLCs is also very low [36], and CpG islands only become 
methylated upon EpiLC differentiation (R.G. Boers, and J Gribnau personal communication). 
Therefore, the strong accumulation of  H3K27me3, and possibly H4K20me1, and ubH2AK119 
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therefore might antagonize or precede the accumulation of  DNA CpG methylation, reminiscent 
of  findings showing a switch in the transcriptional control of  repressed promoters via from 
H3K27me3 to DNA methylation during ES cell differentiation and carcinogenesis [38-40]. 
This study describes many undocumented chromatin modifications on the Xi in XEN cells, 
in vitro derived EpiLCs and differentiated EpiLCs. Most of  our findings fit very well with 
documented observations, although we also found some noticeable exceptions. For instance, the 
stable association of  H3K27me3 on the Xi in XEN cells contrasts previous findings [19, 20]. 
Also, the failure to demonstrate a strong accumulation of  H3K9me2 on the Xi in EpiLCs and 
differentiated EpiLCs is in conflict with earlier described studies in embryonic lineages [7-10]. 
This discrepancy might be explained through differences in detection efficiency, but could also 
be related to differences in cell types that have been used. 
Figure 10. Comprehensive overview of  accumulation of  RING1B, EZH2, SUZI12, JARID2, H4K20me1, 
H3K9me2, H3K27me3 and ubH2AK119 (positive if  found in more than 10% of  the cells).
Conclusion  
In conclusion, what governs stability of  XCI cannot be simply determined by the assessment 
of  the presence or absence of  histone modifications or classified depending on whether XCI 
is random or imprinted. XCI is initiated and maintained by a multitude of  epigenetic layers 
consisting of  histone modifications and DNA CpG methylation. The deposition and maintenance 
of  histone modifications on the Xi is Xist dependent whereas the accumulation of  DNA CpG 
methylation makes XCI maintenance irreversible and Xist independent. In a specific epigenetic 
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5context, XCI is relatively stable regardless whether XCI is random or imprinted. Problems in 
XCI stability may arise when XCI maintenance is still Xist dependent and the changing epigenetic 
context during differentiation and development cannot be implemented fast enough to create 
other epigenetic layers on the Xi. Which heterochromatic chromatin modifications can be found 
on the Xi is dependent on the epigenetic context and plasticity of  the entire genome of  the 
assessed cell. Despite the observed differences in histone modifications associated with the Xi 
in different lineages, our results indicate that both ubH2AK119 and H3K27me3 are the best 
heterochromatic markers for the Xi in all assessed lineages.
Materials and Methods
Embryo Collection and Cell Culture
Ethics statement and embryo collection
All animal experiments were in accordance with the legislation of  the Erasmus MC Animal 
Experimental Commission. Except for the TS cells, all analysed lineages were hybrid, derived 
from embryos from crossings of  129Sv or C57Bl6 female mice with Cast/Eij or males. The 
analysed TS cells were both hybrid and inbred. The ovarian cycle of  females was synchronized 
by intra-peritoneal injections of  Folligonan and Chorullon (both 150 μl, 50U/ml, both one 
injection with 48 hours in between). Following the last injection each female mouse was mated 
with a male mouse. About 20 hours after the last injection, mating was evaluated by looking for 
the presence of  a white plug in the vagina. Females that had mated were euthanized at E3.5 for 
ES or XEN cell derivation or killed at E6.5 for the creation of  TS cells. 
XEN cell line derivation and culture conditions
E3.5 embryos were flushed with M2 medium and placed in M16 medium at 37°C and 5% 
CO2 before being placed in XEN derivation culture conditions. For XEN derivation, E3.5 
embryos were placed into gelatinized wells covered with MEFs and cultured in XEN-medium 
(RPMI 1640; with 20% FBS, 1 mM sodium pyruvate, 2 mM L-glutamine, PS  and 100μ M 
β-mercaptoethanol). Every 1-2 days, fresh medium was added until embryos were attached to 
the gelatinized surface of  the well. After the embryos were attached and showed significant 
outgrowth, the XEN cells were split with 0.25% trypsin/EDTA and cultured in standard XEN 
culture conditions. For combined immunohistochemistry RNA-FISH, cells were grown onto 
plastic slide chamber flasks.
TS cell line derivation and culture conditions
TS cells were derived from E6.5 embryos. The extra embryonic part of  E6.5 egg cylinders were 
plated in six-well plates on irradiated MEFs and maintained in XEN-medium supplemented 
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with 25 ng/ml human recombinant fibroblast growth factor 4 (hrFGF4) and heparin sulfate. 
After the embryos were attached and there was significant outgrowth, the TS cells were split with 
0.25% trypsin/EDTA and further cultured in standard TS culture conditions. For combined 
immunohistochemistry RNA-FISH, cells were grown onto plastic slide chamber flasks.
ES derivation and culture conditions
For ES derivation, E3.5 blastocysts were placed into culture dishes coated with gelatin (0.2%) and 
irradiated MEFs in ES cell medium containing DMEM, 15% fetal calf  serum (FCS), PenStrep 
(PS), 1 mM non-essential amino acids (NEAA), 50mM β-mercaptoethanol, leukaemia inhibitory 
factor (LIF), MEK inhibitor (PD98059, 4µM) and GSK3inhibitor (CHIR99021, 3.3 µM). 
Approximately one week after embryo recovery the outgrowth of  the ICM was enzymatically 
split and plated in the same culture conditions as previously described. After a few passages, 
inhibitors for MEK and GSK3 were removed from the culture medium.
ES differentiation towards EpiLC
ES cells were trypsinized with 0.25% trypsin/EDTA and cultured in EpiLC conditions [41] for 3 
passages (with collagenase) before being analysed. For combined immunohistochemistry RNA-
FISH, cells were grown onto plastic slide chamber flasks.
EpiLC differentiation towards mesoderm
EpiLC cells were for combined immunohistochemistry RNA-FISH cells passaged onto plastic 
slide chamber flasks and grown for an extra 48 to 72 hours in EpiLC medium devoid of  IWP2 
put in the presence of  WNT3 and BMP4.
Immunohistochemistry and RNA-FISH
DNA Xist probe
The Xist probe used was a 5kb cDNA BglII fragment covering exons 3-7 [42]. The probe was 
directly labeled by random priming. A total of  500ng DNA was dissolved in a total volume of  
23 µl. 20µl of  random primers 2.5x was added and denaturation was then performed at 95°C 
for 5 min. Immediately following  the denaturation, the probe was cooled on ice and dNTPs, 
labeled dUTP and Klenow fragment were added. This mix was incubated at 37°C for 2 hours. 
For precipitation, Cot1-DNA, salmon sperm (SS) DNA, tRNA, sodiumacetate 3M and EtOH 
100% were added to the labelled DNA. The mixture was frozen for 20 min in -20°C. To obtain 
the DNA pellet, the tube was centrifuged at 13200 rpm for 20-30 min and the supernatant 
was carefully removed. The pellet was thoroughly resuspended in 70% EtOH by vortexing and 
centrifuging at 13200 rpm for 5-10 min. Supernatant was carefully removed and the pellet was 
air-dried for 10 min. The labeled probe was dissolved with 50+ Hybridization mix and stored 
at -20°C. 
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5Antibodies
Antibody Dilution Host Supplier
H3K27me3 1:500 Rabbit Diagenode CS-069-100
H4K20me1 1:500 Rabbit Abcam 16974
H3K9me2 1:200 Mouse Cosmo Bio (MCA-MABI0007-20-EX)
ubH2A 1:200 Rabbit Cell signalling (8240)
H3K4me2 1:1500 Rabbit Upstate 07-030
H3K9ac 1:1000 Rabbit Sigma H9286
H4K16ac 1:100 Rabbit Abcam 1240-100
H4ac 1:100 Rabbit Upstate 06-598
RNApolII 1:600 Mouse Abcam 817-100
RING1B 1:50 Mouse Generous gift from Dr. H. Koseki
SUZ12 1:100 Rabbit Diagenode pAb-029-050
EZH2 1:200 Rabbit Leica Microsystems (NCL-L-EZH2)
JARID2 1:500 Rabbit Abcam (48137)
RNA FISH
Cells cultured on plastic slide chamber flasks were fixed in 4% paraformaldehyde (PFA) for 10 
min at room temperature and subsequently 3 times rinsed in PBS. The coverslips were incubated 
with 0.2% pepsin dissolved in water and incubated at 37°C in a water bath. After 4 min exposure, 
the pepsin was removed and the coverslips were rinsed in water. The coverslips were post-fixed 
in 4% PFA for 5 min and again 3 times washed with PBS. To dehydrate the cells, an ethanol 
gradient was used with 70%, 90% and 100% EtOH. Cells were hybridized overnight at 37°C 
with the denatured Xist probe (10min at 99°C followed by 45min at 37°C). The next day the 
coverslips were 3 times washed with 0.05x Saline-Sodium Citrate (SSC) in a pre-heated water 
bath at 40°C. The cells were mounted with Vectashield/DAPI. 
RNA FISH and immunohistochemistry
Cells cultured on plastic slide chamber flasks were fixed in 3% PFA for 10 min at room temperature 
and 3 times rinsed in PBS. Permeabilization was performed with PBS containing 20% Triton-X 
100 and 20 μM Vanadyl Ribonucleoside Complex (VRC)(New England Biolabs S1402S). After 
rinsing 3 times in PBS, preparations were blocked in a blocking solution containing bovine 
serum albumin (BSA) (Biolabs, B90015) and 20 μM VRC in PBS for 30 min. The primary 
antibody, diluted in blocking solution, was applied to the wells of  the slide chamber flasks and 
incubated in a humid box for 1 hour at room temperature. After 3 times 10 min washes with 
PBS, the secondary antibody, diluted in the blocking solution was applied to the wells of  the slide 
chamber flask and incubated for 1 hour at room temperature. 
The secondary antibody, was removed by 3 washes in PBS for 5min each. Following removal 
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of  the plastic chamber, the remaining plastic slides were accordingly post-fixed in 4% PFA for 
10 min at room temperature, rinsed in PBS and washed two times with 2x SSC before being 
air dried. The denatured Xist probe was applied on the slides, coverslips were placed and glued 
with rubber cement onto the slide and incubated for 15-20 hours in a dark box at 37°C. After 
3 washes with 0.05x SSC at 38-40°C, DNA was counterstained for 2 minutes in 10µl DAPI. A 
Leica TCS SP 5 confocal microscope and Adobe Photoshop CS 6 and Illustrator were used for 
image acquisition. 
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5Supplementary Figures
Figure S1A: Immuno-RNA FISH detecting RNA pol II, H3K9Ac, H4K16Ac and H4Ac (Rhodamine red) 
together with Xist (FITC) on TS cells (DAPI is DNA).
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Figure S1B: Immuno-RNA FISH detecting JARID2 and SUZ12 (Rhodamine red) together with Xist 
(FITC) on TS cells (DAPI is DNA).
5
147
5Figure S2A: Immuno-RNA FISH detecting RNA pol II, H3K9Ac, H4K16Ac and H4Ac (Rhodamine 
red) together with Xist (FITC) on XEN cells (DAPI is DNA).
Figure S2B: Immuno-RNA FISH detecting JARID2 and SUZ12 (Rhodamine red) together with Xist 
(FITC) on XEN cells (DAPI is DNA).
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Figure S3A: Immuno-RNA FISH detecting RNA pol II, H3K9Ac, H4K16Ac and H4Ac (Rhodamine 
red) together with Xist (FITC) on EpiSCs (DAPI is DNA).
5
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5Figure S3B: Immuno-RNA FISH detecting JARID2 and SUZ12 (Rhodamine red) together with Xist 
(FITC) on EpiSCs (DAPI is DNA).
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Figure S4A: Immuno-RNA FISH detecting RNA pol II, H3K9Ac, H4K16Ac and H4Ac (Rhodamine 
red) together with Xist (FITC) on diferentaited EpiSCs (DAPI is DNA). Figure S4B: Immuno-RNA 
FISH detecting JARID2 and SUZ12 (Rhodamine red) together with Xist (FITC) on differentiated EpiSCs 
(DAPI is DNA).
5
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5Figure S4B: Immuno-RNA FISH detecting JARID2 and SUZ12 (Rhodamine red) together with Xist 
(FITC) on differentiated EpiSCs (DAPI is DNA).
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6Chapter 6
Maduro C.M and Gribnau J.
In mammals, males are the heterogametic sex having an XY sex chromosome pair, whereas 
females are homogametic having an XX sex chromosome pair. The Y chromosome is small 
and harbors only a few genes mainly involved in male sex determination and spermatogenesis 
1-3, whereas the X chromosome contains over a thousand genes important for both male and 
female development and homeostasis 1,2. XX females have double the amount of  X encoded 
genes as compared to XY males and this imbalance requires a dosage compensation mechanism 
to equalize expression of  these X encoded genes in the two sexes. Dosage compensation in 
mammals is achieved through a process called X chromosome inactivation (XCI), in which one 
of  the two X chromosomes in female cells is inactivated. In the following sections, regulation and 
timing of  the different phases of  XCI are discussed and how, together and through redundant 
processes, activation of  XCI is ensured and maintained throughout cell divisions. 
Initiation of  XCI 
Random XCI is a stochastic and tightly regulated process in which either the maternal or 
the paternal X chromosome can be inactivated. XCI ensures one active X chromosome per 
diploid genome by regulation through one or more pathways to ensure proper inactivation and 
circumvent inactivation of  both or continued activity on both X chromosomes 4. Regulation 
of  XCI is achieved by a counterbalance of  inhibitors and activators of  XCI acting on the 
key regulators of  XCI, Xist and Tsix, which will determine whether XCI occurs and which X 
chromosome will be inactivated.
Key regulators of  XCI: Xist and Tsix  
Key regulators of  XCI are the two lncRNAs, Xist 5 and Tsix 6, involved in activation and 
repression of  XCI respectively. Xist is expressed exclusively from the inactive X chromosome 
(Xi), spreads and coats the entire X chromosome whilst recruiting chromatin remodeling factors 
to render the X inactive 7,8. Tsix is a negative regulator of  Xist and promotes repression of  XCI, 
keeping the X chromosome active. Regulation of  Xist and Tsix is achieved through activators 
and inhibitors. However, analysis of  independent Xist and/or Tsix regulation is hampered as a 
result of  overlapping antisense transcription of  the two lncRNAs 9. Effects on XCI as a result of  
a deletion of  the activators Jpx/Ftx/Xpr/Rnf12 in cis for example, can be rescued by a deletion 
of  Tsix in cis 10 and in the same way XCI can be dysregulated in normal differentiated female cells 
(XiXa) by a deletion of  Tsix on the active X (Xa) chromosome resulting in ectopic Xist expression 
from the Xa 11. Similarly, a mutation of  Tsix in undifferentiated female ES cells results in ectopic 
upregulation of Xist 12,13. Thus, Tsix expression interferes with and masks regulatory effects 
exerted on the Xist regulatory network and vice versa, highlighting the complication in studying 
regulation of  Xist and Tsix without interference of  the antisense partner. To study regulation 
of  Xist and Tsix on an uncoupled allele, we replaced the first exons of  Xist with an EGFP and 
Tsix with an mCherry cassette, generating 3 different cell lines with either Xist-EGFP, Tsix-
mCherry or both reporters on the same allele (Chapter 3). Expression of  the reporters remained 
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6under control of  the endogenous promoters with a poly-A signal terminating transcription 
downstream of  the reporter, preventing overlapping antisense transcription. On an uncoupled 
allele we confirmed that Tsix is involved in repression of  Xist, but also show that Xist is involved 
in down regulation of  Tsix expression on the Xi as well as on the Xa. In addition, we found that 
expression of  Xist and Tsix is mostly anti-correlated but rather than a strict anti-correlation, 
they appear regulated by trans-acting factors, inhibitors and activators, in a stochastic fashion. An 
XCI effect of  RNF12 (activator) or REX1 (inhibitor) was more pronounced in cells with both 
Xist-EGFP:Tsix-mCherry reporters as compared to cells with either Xist-GFP or Tsix-Cherry 
alone, highlighting that antisense transcription masks the regulatory impact of  XCI activators or 
inhibitors and emphasizing the importance of  these cells with both Xist-EGFP:Tsix-mCherry in 
identification of  novel activators and inhibitors of  XCI. In addition, the double Xist-EGFP:Tsix-
mCherry cells offer an easy readout and enable distinction between direct and indirect effects of  
regulators on the promoters of  Xist and Tsix. 
With these Xist-EGFP:Tsix-mCherry cells we were also able to observe distinct populations of  
cells showing different levels of  Tsix expression in cells grown in 2i medium and cells which 
have lost their wildtype X chromosome. These two distinct populations also showed differences 
in expression of  other genes in the Xic, indicating that these semi-stable transcriptional states 
reflect fluctuating chromatin conformations that can be stabilized in trans by trans-acting factors. 
Our data suggests the presence of  differential epigenetic states established by intrinsic and 
extrinsic factors, capable of  providing stable, mutually exclusive, on/off  switches of  genes in 
the Xic and predicts the responsiveness of  the Xic to its regulators prior to initiation of  XCI. 
A polymer model, which can deconvolve sub-TAD contact frequencies measured by 5C into 
single-cell chromatin configurations, also predicted two main classes of  conformations of  the 
Tsix TAD 14. In addition, this study shows that the Tsix TAD of  the two X chromosomes in a 
single nucleus differ in transcriptional activity which is related to the chromatin conformation 
of  the TAD from which they are expressed. Moreover, intrinsic fluctuations in conformation of  
the Tsix TAD, coupled to variation in transcription, may play a role in transcriptional asymmetry 
between the two Xics which ensures responsiveness leading to upregulation of  Xist on only one 
X chromosome already prior to initiation of  XCI. Furthermore, considering the alternate states 
model 15, which showed that the two Xics of  the X chromosomes differ prior to XCI in ES 
cells and is no longer observed in differentiated cells, we cannot exclude that XCI encompasses 
multiple ways to ensure XCI to occur properly. Nevertheless, these states, as determined in 
our study, are only observed in male cells or upon addition of  2i medium. In serum conditions 
switching occurs more frequently, resulting in one homogeneous population, facilitating the 
dynamics required for the mutual exclusive XCI process. 
 In Chapter 3, we also observe semi-stable promoter activity of  Xist and Tsix from mother cell 
to daughter cells. The stability of  transcriptional states observed represent distinct states of  
transcriptional activity and likely plays a role in epigenetic memory, which is clonally propagated 
to daughter cells for many cell divisions. 
Activation of  XCI: Xist activators and XCI activators  
Initiation of  XCI is regulated by a balance of  autosomally encoded XCI inhibitors setting a 
threshold for XCI to occur, and the X encoded XCI activators, allowing XX female cells to 
overcome the threshold to initiate XCI 16. Activation of  XCI is achieved by activation of  Xist and/
or repression of  Tsix by XCI activators. Factors exclusively activating Xist, which are autosomally 
encoded, are termed Xist activators. YY1 has been previously described as an Xist activator 
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6which competes with the XCI inhibitor REX1 for binding sites at Xist downstream regulatory 
elements 17. Xist activators activate Xist in trans but are not involved in the counting process as 
these factors are equally expressed in male and female cells. In Chapter 2, we describe another 
Xist activator, Rnf6. Rnf6 is highly homologous to Rnf12 and a deletion of  Rnf6 in Rnf12+/- ES 
cells has an increased effect on XCI. No additive effect of  deleting the second copy of  Rnf6 
on XCI was observed, suggesting that deleting an Xist activator affects the threshold but is not 
able to lower the threshold further when completely absent as XCI activators are the key players 
in overcoming the threshold for XCI to occur. In vitro ubiquitination studies indicate that Rnf6 
most likely acts on XCI through proteasomal degradation of  REX1. Xist activators are different 
from XCI activators as the latter are X-encoded, allow a cell to count the number of  active X 
chromosomes in a cell through mechanisms involving indirect or direct activation of  Xist and/
or repression of  Tsix, to initiate XCI. Moreover, the XCI activator will be silenced in the process 
of  XCI, allowing feedback to prevent the remaining X chromosome from being inactivated. The 
only X encoded XCI activator reported so far was the E3 ubiquitin ligase Rnf12 4,10,18. In Chapter 
2 we describe an additional XCI activator, the E1 activating enzyme Uba1. In XCI, Rnf12, Rnf6 
possibly along with Uba1, function by targeting the XCI inhibitor and pluripotency factor REX1 
for proteasomal degradation through the ubiquitin pathway. 
Ubiquitination and XCI  
In Chapter 2 we explored ubiquitination and aspects of  the RNF12 mediated degradation of  
REX119 in the context of  XCI in more detail. The outcome of  ubiquitination of  a target protein 
depends on the function of  the E1, E2 and E3 enzyme and the manner in which ubiquitin is 
loaded onto the target protein as well as the lysines which are preferentially ubiquitinated within 
the target protein. We showed that the main and X-encoded E1 activating enzyme, UBA1, is 
an activator of  XCI. As UBA1 is an E1 activating enzyme, UBA1 could be the start-point and 
part of  an activation cascade such as that of  the targeted degradation of  REX1 by RNF12 
and RNF6. In a cell, E1 levels are mostly saturated, making the reaction velocity independent 
on the substrate or enzyme present (Michaelis-Menten equation) 20,21. However, at lower E1 
concentrations, when the E1-ub formation is still linear, this could indeed have an effect on 
the outcome of  the reaction. When we consider this pathway in activation of  XCI, we propose 
a model involving an activation cascade ultimately leading to proteasomal degradation of  the 
XCI inhibitor REX1, relieving the brake on Xist expression and allowing XCI to be initiated. 
In this activation cascade, the E1 activating enzyme UBA1 activates ubiquitin and transfers this 
to an E2 conjugating enzyme, which subsequently binds either RNF12 or RNF6, which in turn 
allows transfer of  active ubiquitin molecules to REX1, targeting it for proteasomal degradation. 
However, further protein data, analyzing an effect of  Uba1 on proteasomal degradation of  
REX1, is required to establish a role for Uba1 in this activation cascade. It appears that in XCI, 
REX1 is central, as initiation of  XCI involves the proteasomal degradation of  REX1 by the 
ubiquitin cascade as well as regulation by the Xist activator, Yy1, which competes with REX1 for 
binding sites at the Xist promoter. However, knockout mice for REX1 22 or RNF12 23 are viable 
and a deletion of  the REX1/YY1 binding sites at the Xist promoter does not affect XCI 24. This 
raises the question on how important this pathway really is in vivo. It seems likely that XCI is 
regulated by redundant and linked pathways to ensure that XCI does indeed progress. Similarly, 
to ensure dosage compensation in D. melanogaster and C. elegans, for example, several X-encoded 
numerator genes are required and together regulate the key regulatory genes Sxl and Xol-1, 
respectively 25. Since deletion of  Uba1 in Rnf12+/- ES cells resulted in significantly affected XCI, 
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6but still showed a fraction of  cells initiating XCI, this suggests presence of  other X-encoded 
XCI activators. Recently, a study proposed that the factors involved in the counting process of  
XCI, are escaping genes which further activate Xist and help trigger X-linked gene silencing 11. 
However, in initiation of  XCI, initial activation cues resulting in upregulation of  Xist need to 
occur prior to Xist spreading and silencing the X chromosome and feedback through silencing of  
the activator in cis, is required to prevent the other X chromosome from being inactivated, which 
is difficult to achieve if  these activating factors where escaping genes. It cannot be excluded that 
genes escaping XCI do have a role in further promoting the silent state, but a role for escaping 
genes in initiation of  XCI and the counting process, seems unlikely.
Identification of  factors regulating of  XCI  
In Chapter 2, Chapter 4 and Addendum 1, we set out to identify novel factors involved in 
activation of  XCI. In Chapter 2 and Addendum 1, we carefully selected candidate genes based 
on known functions/interactions and used two different approaches to analyze for an effect 
on XCI. We overexpressed candidate genes in male cells, which in case of  an activator would 
result in ectopic Xist cloud formation and inactivation of  the single X chromosome in male 
cells as opposed to a heterozygous deletion of  a candidate gene in female cells, which in case 
of  an activator would significantly affect or abolish XCI. Overexpression of  XCI activators in 
male cells results in cell death, which makes analysis more difficult, as was found for Rnf12. Two 
of  the five candidate genes displayed ectopic Xist cloud formation, nonetheless only in a small 
percentage of  cells. This required further analysis of  Cited1 (Addendum A) and Rnf6 (Chapter 
2) in female cells and is also how we screened two additional candidate genes, Uba1 (Chapter 2) 
and Phf6 (Addendum A). This second strategy, consisted of  generating heterozygous knockouts 
for the candidate genes in female Rnf12+/- ES cells using the CRISPR/Cas9 technology. As 
Rnf12+/- cells show reduced XCI initiation (Chapter 2 and 4), a heterozygous deletion of  an 
activator would result in further affected XCI, which is what we observed for Uba1 and Rnf6. 
With both candidate gene approaches, two out of  seven candidate genes appeared to have 
a function in initiation of  XCI. Nevertheless, these two approaches and careful selection of  
candidate genes are very laborious and precarious as activators can easily be falsely excluded. 
We therefore initiated a large-scale deletion of  approximately one third of  the X chromosome 
in a semi-unbiased approach in which a 50Mb candidate region, telomeric to the Xic, containing 
about 202 genes, was deleted in Rnf12+/- cells. We observed near complete abolished XCI, of  
which the slight residual Xist expression may be the attributed by of  the presence of  two copies 
of  Uba1 or another XCI activator, located outside of  the deleted region. Taken together, our 
results indicated the presence of  at least three XCI activators involved in activation of  XCI.
Comparing the three different strategies used, we can conclude that firstly, generating 
heterozygous knockouts in female cells generates a better readout than male cells, which die upon 
inactivation of  the X chromosome. In addition, in female cells all the known activators can be 
deleted in one cell to allow a better readout of  factors with a lower impact on activation on XCI 
which would be missed otherwise. Second, when we compare the candidate gene approach versus 
the candidate region approach, the latter seems favorable as we now have a 50Mb candidate region, 
which would be practical to narrow down to a smaller region(s) followed by a candidate selection 
and CRISPR/Cas9 technology to pinpoint candidate genes involved in initiation of  XCI.   
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6Establishment and maintenance of  the Xi  
When XCI is initiated and Xist RNA spreads along the X chromosome, euchromatic marks 
such as H3K4 methylation and H3K9 actetylation are lost and repressive marks such as 
H3K9me2 accumulate 7,8. Polycomb complex 1 and 2 (PRC1 and PRC2) are recruited 26-29 
catalyzing H2A119ub 28 and H3K27me3 8, macroH2A is incorporated 30,31 and finally CpG 
island methylation accumulates 32,33 further ensuring the silent state. In the mouse, two forms 
of  XCI exist: imprinted XCI (iXCI) and random XCI (rXCI). Besides difference in timing, it 
has been reported that iXCI is less stable with regard to the inactivated X as compared to rXCI 
34-38. In order to understand the difference in stability of  the Xi in these two forms of  XCI, we 
generated TS, XEN (imprinted XCI), ES and EpiSCs (random XCI) which were also further 
differentiated towards the mesodermal lineage, all with the same genomic background to obtain 
a comprehensive overview of  all the histone modifications associated with the Xi in these cell 
types representing different embryonic lineages.
Loss of  euchromatic marks such as H3K4me2, H3K9ac, H4ac, H4K16Ac and RNA PolII 
hallmarks the initial shift from the active state to silencing of  the X chromosome. This is followed 
by accumulation of  H3K27me3 and H2AK11Ub indicating early chromatin changes to the silent 
state, and was also observed in all lineages. Even though all cell types displayed accumulation 
of  H3K27me3 and H2AK119Ub on the Xi, marking the X transcriptionally inactive, subunits 
of  the PRC2 (EZH2, SUZ12 and JARID2) and PRC1 (RING1B) complex, catalyzing these 
modifications, were not always detected.  This indicates that either these complexes were below 
the detection limit of  our immunostaining, or as previously reported, PRC2 association even 
though constant may be very transient 39 making detection of  its accumulation more difficult by 
immunostaining. As for PRC1, only subunit RING1B was analyzed and the combined immune-
FISH did not work for all linages, we can therefore not completely exclude accumulation of  
PRC1 on the Xi in specific cell types from these results. 
Presence of  H3K9 methylation on the Xi has been controversial, however more recently, 
H3K9 methylation has been found enriched at intergenic and gene poor regions of  the Xi and 
interspersed between H3K27me3 domains most likely catalyzed by Setdb1 40. In addition a role 
for H3K9 methylation in late establishment and early maintenance of  silencing by silencing 
of  repeats and so facilitating alterations to the conformation of  the Xi, thereby initiating the 
maintenance phase has been proposed. In Chapter 5, we show accumulation of  H3K9me2 
only on the Xi in the extraembyonic TS and XEN cells, whether or not this mark is present in 
the other cell lineages can be debated. Keniry et al report H3K9me2 in a study using ChIP-seq 
and not observing enrichment of  H3K9 methylation on the Xi in our study could be related 
to H3K9 detection being more difficult by immunofluorescence40. To be able to conclude the 
presence of  differential H3K9 methylation in iXCI versus rXCI we need to look at this chromatin 
mark on the Xi in more detail than capable with immunofluorescence. Another chromatin mark 
associated with the Xi, H4K20me1, was observed in TS, XEN and EpiSCs and is most likely 
catalyzed by Pr-Set7 or Set8, however involvement of  these methyltransferases in XCI is unclear 
41-43 and might be a general mark associated with inactive chromatin rather than involved in the 
stability of  the inactive state as no differential H4K20 methylation was observed in the cell types 
displaying iXCi or rXCI. 
Taken together, our results indicate only few distinct differences in chromatin modifications 
present on the Xi in iXCI as opposed to rXCI. The stability of  the inactive state depends 
rather on the plasticity of  a cell. As the X chromosome transits from an active to an inactive 
state, H3K4me2, H3K9ac, H4ac, H4K16Ac and RNA PolII are lost and directly followed 
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6by H3K27me3 and H2AK119Ub accumulation on the Xi as Xist RNA spreads along the X 
chromosome and further silences repeat regions by methylation of  H3K9. DNA methylation 
will lock down the inactive state for the next phase in XCI, maintenance of  the Xi, which is most 
likely less pronounced or even absent in iXCI which could attribute to a less stable silencing 
found in iXCI 38,44.
Regulation of  XCI in initiation, establishment and maintenance of  the Xi rely on several different 
and sometimes redundant pathways to ensure proper execution of  XCI.  The initiation phase and 
activation of  XCI depends on the upregulation of  Xist, which as the different chapters in this thesis 
explain, can be achieved in different ways. In addition, inhibitors and activators do not appear to 
be strictly autosomal or X-encoded as was previously believed, rather multiple layers and levels 
of  regulation of  Xist, together, all ensure proper activation of  XCI. Multiple layers of  epigenetic 
modifications are also instrumental in the establishment phase and maintenance phase, these layers 
are different between iXCI and rXCI to facilitate embryonic requirements of  plasticity related to cell 
fate decisions. This makes XCI an intriguing yet difficult epigenetic phenomenon to unravel.  
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         Addendum 1  
Abstract 
Proper initiation of  X chromosome inactivation (XCI), to equalize gene dosage between XX 
females and XY males, requires upregulation of  X-encoded activators to allow a female cell 
to overcome the threshold for XCI to occur. So far, Rnf12 and Uba1 have been reported as 
activators of  X chromosome inactivation, nevertheless a heterozygous deletion of  both genes 
in female cells does not lead to full abrogation of  XCI upon differentiation and suggests the 
presence of  other activator(s). Here we report several candidate genes which we have tested to 
determine whether they function in initiation of  XCI. We found that Nsbp1, Dax1, Pja1,Cited1 
can be excluded as regulators of  XCI initiation and indicate a role for Phf6 at later stages of  XCI. 
Introduction  
X chromosome inactivation (XCI) evolved as a dosage compensation mechanism ensuring 
equal gene dosage of  sex-chromosomes between eutherian XX females and XY males. XCI 
is mostly studied in mouse embryonic stem (ES) cells, as these cells recapitulate random XCI 
upon differentiation. Random XCI in vivo occurs early in development of  the female embryo 
and implies that, in a female cell it is either the maternal or the paternal X chromosome which 
can be inactivated [1]. It is the balance between X-encoded activators and autosomally encoded 
inhibitors of  XCI as well as the stochasticity of  the process which determines the probability 
to initiate XCI. In addition, feedback through inactivation of  XCI activators in cis prevents 
inactivation of  both X chromosomes [1, 2]. Studies on X/A translocations indicated that initiation 
of  cis-inactivation depends on the presence of  a unique region on the X chromosome, the X 
inactivation center (Xic) [3]. In addition, studies on female cells with truncated X chromosomes 
suggested that at least two copies of  the Xic are required for XCI to occur [4]. The Xic has 
therefore been described as the minimum region both necessary and sufficient to initiate XCI. 
More recently it has been proposed that two distinguishable Xics exist: the cis-Xic and the trans-
Xic [5]. The cis-Xic contains the three key players of  XCI, which are Xist and its inhibitors Tsix 
and Xite, but also cis activators of  Xist such as Jpx, Ftx and Xpr [6]. The trans-Xic contains all the 
factors that act in trans to activate Xist either directly or indirectly. The trans-Xic comprises the 
autosomally encoded inhibitors, which set up a threshold for XCI to occur, and the X encoded 
activators which allow a cell to determine the number of  active X chromosome in a cell and 
initiate XCI when this number is more than 1 per diploid genome. Two X-linked activators have 
been described, Rnf12 [2, 6-8] and Uba1 (Chapter 2). Studies with Rnf12+/-:Uba1+/- ES cells have 
shown that Rnf12 and Uba1 are not the only activators of  XCI, as these cells still initiated XCI in 
a percentage of  cells, whereas wildtype male cells do not. 
Here we report studies determining the function of  five candidate genes in initiation of  XCI 
using two different strategies. Candidate genes were selected based on a relevant known function, 
have to be subject to XCI to allow feedback and also based on their location in close proximity 
to Xist. Candidate genes included: Nsbp1, Dax1, Pja1, Cited1 and Phf6. Nspb1 affects chromatin 
structure and function and can exert nucleosomal binding and transcriptional activation [13, 
14]; Dax1 plays a role in sex reversal and was shown to downregulate Oct4 expression [15, 
16] and bind RNF12 [Gontan, unpublished]; Cited1 is a CBP/p300 trans-activator which 
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also interacts with Smad5, estrogen receptors α and β and TFAP2 [17-20]; and Pja1 is an E3 
ubiquitin ligase, also named Rnf70, and part of  the same family as Rnf12 [21]. As for Phf6, 
unpublished knockdown studies (Van Vlierberghe) resulted in downregulated Xist expression. 
Experimental procedures 
BACs and plasmids  
The BACs (CHORI) used in this study were RP23-346H6 (Dax1), RP23-312H18 (Pja1), 
RP23-204G22 (Cited1) and RP23-332L18 (Nsbp1). Recombination between the BAC and an 
ori-less recombination vector to introduce a kanamycin/neomycin resistance cassette, allowing 
selection in ES cells, into the BAC backbone was described previously [9]. The pSpCas9(BB)-
2A-Puro (PX459) (Addgene plasmid # 48139) was used to insert the CRISPR guide RNAs [10]. 
Culturing ES cells  
Cell lines, culture media and culture conditions for ESC culture and differentiation were described 
previously [7, 11]. The BACs (linearized) were introduced in F1 wildtype male ES cells and 
CRISPR vectors were introduced in hybrid F1 129sv/Cast female ES cells with a deletion of  Rnf12 
on the 129 allele (Chapter 2), by electroporation in a 0.2cm electroporation cuvette (BioRad) at 
118kV, 1200μF and ∞Ω in a Gene Pulser Xcell Electroporation System (BioRad). After 24 hours 
of  recovery, cells were grown on ES medium containing neomycin (270μg/ml) or puromycin 
(1ug/ml) for seven days or 48 hours for BACs and the CRISPR vectors respectively.  
 
Deletions with the CRISPR/CAS system  
CRISPR guides were designed by using the CRISPR design tool (http://crispr.mit.edu/). The 
designed CRISPR guide oligos with 5’- CACC and 3’- CAAA overhangs (Table 1) were cloned 
into the pX459 CRISPR vector (Addgene) [10] by a simultaneous digestion-ligation reaction 
[12]. First, the pX459 vector was digested with BbsI (NEB) to allow the replacement of  the 
restriction sites with direct insertion of  the annealed oligo guides and used to transform heat 
competent bacteria. A combination of  two guides  was used in each targeting of  ES cells for 
which the cells were screened as a pool to ensure the deletion was present, followed by single 
clone screens with different primers (Table 2).
 
Xist RNA Fluorescent in situ hybridization  
Procedure, probe labelling and antibodies have been described previously [7, 11]. 
 
RNA isolation from ES cells and cDNA synthesis  
TRIzol® (Invitrogen) was added to each sample and RNA was isolated according to 
manufacturer’s instructions. RNA samples were diluted to contain 2μg RNA in 10μl. Before 
cDNA synthesis, DNase (Invitrogen) was added to the RNA samples, for 30 minutes at 37oC, 
to remove any contaminating genomic DNA after which the DNase was heat-inactivated at 
65oC for 10 minutes. Random Hexamers (Applied BioSystems) and dNTP mix (Invitrogen) was 
added and incubated at 65oC for 5 minutes and subsequently cooled on ice for 1 minute. 5x First 
Strand Buffer, 0.1M DTT and RNaseOUT (Invitrogen) were then added to the samples and 
incubated at 25oC for 2 minutes before adding SuperscriptII Reverse transcriptase (Invitrogen). 
The samples were then incubated at 25oC for 10 minutes followed by 50 minutes at 42oC and 
finally, 15 minutes at 70oC. The obtained cDNA was diluted with 200µl H 2O, of  which 3-5µl was 
used in a Q-PCR reaction.
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Table 1: Oligo’s for CRISPR guides for deletion of  Cited1 and Phf6.  5’- CACC and 3’- CAAA overhangs are indicated 
in bold and the preferred G as a starting nucleotide is underlined. 
Gene Guide oligo
Cited1 Combination 1: Fw 1: 5’CACCG TCTCATTGATTCTGACCCGG 3’
Rv 1:  5’AAAC CCGGGTCAGAATCAATGAGA C3’                                                
                                                                                                                                                      
            
Fw 3: 5’CACCG AGCCCCGCGCCGATAGGTTG 3’
Rv3:  5’AAAC CAACCTATCGGCGCGGGGCT C3’
Combination 2: Fw2:  5’CACCG CCAATGAGCTTCCCGAGCTG 3’
Rv2:  5’AAAC CAGCTCGGGAAGCTCATTGG C3’
Fw 3: 5’CACCG AGCCCCGCGCCGATAGGTTG 3’
Rv3:  5’AAAC CAACCTATCGGCGCGGGGCT C3’
Combination 3: Fw2:  5’CACCG CCAATGAGCTTCCCGAGCTG 3’
Rv2:  5’AAAC CAGCTCGGGAAGCTCATTGG C3’
Fw4: 5’CACCG TACTTACGGAGGGCCCGAGT 3’
Rv4:  5’AAAC ACTCGGGCCCTCCGTAAGTA C3’
Phf6 Combination 1: Fw2:        5’CACCG GCCGCCCCTGCCCGTTGTTA3’
Rv2:    5’AAAC TAACAACGGGCAGGGGCGGC C3’
Fw3:        5’CACCG TGGGAGGTTAACTAATGATG 3’
Rv3:    5’AAAC CATCATTAGTTAACCTCCCA C3’
Table 2: Primers  for detection wildtype allele, deletion and allele check of  the deletion of  Cited1 and Phf6
Wildtype allele 5’-3’ PCR over deletion 5’- 3’ Allele check 5’-3’
∆Cited1 Fw AACAGAATCGGTGGCTTTTT AACAGAATCGGTGGCTTTTT AAACACCCTCCTCAAACTGG 
              Rv CCAACCTTGGAGTGAAGGAT GGGCGAGAAGTGACCATAAT GAGGTAAAGGACGCTTGGAG
AscI SNP on 129
∆Phf6  Fw CTCTCCTCGAATGAAAGGAA TCTCTCCTCGAATGAAAGGAA TGGCTTTCTAATGCAGATGG 
             Rv TTTTCTTTTTCTCCCCCTCA CGCTGTTCTACCAGCTACAGA GTGGCTCACAACATGGAATC
ScaI on CAS
 
Results  
Additional copies of  candidate gene Cited1 induce ectopic cloud formation in male cells  
Activation of  XCI depends on the ability of  the X-encoded XCI activators to overcome the 
threshold set by the XCI inhibitors. X-encoded XCI activators allow a female cell with two X 
chromosomes to initiate XCI, whereas males with one X chromosome cannot. In order to test 
candidate genes as potential XCI activators, these candidate genes were introduced in extra 
copies in male cells. If  the candidate gene is indeed an XCI activator, the male cells will initiate 
XCI on their single X chromosome as was shown for Rnf12 (Figure 1A). Introduction of  a BAC 
containing Rnf12 into male cells, resulted in ectopic Xist cloud formation in ~9% and ~21% of  
the cells with one and two extra copies of  Rnf12 respectively [2]. Using a BAC transgene approach, 
we introduced extra copies of  Nsbp1, Dax1, Pja1 and Cited1 in male ES cells and analyzed for 
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ectopic Xist cloud formation by Xist RNA FISH (Figure 1A). Only when extra copies of  Cited1 
were introduced in male cells ectopic Xist cloud formation was observed in different clones, 
but not in male control cells (Figure B and C). However, unlike Rnf12, ectopic clouds were only 
observed in up to 3% of  male cells with extra copies of  Cited1 (Figure 1D). Moreover, no clear 
dosage correlation between copy number and cloud formation was observed in males with extra 
copies of  Cited1, even though the percentage of  cells with Xist clouds appeared to increase with 
copy number (Figure 1D). 
        
Figure 1: A) Top: Region on the X chromosome showing location of  the candidate genes Dax1, Pja1, Cited1 
and Nsbp1 and the corresponding BACs used are shown below (black). BACs shown in blue were used in 
the screen to identify Rnf12 of  which the BAC shown in red resulted in ectopic Xist cloud formation in male 
cells [2]. Bottom: These BACs were introduced in male cells and if  the BAC would contain an activator of  
XCI, ectopic Xist cloud formation would be observed after differentiation of  these cells, followed by cell 
death when the single X chromosome is inactivated. B) Xist RNA FISH on male 129sv/Cast cells at day 3 
of  differentiation with extra copies of  the candidate genes Nsbp1, Dax1, Pja1 and Cited1. Only when extra 
copies of  Cited1 was introduced in male cells, Xist clouds (green) were observed. C) Xist RNA FISH on three 
Cited1 clones showing Xist clouds (red). D) Cited1 clones with 1 (blue), 2 (green) and 3 (red) extra copies of  
Cited1 with the corresponding percentage of  cells observed with Xist clouds depicted for each clone.   
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Loss of  Cited1 does not result in reduced Xist expression  
In order to further test a role for Cited1 in XCI, we generated clones with a ~4.6 kb deletion of  
Cited1 on the 129sv allele, the Cast allele or on both alleles in female Rnf12+Cast/129- cells (described 
in Chapter 2), using the CRISPRS/Cas9 technology (Figure 2A). If  Cited1 would be involved 
in initiation of  XCI, a heterozygous deletion would further affect XCI in these Rnf12+/- cells 
visualized as a reduction in the percentage of  cells with Xist clouds by Xist RNA FISH and 
reduced Xist expression by q-PCR (Figure 2A bottom figure). We generated 8 clones with a 
deletion of  Cited1 (Figure 2B), of  which two clones were mixed clones (Figure 2C clone 2 
and clone 3). The analysis was continued with 3 clones with the deletion of  Cited1 on the 129 
allele (clone 1, 5 and 7), one clone with the deletion on the Cast allele (clone 8) and one clone 
which had the deletion on both alleles (clone 6). These 5 clones, now referred to as ∆Cited 129-
1, ∆Cited 129-2, ∆Cited 129-3, ∆Cited Cas and Cited KO, still retained two X chromosomes 
(Figure 2D) and were analyzed by q-PCR for Cited1 and Xist expression after 4 and 6 days of  
differentiation. In the Cited KO cells, no Cited1 was observed after 4 or 6 days of  differentiation 
as expected, whereas the ∆Cited Cas and ∆Cited 129-1 clones showed similar Cited1 levels after 
both 4 and 6 days of  differentiation and the ∆Cited 129-2, ∆Cited 129-3 clones showed an 
increase in Cited1 expression from day 4 to day 6. Nevertheless, on both days Cited1 expression 
was reduced in all clones as compared to wildtype levels (Figure 2E).  When analyzing Xist 
expression after 4 days of  differentiation, there was no difference in Xist levels between any of  
the clones with the Rnf12+/- cells, however, after day 6 of  differentiation, Xist levels in ∆Cited 
129-1, ∆Cited Cas and Cited KO were significantly increased as compared to the Rnf12+/- cells 
(Figure 2F). In these 3 clones, no Cited1 upregulation was observed from day 4 to day 6, whereas 
in ∆Cited 129-2 and ∆Cited 129-3 clones showing no significant difference compared to Rnf12+/- 
cells, this upregulation was absent. Taken together, the results show that Cited1 is not an XCI 
activator and might even be involved in repression of  Xist. 
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Figure 2:A) Cited1 gene with deletion guides, generating a deletion of  approximately 4.6 kb, and 
location of  primers used to screen the obtained clones. The guides were introduced in Rnf12+/ - cells and 
analyzed by Xist RNA FISH and Xist QPCR for an effect on XCI after differentiation. B) PCR over 
the deleted region in 8 clones. C) Allele specific PCR  of  Cited1 allele identifying the targeted allele in 
the 8 clones. D) PCR over DXMit44 and DXMit65 markers to determine whether the clones retained 
two X chromosomes. E) Relative Cited expression normalized to β-actin in wildtype, Rnf12+/- , Cited KO, 
∆Cited Cas, ∆Cited 129-1, ∆Cited 129-2 and ∆Cited 129-3 cells (all clones are in a Rnf12+/- background). 
(Error bars indicate SEM). Cited KO cells have no Cited1 expression at day 4 or 6 as expected and the 
heterozygous clones have reduced Cited1 expression as compared to wildtype and Rnf12+/- cells. F) 
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Relative Xist expression normalized to β-actin in wildtype, Rnf12+/- , Cited KO, ∆Cited Cas, ∆Cited 129-
1, ∆Cited 129-2 and ∆Cited 129-3 cells (all clones are in a Rnf12+/- background). (Error bars indicate 
SEM; t-test comparing Rnf12+/-  to Cited1 clones, * p<0.05; ** p<0.001 and *** p< 0.0001). Xist levels 
in ∆Cited 129-1, Cited Cas and Cited KO are significantly increased as compared to the Rnf12+/- cells. 
Loss of  Phf6 affects later stages of  XCI  
Knockdown of  Phf6, a chromatin adapter protein, using shRNAs in human female CD34+ 
T-cell precursors followed by gene expression profiling showed Xist as one of  the strongest 
downregulated genes as compared to control cells (Van Vlierberghe, unpublished). We therefore 
generated a 42.6 kb deletion of  Phf6 (Figure 3A), in female Rnf12+/- cells with a deletion of  Rnf12 
on the 129 allele (described in Chapter 2). We generated two clones (Figure 3B) of  which one 
clone, clone 78, obtained the deletion on the Cast allele and the other clone, clone 169, obtained 
the deletion on the 129 allele (Figure 3C). The cells were differentiated for 3 days and analyzed 
by Xist RNA FISH. At day 3 of  differentiation, no apparent difference was observed in the 
percentage of  cells with Xist clouds between the two Phf6 clones and the Rnf12+/- cells (Figure 
3D). Analysis of  Xist expression and reviewing more time points with longer differentiation, 
resulted in a significant increased  Xist expression at day 0 in both clones as compared to Rnf12+/- 
cells followed by significantly decreased Xist expression at day 6 for both clones. As the effects 
of  the Phf6 mutation are different throughout the differentiation time course, a role for Phf6 in 
XCI remains inconclusive as in the early stages of  XCI the two clones show no affected XCI, 
however a role for Phf6 in later stages needs to be further elucidated. 
Figure 3: A) Phf6 gene with deletion guides, generating a deletion of  approximately 42.6 kb, and location 
of  primers used to screen the obtained clones.B) PCR over the deleted region of  Phf6 in clone 78, 169 
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and the targeted pool. C) Allele check Phf6. Clone 78 obtained the deletion on the CAS allele and clone 
169 has obtained the deletion on the 129 allele. D) Xist  RNA FISH results depicting the percentage 
of  cells with Xist  clouds in wildtype, Rnf12+/- cells and the two Phf6 clones at day 3. E) Relative Xist 
expression (normalized to β-actin) of  wildtype, Rnf12+/- cells and the two Phf6 clones at day 0, 2,4,6 and 8 
of  differentiation (error bars represent standard deviation; t-test comparison between Rnf12+/- cells with 
clone 78 and clone 169; * p< 0,05.
Discussion and conclusion  
In order to identify XCI activators we used the candidate gene approach in which we carefully 
selected Nsbp1, Dax1, Pja1, Cited1 and Phf6. However, all these genes did not appear to behave 
as activators of  XCI, which shows that a candidate approach can be laborious and precarious. 
Cited1 did induce ectopic Xist cloud formation in male cells, but had the opposite effect expected 
from an XCI activator when deleted in female cells. One explanation could be that the BAC 
used to introduce extra copies in male cells contained other genes besides Cited1 responsible 
for the formation of  these ectopic clouds. Besides Cited1 the BAC contained two predicted 
genes and one miRNA and this can be looked further into. Cited1 has been reported to be an 
immediate target of  Wnt signaling and an important regulator of  the Wnt pathway [22], which 
when affected can result in increased in proliferation. Moreover, in the Wnt pathway Cited1 has 
been described to function in a ‘just right’ model, which implies that Cited1 over-expression and 
loss of  expression can lead to the same result (e.g. tumorigenesis), which is also what we observe, 
as both overexpression and loss resulted in more Xist (clouds or expression) as compared to 
control cells. Even though dosage of  Cited1 expression requires proper regulation, we exclude 
Cited1 as an XCI activator initiating XCI.
A heterozygous deletion of  Phf6 in Rnf12+/- cells resulted in downregulated Xist expression but 
only after the time window of  reversible XCI, whereas within the time window of  XCI the 
clones seemed to behave better than the Rnf12+/- cells which suggests that Phf6 is not an XCI 
activator involved in initiation of  XCI. However, at day 6 and day 8 XCI seemed affected which 
could indicate a role for Phf6 in the establishment phase involving changes to the chromatin and 
fits with a known role of  Phf6 as a chromatin adapter protein. Loss of  Phf6 could then affect the 
establishment of  the Xi leading to e.g. loss of  Xist spreading along the Xi and loss of  XCI in a 
proportion of  cells. Nonetheless, we do not have sufficient data to support such a role for Phf6 
and this needs to be further elucidated.
In this study we used two different approaches to screen candidate genes, introducing extra 
copies of  a candidate gene in male cells in which addition of  an activator would result in ectopic 
Xist cloud formation, as opposed to a deletion of  a candidate gene in female Rnf12+/- cells, in 
which a heterozygous loss of  an activator would lead to affected XCI. The latter provides a 
better readout since in male cells identification of  XCI activators with a relatively small activity 
would be difficult. Moreover, inactivation of  the single X chromosome in male cells would result 
in cell death and ectopic clouds formed are different from the Xi in female cells [23]. When using 
female cells on a hybrid background the targeted allele can be easily identified in addition to 
which X chromosome is inactivated and are therefore a more convenient system to identify XCI 
activators. To screen more efficiently, the region containing XCI activators can be narrowed down 
first in Rnf12+/-:Uba1+/- cells (described in Chapter 2), in which a candidate region would result in 
abolished XCI, followed up by a candidate gene approach of  genes located in this region.   
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Addendum 2  
Summary  
Dosage compensation of  X encoded genes in placental mammals is achieved by near complete 
inactivation of  one of  the two X chromosomes in female cells. Even though X chromosome 
inactivation (XCI) has been discovered over 50 years ago, the complete mechanism ensuring 
proper inactivation of  only one X chromosome and maintenance of  the inactive X (Xi) is not 
yet fully understood. This thesis focusses on the activation of  XCI, the initiation phase, in which 
XCI is established on one X chromosome and also touches upon maintenance of  the inactive 
state. The two key players Xist and Tsix, both lncRNAs, ensure one X chromosome is in the 
proper state prior to XCI by differential expression and chromatin conformation of  the two 
X chromosomes. When a cell initiates XCI, autosomally encoded XCI inhibitors, acting as de-
nominators, will be down regulated and X encoded XCI activators, acting as numerators, will 
be upregulated.  XCI inhibitors, inhibiting Xist or promoting Tsix expression, consist mainly of  
pluripotency factors and link XCI to loss of  pluripotency. XCI activators, promoting Xist and 
inhibiting Tsix expression, have been less well characterized. XCI activators, as they are X encod-
ed, are differentially expressed between males and females and allow female specific initiation of  
XCI. Initiation of  XCI on one of  the two X chromosomes is a tightly regulated but stochastic 
process in which each X chromosome has an equal probability of  being inactivated. Regulation 
of  XCI is achieved by the counterbalance of  the XCI inhibitors and XCI activators. Rnf12, an E3 
ubiquitin ligase, has been identified as a potent XCI activator and downregulates XCI inhibitor 
REX1 by proteasomal degradation. In this thesis we report Uba1, an E1 activating enzyme, as a 
novel XCI activator which could along with Rnf12 be involved in a cascade in the proteasomal 
degradation of  REX1. REX1 functions most likely by competing with the Xist activator YY1 for 
binding sites at the Xist promoter and thereby inhibiting Xist expression. Xist activators differ 
from XCI activators as they exclusively activate Xist and are autosomally encoded. In this thesis 
we identified autosomally encoded Rnf6, a close homolog of  Rnf12, as a novel Xist activator and 
propose a function for Rnf6 in XCI by aiding in the downregulation of  REX1. The interaction 
between UBA1, RNF12, RNF6 and REX1 is a good example of  the possible interplay between 
activation and inhibition of  XCI. Even though we have identified novel players in initiation of  
XCI, our data also shows there must be other factors at play which remain to be identified. Once 
XCI is initiated and Xist RNA spreads and coats the X chromosomes it recruits different chro-
matin remodeling factors to further induce the silent state. At the same time, downregulation 
of  XCI activators by inactivation of  the X chromosome allows proper feedback and prevents 
inactivation of  the second X chromosome. Ultimately DNA methylation appears to be the final 
lock required to maintain the inactive state throughout cell divisions. All things considered, XCI 
remains an intriguing epigenetic phenomenon which appears to involve multiple intertwined and 
redundant pathways and regulators. 
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Samenvatting  
In zoogdieren worden mogelijke concentratieverschillen in X gecodeerde genproducten wordt 
gelijk gemaakt tussen XX vrouwelijke en XY mannelijke cellen bereikt door één van de  twee 
X chromosomen in vrouwelijke cellen uit te schakelen. Dit X chromosoom inactivatie (XCI) 
proces is meer dan 50 jaar geleden ontdekt. Echter het mechanisme dat ervoor zorgt dat slechts 
één X chromosoom wordt geïnactiveerd, en de processen betrokken bij het onderhouden van 
de geïnactiveerde X (Xi) zijn nog steeds niet volledig begrepen. Deze thesis richt zich op het 
activeren van XCI, de beginfase waarin XCI op één X chromosoom wordt geïnitieerd. Daarnaast 
zijn mechanismen betrokken bij het onderhouden van de geïnactiveerde staat onderzocht. De 
twee hoofdrolspelers Xist en Tsix, die allebei lange niet coderende RNAs afschrijven, zorgen 
ervoor dat alleen één X chromosoom wordt uitgezet. Initiatie van XCI wordt bepaald door 
autosomaal gecodeerde remmers van XCI en X gecodeerde activators van XCI. Veel factoren 
die een belangrijke rol spelen bij het in stand houden van de ongedifferentieerde ‘pluripotente’ 
staat van embryonale stamcellen vervullen de functie van XCI remmers. Dit doen zij door Xist 
expressie te onderdrukken en Tsix expressie te bevorderen. Hierdoor wordt XCI gekoppeld 
aan ontwikkeling en cel differentiatie. Omdat XCI activators X gecodeerd zijn komen deze 
genen verschillend tot expressie in mannen en vrouwen, en dit leidt tot exclusieve vrouwelijke 
XCI initiatie. Initiatie van XCI is een sterk gereguleerd maar stochastisch proces waarin elk 
X chromosoom een even grote kans heeft om geïnactiveerd te worden. Regulatie van XCI 
wordt dus bereikt door het tegengewicht van de XCI remmers en XCI activators. Rnf12 is een 
E3 ubiquitin ligase, geïdentificeerd als een krachtige XCI activator en functioneert door het 
geprogrammeerd afbreken van de XCI remmer REX1 door het proteasoom. In deze thesis 
tonen wij aan dat Uba1, een E1 activerend enzym dat ook een rol speelt bij de afbraak van 
eiwitten, als een nieuwe XCI activator, samen met Rnf12, betrokken is in activatie van XCI. In 
XCI functioneert REX1 hoogstwaarschijnlijk door te concurreren met de Xist activator YY1 
voor bindingsplaatsen in de Xist regulatoire gebieden en onderdrukt daarmee Xist expressie. 
Xist activators verschillen van XCI activators, omdat Xist activators uitsluitend Xist activeren 
en autosomaal gecodeerd zijn. In dit proefschrift hebben wij het autosomaal gecodeerde Rnf6 
geïdentificeerd, een homoloog aan Rnf12, als nieuwe Xist activator, en stellen een functie voor 
Rnf6 in XCI voor bij het helpen van de afbraak van REX1. De wisselwerking tussen UBA1, 
RNF12, RN6 en REX1 is een prachtig voorbeeld van de complexe interactie tussen remmers 
en activators van XCI. Ook al hebben we nieuwe spelers in initiatie van XCI geïdentificeerd, 
laat dit onderzoek ook zien dat er andere factoren meespelen die nog geïdentificeerd moeten 
worden. Zodra XCI wordt geïnitieerd en Xist RNA over de X chromosomen spreidt, werft 
Xist verschillende chromatine hermodelleringsfactoren om de inactieve staat te induceren. 
Tegelijkertijd geeft het uitschakelen van XCI activators door inactivatie van het X chromosoom 
goede feedback en voorkomt uitschakeling van het tweede X chromosoom. DNA methylering is 
hoogstwaarschijnlijk het benodigde laatste slot te zijn om de inactieve staat te behouden. Alles bij 
elkaar genomen, blijft  XCI een intrigerend epigenetisch fenomeen dat als krachtig model dient 
om gen regulatie te bestuderen in een brede context.
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